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Chapter 1 
INTRODUCTION 
The Marfan and Ehlers-Danlos syndromes have always received great public 
interest and fascination. Individuals with the Marfan syndrome impress with their 
tall statlls, long extremities, hands and feet, and patients affected with the Ehlers-
Danlos syndrome are known for their agility in performing acts and tricks of 
hypermobility before theatre and circus audiences. From the medical point of view, 
many of these patients are at risk of an early death because of cardiovascular 
complications caused by aneurysms and cardiac insufficiency in the Marfan syndrome, 
and by aneurysms and vascular fragility in the Ewers-Danlos syndrome. Moreover, 
many cases are of autosomal dominant inheritance, with a risk of 50% for a child to 
inherit the disorder from an affected parent. 
The Marfan syndrome and the various types of the Ehlers-Danlos 
syndrome (EDS) are rare inheritable disorders of connective tissue resulting in a 
generalized weakness of the supporting tissues of the body. 193,IW Affected women 
may experience significant health problems for themselves and their offspring 
during and after pregnancy. For this study the Marfan and Ehlers-Danlos syndromes 
were chosen from the group of genetic connective tissue disorders for three reasons. 
First, because they share some of the clinical features, which include severe 
complications; second, because the syndromes show mainly an autosomal dominant 
pattern of inheritance; third, because the disorders have a similar prevalence. The 
activities of the patient associations in the Netherlands were an incentive to collect 
families with affected individuals for the study. 
The connective tissue abnormalities cause a variety of signs and symptoms in 
skin, ligaments, joints, blood vessels, and internal organs. The Marfan syndrome is 
due to a mutation in the fibrillin gene201.l15 , the Ewers-Danlos syndrome is caused by 
mutations in one of the collagen genes, causing collagen fiber anomalies. 127,246.252.253.25-I 
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Wide intrafamilial variability is generally observed in autosomal dominant inberited 
disorders. 22,27,31 
In 1896, Bernard Marfan reported a patient with arachnodactyly and long 
extremities. 182 The syndrome became recognized among sportsmen in whom an 
increased body length is advantageous. There is still debate whether or not Abraham 
Lincoln was affected with the Marfan syndrome. Lincoln was a lean man, over six 
feet tall. Some far relatives, who have been located later, may also have had the 
Marfan syndrome. With recent technical developments it may be possible to study 
tissue of Lincoln, which is kept in the National Museum of Medicine in Washington. 
Approval of such studies has already been granted. I9l 
The prevalence of the Marfan syndrome is approximately 1:5000 252•253 In the 
Netherlands, with 200.000 births annually, approximately 40 Marfan mothers may be 
expected to give birth every year, and about 46 babies with the Marfan syndrome will 
be born, presuming that the birth rate in affected women and the reproductive fitness 
of Marfan mothers and fathers are similar to that in a general population, and taking 
into account the 15 % mutation rate. 
In 1668, the Dutch physician Job van Meekeren was the first to describe a case 
of Ehlers-Danlos syndrome. I95 He reported the examination of a Spanish man with a 
strange abnormality of the skin. The famous violin player Paganini (19th century) was 
probably affected with the Ehlers-Danlos syndrome, and the hypermobility of his 
fingers may have contributed to his skills. 
The prevalence of the EDS is more difficult to determine than that of the 
Marfan syndrome, because various subtypes are recognized. An overall estimate of its 
prevalence is 1: 5.000.33.205 This implies approximately 40 EDS mothers who give 
birth each year in the Netherlands, and about 40 infants with the EDS will be born 
yearly, assuming a birth rate identical to that in the general population (mutation not 
included). The mutation rate for the Ehlers-Danlos syndrome cannot be estimated, 
especially since the locus heterogeneity and the various mechanisms of inheritance of 
the disorder are not known. No molecular studies are known addressing this question 
with the new technologies. 
A gynecologist may be confronted only once in his or her career with one of 
the syndromes and remain unaware of the variety of complications that may occur in 
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pregnant women. 2IXi ·J15 In the Marfan syndrome aortic dissection is the most dramatic 
complication which, in pregnancy, may result in maternal death. Other complications 
associated with both the Marfan and EWers-Danios syndromes during pregnancy and 
delivery are due to the fact that tissues are fragile, vessels are vulnerable, joint laxity is 
increased, and hemostasis may be affected. However, knowledge regarding the effects 
of pregnancy on the symptoms and complicatious of the Marfan and EWers-Danios 
syndromes and concerning the effects of these syndromes on the course and outcome 
of pregnancy is mainly based on case reports, or reviews presenting a summary of 
previous case reports supplemented with one or two new cases. Selection bias is a 
significant problem and only a few consecutive series of patients are 
available. 176,247,165,29S Even less is known about pregnancy in unaffected women 
carrying an affected fetus. Tltis paucity of information precludes adequate 
preconceptional assessment of risk and counseling, and antenatal and perinatal care of 
affected women. 
The Dutch Marfan Association and the Ehlers-Danlos Association look after 
the interests of the patients and their relatives. The associations were founded in 1981 
and 1987, respectively, and both have approximately 170 members. These associations 
and their members were asked to participate in data collection regarding mother and 
child, and their collaboration offered an Opportultity to analyse the relatiouship 
between the syndromes and pregnancy. 
The present thesis has addressed the following objectives: 
To review the literature on the Marfan and Ehlers-Danlos syndromes, in particular 
in relation to obstetric aspects, 
To assess the course and outcome of pregnancies in women with the Marfan and 
Ehlers-Danlos syndromes based on data obtained from the membership of the 
Dutch patient associations. 
To formulate guidelines for preconceptional assessment of risk, and for medical 
and obstetric care of pregnant women with these syndromes. 
13 
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Chapter 2 
mSTORY, PATHOGENESIS, AND CLINICAL 
PRESENTATION OF THE MARFAN AND 
EHLERS-DANLOSSYNDROMES 
2.1. Historical aspects of the Marfan s}'ldrome 
On February 28, 1896, Antoine Bernard-Jean Marfan, a Parisian professor of 
pediatrics, presented at the Societe Medicale des Hiipitaux de Paris a case of a 5-year 
old girl with disproportionately long, thin limbs and digits, so called "pattes 
d'araignee", or spider legs (Fig. 2.1 and 2.2)'" He called the condition 
dolichostenomelia, i.e. long, thin extremities. In 1902 Achard introduced the term 
arachnodactyly, and 10 years later Salle gave the fIrst complete description of a patient 
with what would later become known as the Marfan syndrome. 2,270 
In 1931, Weve, a professor of ophthalmology in Utrecht, described the 
autosomal dominant inheritance and named it "dystrophia mesodennalis congenita, 
typus Marfan".333 In 1938 Apert, a student of Marfan's, introduced the designation 
Marfan syndrome.' In 1943 Baer and Taussig described the characteristic 
cardiovascular manifestations of the syndrome and emphasized that cardiovascular 
problems constitute the main cause of death in these patients." In 1951 Moses 
demonstrated in a study of more than 200 Marfan patients the histopathologic 
abnormalities of the aortic wall and drew attention to the combination of 
arachnodactyly, ocular manifestations and the family history.107 In 1955 McKusick, 
one of the founding fathers of medical genetics, defined the Marfan syndrome as an 
inheritable disorder of connective tissue following Weve's idea (see chapter 2.6).191 
The term Marfan syndrome remains the preferred designation until now. 
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Figmc2.1 
Figmc2.2 
Antoine Bernard-Jean Marfan (1858-1942). Professor of Pediatrics. 
Arachnodactyly as shown in the original case report of Marfan. 
Bull Mem Soc Med Hop 1896; 13: 220-1. 
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2.2. Historical aspects of the Ehlers-Danlos syndrome 
In 1668 Job Janszoon van Meekeren, a surgeon from Amsterdam, described a 
23-year old Spaniard, Gregorius Albes, with a strange abnormality of the skin (Fig. 2.3 
and 2.4)-"5 First, he points out that Spaniards are always cruel and the most 
"unbending" people of the world, a remark to be interpreted in the light of the fact that 
the Dutch just fInished an 80 years war with Spain. Than he reports how amazed he 
was to see a Spaniard who could !!bendt! (stretch) his skin so enormously that he could 
pull the skin of his chin over his eyes and down to his chest. This phenomenon was 
limited to the skin of the right side of the body. No mention was made of abnormal 
scarring or joint laxity. 
Figure 2.3 Foreground: Spaniard with hyperextellsible skin. On the table a woman with a 
distended abdomen, because of ascites and an ovarian tumor. She is the wife of 
Govert Flinck, a famous Dutch painter. Her case is also described in the book of 1. 
van Meekeren19S 
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Original case report of Job van Meekeren (1668), describing !lEen rekkelijke Spanjert" 
("a stretchable Spaniard,,).l95 
In 1891 Tschernogubow, a Russian dermatologist, was the first to give a full 
description of the syndrome.3J8 It concerned a 17-year old boy with a skin that was 
described as pale, lusterless, velvety, tllin, hyperextensible ("it is easily pulled away, 
far beyond normal limits, and rapidly like elastic it regains its normal position"), friable 
with scar formation in an strange fashion u, and with secondary wound dehiscense 
because all sutures would cut through the skin. His joints were extremely mobile and 
there was subluxation of a hip and an elbow. Until today the Russian medical literature 
uses the designation uTschernogubow syndrome". 
In 1901 Eduard Ehlers, a dermatologist in Copenhagen, reported a patient with 
"cutis laxa", a marked tendency to hemorrhage, and loose-jointedness (Fig. 2.5)." In 
1908 Henri-Alexandre Danlos, a dermatologist in Paris, described another patient with 
hyperelastic, thin and fragile skin, and explained the molluscoid pseudotumors as 
chronic contusions of the vulnerable tissues (Fig. 2.6)." 
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Figure 2.5 Eduard Ehlers (1863-1937). Danish dcnnatologist. 
Later eponyms for the disorder included: "Gunmlihaut". dermatolysis. cutis pendula. 
cutis hyperelastica, chalasodermia, !lIndian rubber man". The eponym of the Ehlers-
Danlos syndrome was fIrst suggested by Poumeau and Soulie,'" In 1933 Parkes Weber 
attempted to bring some nosologic order into the group of conditions with lax skin and 
loose joints. together or alone. and defended the use of the eponym "Ehlers-Danlos 
syndrome II to denote the specific disorder.328 
19 
Figure 2.6 Henri-Alexandre Danlos (1844-1912). Postgraduate in chemistry and specialist 
physician. 
2.3. Prevalence and genetics of the Marfan syndrome 
The Marfan syndrome is an autosomal dominant disorder of the connective 
tissue. 71 ,252 It affects skin, ligaments, joints, vascular tissue and various organs. The 
prevalence of the Marfan syndrome was earlier estimated as 1 : 25.000, but recently as 
1 : 5.000."·252.253. The higher estimated prevalence may be due to increased public 
attention to the syndrome, to the use of more specific and exact diagnostic criteria, and 
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increased medical attention. The syndrome shows a wide variability in severity, or 
(clinical) expression. Variation in expression of a disorder, e.g. variation among 
affected members of the same family who may be assumed to carry the same major 
gene, is due to differences in the genetic constitution of the individual and to differences 
in the environment. Expression is the phenotypical variability of a genotype, and it is 
equivalent to the grade of severity in clinical medicine. 193 The expression may be 
reduced to an extent that the gene escapes detection by clinical methods, and is said to 
be ilonpenetrant. Penetrance is an all-or-none affair, dependent on whether the methods 
for studying the phenotype do or do not permit identification of the specific genotype in 
an individual. In a group of persons with the same genotype there may be some with 
manifestations so mild that they do not deviate sufficiently from the normal group to be 
recognized as affected. In collagen disorders, gene mutations that cause the most severe 
clinical symptoms are usually new mutations in one allele that occur either during the 
generation of the germline in Oile of the parents or during meiosis in the fertilized 
egg.240 Most variants are caused by mutations that are specific for a given family. 
Similar mutations in the same gene can produce different disease syndromes in terms of 
severity and the major tissues involved. The number of recurrent mutations is so 
infrequent, that there are no common mutations responsible for this disorder in 
unrelated patients and no ihot spots' that contain most oftlle mutations.2J8,239 
In the case of multifaceted syndromes such as the Marfan syndrome, each 
component may show partially independent behavior with regard to penetrance and 
(clinical) expression. In the Marfan syndrome, any of the three major components 
(ocular, aortic, skeletal) may be present with little or no involvement in the other two 
areas. 19USQ,252 
About 15 % of Marfan syndrome cases are the result of a new mutation, and 
expression varies widely, 19-t,250,252 Genetic disorders that interfere seriously with 
reproductive capability show less variability in expression than do milder conditions. lEO 
2.4. Prevalence and genetics of the EDS 
The EDS is a heterogenous group of inheritable disorders of connective tissue. 
Like the Marfan syndrome it affects skin, ligaments, joints, blood vessels, and internal 
organs.27,31,31,3Q.t Nine different types are recognized, defined according to clinical signs 
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and symptoms and pattern of inheritance (see chapter 2.7).31 Some are autosomal 
dominant, others are recessive, and some are X-linked. The prevalence is estimated to 
be I : 5.000 in a general population. Ninety percent of all EDS cases concern type I, 
II, or 111 (each in 30%), and about 10% concerns type IV; other types arc rare. 
(Clinical) Expression is variable as in the Marfan syndrome, and a fanlily history is 
present in the majority of cases. The mutation rate in the Ewers-Danlos syndrome is 
unknown, because of the locus heterogeneity and the various mechanisms of inheritance 
of the disorder. No molecular studies are known addressing this question with the ne\\' 
technologies that are currently available. 
2.5. Biology of connective tissue 
In order to understand the pathogenesis, diagnosis, and clinical manifestations 
of the Marfan syndrome and EDS, it is mandatory to consider the biology of 
connective tissue. J2,145,238,239,240,299 
The distinguishing feature of connective tissues is that the component 
macromolecules are assembled into an insoluble extracellular matrix. The 
macromulecules include at least 19 different types of collagens: the related fibrous 
proteins known as elastin and fibrillin and a series of other proteoglycans. I60,239,240 
Differences in the connective tissues of bone, skin, and cartilage are in part 
explained by differences in the content of specific components and in the three-
dimensional organization of the molecular components. Connective tissue largely 
forms by self-assembly, in which a molecule of the correct size, shape, and surface 
properties binds to other molecules with the same or similar structure in a 
spontaneous but ordered manner. The steps in the formation of collagen formation 
are listed below. 110,145,140 The fibril that forms collagen is a long, thin rod consisting 
of three polypeptide alpha chains wrapped into a rigid triple helix. I45."o The fibril 
has a triple-helical confirmation, because each of the three alpha chains has a simple 
repetitive amino acid sequence of about 1000 amino acids in which glycine appears 
as every third amino acid. Most of the steps are under genetic control and may be 
disturbed as a result of mutation. 216 Collagen fibres have considerable tensile strength 
which is increased by cross-linking reactions that form covalent bonds between alpha 
chains in one molecule and alpha chains in adjacent molecules. Elastin, however, is 
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a single polypeptide that does not fold into a defined three-dimensional structure and 
is not synthesized as a larger precursor molecule. 
Synthesis alld breakdoWII of col/agell 
The synthesis of collagen takes place in several steps, as summarized in figure 
2.7).145.236,239,240 
1. TIle synthesis of the frrst precursor of collagen, the pre-pro-alpha chains, takes place on the 
polysomes of the endopiasmatic reticulum of the cell (a fibroblast or smooth-muscle cell), 
Messenger RNA reads the code of the polyribosomes. The amino acids are coupled on the 
transfer RNA. 
2. The first part of the pre-pro-alpha chain, the signal peptide, is recognized by the receptor 
protein on the cndopiasmalic reticulum. The pre· pro-alpha chain is now transported to the 
cytosol, where synthesis of the protein takes place. 
3, The signal peptide is split off 
4. Hydroxylation of proline to 4-hydroxy-prolinc; this is activated by Fc and vitamin C. 
TIle 4-hydroxy-prolines provide the stability of the triple helix. 
5. Hydroxylation of lysine to 5-hydroxy-Iysine. This is essential for the binding of carbohydrate 
molecules and it gives stronger binding in the process of aging of collagen. 
6. Hydroxylation of proline to 3-hydroxy-proline. It seems that not all proline and lysine residues 
arc hydroxylatcd at random, but that the position of the residues in the proteins is important. 
7. Coupling of galactose to 5-hydroxy-lysinc 
8. Coupling of glucose to galaetose-O-Iysine. The coupling of galactose and glucose is probably 
important in the formation of fibrils. It also is crucial in the recognition of the collagen 
molecule by fibronectin. 
9. Forming of the triple helix. In the terminal parts of three pro-alpha-chains (in the case of 
collagen type 1:2 alpha I and one alpha 2 chain) S-S bridges develop between cystein residues 
of different chains. The stability of the triple helix is mainly due to the amount of 4-
hydroxyproline residues. 
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10. Transport to the GoIgi apparatus. 
11. Application of a matmose group, important for recognition of the procollagen in the process of 
exocytosis. 
12. Export of pro collagen from the cell. 
13. Separation of the procollagen-extremities gives tropocollagen. Procollagen aminoprotease and 
carboxyprotease katalyse the separation of the N- and C-terminal parts of procolJagen. 
.Figure 2.7 
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I) Protein synthesis. 2)Transport through endopiasmatic reticulum membrane. 3) 
Cleavage of signal peptide. 4) 4-Hydroxylation of proline. 5) Hydroxylation of 
lysine. 6) 3-Hydroxylation of proline. 7) Formation of galactose-O-lysine. 8) 
Formation of glucose-galactose-O lysine. 9) Triple helix formation. 10) Transport to 
Golgi apparatus. 11) Introduction of matillose-rich group. 12) Export of procolJagen 
out of the cell. 13) Proteolysis of the procollagen terminals. 14) Oxydation of lysine. 
15) Transport of collagen fibril. 16) Incorporation in the collagen fibril. 17) Cross-
linking of collagen. 
( Adapted from Kielty CA et aI, with permission of WiJcy-Liss inC.)145 
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14. Oxydation of lysine to allysine. AUysine plays a key roll in the aging process of collagen. 
15. Transport to the growing collagen-fibril. TIle sequence of steps 13, 14, and 15 is not known. 
16. Incorporation of tropocollagen into the growing collagen fibril. The extracellular milieu, which 
contains a complex of proteins and mucopolysaccharids, is important for the formation of 
fibrils. Hereditary disorders with a defect in the degradation of these mucopolysaccharids cause 
skeletal abnommlilies. 
17. Aging of the collagen. The tropocollagen molecules are bound by weak hydrogen bridges. 
AUysin groups cause strong binding of the tropocollagen. Allysin also binds with NH2-groups 
of lysine and hydroxylysine. By this process the collagen becomes stronger. 
The synthesis of collagen is stimulated by thyroxin, growth hormone, and 
estrogens, and by shortage of insulin or insulin receptors. 231 The breakdown of collagen 
is stimulated by Ca ions. Tropocollagen is split into two parts and tlle triple helix dis-
solves and is split by other enzymes.1(" 
The concentration of hydroxyprolin in urine is measurable and reflects synthesis 
and lysis of collagen. In diseases such as hyperthyreoidism, hyperparathyreoidisrn 
(bone destmction), large burns, puberty, and bone disorders an elevated secretion of 
hydroxyproline in urine occurs. 35 
2.6. Pathogenesis of the Marfan syndrome 
The recently detected gene defect of the Marfan syndrome confirms 
fundamental ideas of a gene defece" and supports the older mesodermal theory, and the 
theory that the syndrome is caused by a basic metabolic defect. All the observations 
converge since mutations in the fibrillin-l gene are regarded as pathognomonic for the 
Marfan syndrome. 
TIIC mesodermal theory postulated that the key problem was a disorder of the differentiation of 
the mesodenn. However, ocular manifestations did not fit in with the mesodermal theory, because most 
ocular stmctures, including the lens, are of ectodermal origin.33J 
It has also been speculated that the Marfan syndrome could reflect a basic metabolic defect. 
Rats tliat are fed the seeds of the sweet pea (Lathyms odoratus) develop a disorder called lathyrism, with 
kyphoscoliosis and other changes similar to those found in Marfan syndrome.19J,m.1l9 The toxic product 
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producing the changes found in lathyrism is Il-amino-propionitrile. The rats are protected from these 
pathologic changes when gelatin and caseYn are added to the sweet pea diet. 
The tissues involved in the Marfan syndrome are rich in Type I collagen.236•2J7 
Many of the characteristics of the syndrome can be produced in young animals by 
induction of severe copper deficiency or by administration of nitriles, which inhibit 
lysyloxidase.2J6 For that reason it was thought that the Marfan syndrome may be caused 
by mutations in the genes for Type I procollagen, or for the enzymes that process the 
protein. Later, other observations suggested a defect in the cross-linking of collagen.237, 
m 
Studies in six patients have demonstrated a decreased content of elastin in the 
aorta. Because of the close association between elastin and collagen in this tissue, it is 
possible that a mutation that alters one of these macromolecules could also change the 
function of the other one.236 
In 1990 a cause-and-effect relationsltip was established between mutations in the 
gene on chromosome 15 (chromosome 15qI5-21) encoding fibrillin (FBN-I), a 
glycoprotein component of the nticrofibril, and the Marfan phenotype.",!4il.I".I", 
Linkage between FBN-I and the classic phenotype of Marfan syndrome has been 
observed in all families tested, suggesting that FBN-I defects are the predominant, if 
not the sale, cause of the disorder. 106,'" The fibrillin protein is encoded by a gene that 
is composed of 57 exons and is extremely large (350 kD), and Marfan's syndrome can 
be caused by a variety of different mutations." The function of fibrillin has not been 
defined, but the data suggest that fibrillin self-assembles into a fibrillar structure and 
that the confirmation and surface properties of the entire molecule are critical for 
normal assembly. 199,239,24(} Therefore, the functional consequences of mutations that 
change the amino acid sequences of fibrillin may be similar to the effects of mutations 
that change the confirmation of a fibrillar collagen. Unfortunately, the rate of detection 
of mutations in the Marfan syndrome has been extremely slow and, with one exception, 
all mutations identified to date are unique to a single fanilly.2J6,2JS These factors have 
precluded the widespread use of direct analysis of mutations for (presymptomatic) 
diagnosis. 
Primary mutations in fibrillin-I are associated with a wide range of phenotypes 
that show considerable variation in the timing of onset, tissue distribution, and severity 
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of clinical manifestations. 201.3 15 Some of these conditions, such as mitral valve prolapse 
syndrome, MASS (Illitral valve prolapse, borderline and nonprogressive aortic 
dilatation, and skin and skeletal manifestations) phenotype, or isolated skeletal 
disorders, show significant overlap with the Marfan syndrome and are quite conunon in 
the general population and must be accurately differentiated from the Marfan syndrome 
(see Chapter 2.8). 
2.7. Pathogenesis of the EWers-Danlos syndrome 
Alterations in the morphology of collagen fibrils have been observed in patients 
with almost every type of Ewers-Danlos syndrome. 1J7·"",305,)25 The abnormalities 
include an increase or a decrease in the diameter of collagen fibers, irregular 
appearance of fibrils in cross-section, or increased variability in fibril 
diarneters.9J,157,231,m Some forms are produced by mutations in genes for Type I and 
Type ill procollagens, but others appear to be caused by defects in enzymes required for 
the assembly or processing of the procollagens (see table 2.1).'40 
Types I, II, III 
The EDS types I, ll, and III are clinically characterized by varying degrees of 
skin, joint, and musculoskeletal involvement. The collagen structure shows patterns of 
structural changes in the matrix that may be used to confirm a diagnosis, but in the 
absence of biochemical data the pathogenetic mechanisms remain unclear. The defect in 
this disorder involves probably mutations in the Type V collagen genes COL5Al and 
COL5A2.71,197 Ultrastructural findings suggest a disturbed collagen fibrillogenesis 1l7 , 
and on transmission electron microscopy typical patterns of fibrils are recognized in 
most cases. 2J3 
Type IV 
Type IV Ewers-Danlos syndrome is a rare but severe form of the syndrome 
because it frequently produces rupture of large arteries and hollow organs. 21•71 All 
patients studied to date had a defect in Type III procoliagen.71 •2JO•2lJ Sometimes these 
changes prevent or delay folding of the chains into the triple helix and therefore inter-
fere with normal secretion. Sometimes the Type III procollagen that contains abnormal 
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Table 2.1 Overview of the main clinical features and connective tissue dcfccts in the Ehlers-Danlos syndrome 
Type General name Mode of Main fcatures Connective Stmctural 
Inheritance tissue defect consequences 
EDSI Gravis type AD Cardinal features in ? Cauliflower fibrils on 
severe degree. Vascular TEM 
and intestinal 
complications occasionally 
EDS II Mitis typc AD Cardinal feahlres ? Cauliflowcr 
in mild degree.Marked fibrils on TE~'[ 
articular hypemlObiltity 
EDS III Hypennobile AD Moderate dermal byper- ? Irregular fibril 
type extensibility joint laxity onTEM 
EDS IV Vascular type Heterogenous Variable stigmata. Pm-alpha 1(111) Marked decrease 
in type 
Subtypes: Severe bntising, hyper- III collagen. 
-lV-A Acrogerie type AD pigmentation,and scarring.Pro-alpha 1(111) Unstable triple 
helix. 
-IV-B Acrogeric type AR TIlin skin,prominent Pro-alpha I(Ul) Decreased 
secretion 
-IV-C Acchymotic type AD venous plexus,vascular Other ('/) rate of type III 
-IV-O Others AD/AR mpture,colon mptures. Unidentified collagen 
Characteristic facial 
appearance,pneumo-
thorax,uterine mpture. 
Acrogcria 
EDS V X-Linked type XL Cardinal features 
in moderate degree. 
X-Linked inheritance 
EOS VI Ocular-scoliotic AR Cardinal features Reduced Hydroxyiysine 
type in scvere degree. lysine deficicnt 
Eye involvemcnt. hydroxylase and defective 
Scoliosis. activity (?) cross-linking 
Muscle hypotonia 
Subtype-s: 
-VI-A Nonnal Iysyl hydroxylase 
-VI-B Decreased lysyl hydroxylase 
28 
Type General name Mode of 
Inheritance 
EDS Vll Arthrochalasis Heterogenous 
multiplex 
congenita 
Subtypes: 
-VII-A AD 
-VII-B AD 
-VII-C AR 
EDS VII Periodontitis AD 
type 
EDS IX Vacant (fonnerly 
occipital hom 
syndrome), X-linked. 
Cutis laxa recategorized, 
as a disorder of copper 
transport 
EDS X Fibronectin AR 
abnonnality 
EDS XI Vacant (fonnerly 
familial joint instability). 
Now recatagorized with 
the familial articular 
hypermobility 
syndromes) 
Main features 
Cardinal features 
with marked articular 
hypermobility,short 
stature,micrognathia. 
Congenitalluxations 
Cardinal features 
in moderate degree. 
Early tooth loss. 
Gingival recession. 
Agressive periodontitis. 
Cardinal features, 
but skin texture normal. 
Petechiae, striae 
distensae 
Connective 
tissue defect 
Procollagen 
N-protcinasc 
deficiency 
Structural 
consequences 
Persistence of 
pN-collagen 
resistant to 
procollagen 
N-proteinase 
and persistancc 
Structural defect of irregular and 
of proal ph a 1. hieroglyphic 
Structural defect fibrils 
of pro-alpha 2. 
Procollagen 
N-proteinase 
deficiency 
Unknown Irregular 
diameter of 
fibrils 
Defective Fibroblasts 
copper abnoTlllalIy 
metabolislll. soluble 
Abnormal 
cross-linking 
Unknown Lack of 
cohesion 
between 
collagen 
fibers, 
abnormal 
platelet 
aggregation 
AD=uutosomal dominant, AR=autosomai recessivc, XL=X-linked, TEM=transmission electron microscopy 
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chains is extremely sensitive to digestion by proteinases, degraded and not available to 
form fibrils in ViVO. 299,301 
Defects in the type III collagen gene (COL3Al) have been demonstrated in some 
cases and include point mutations altering glycine residues \ViOlin the triple helical 
domain of type III collagen. 
Type V 
Type V Ehlers-Danlos syndrome is a very rare type and a clear enzym 
deficiency could yet not be found. De Ferrante et al (1975) reported a deficiency of 
lysyl oxidase, but these observations could not be confirmed by others."·285 The 
collagen of patients with this type of EDS is weak and is broken down faster than that 
in healthy individuals.69,232.233,305 
Type VI 
Type VI is characterized by severe skeletal deformities and ocular changes. A 
deficiency of Iysyl-hydroxylase and a marked decrease in the hydroxylysine content of 
type I collagen in skin and other tissue has been found in most but not all patieuts."·'" 
It seems to be related to a deficiency of hydroxylysine-derived intermolecular cross-
links. 
Type VII 
Type VIl is characterized by laxity of joints that is severe enough to produce 
dislocations of knees and hips. Two variants involve impaired removal of the N-
propeptides from procollagen but are due to different molecular defects. J<)j In one of 
these variants, called Type Vila, the N-propeptides are incompletely removed because 
of a deficiency of procollagen N-proteinase. 112 In the second variant, Type Vllb, the 
molecular defect is a structural alteration of the pro-alpha 2(1) chain, which presents 
cleavage of the chain by procollagen N_proteine. lOJ•325 The consequence of the defect is 
persistance of partially processed collagen containing the N-propeptide of the pro-alpha 
2 (I) chain.)()I 
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Type VlIl 
In type Vlll periodontitis is present and early loss of teetil occurs. No specific 
biochemical defect or marker has been found so far. 213 
Type IX 
Type IX is characterized by hyperelastic skin, normal scar formation, skeletal 
changes such as exostoses, and sometimes vascular changes. Several disorders involve 
defects in copper metabolism that produce defects in the formation of collagen 
fibrils. 36.'49 These disorders include Ehlers-Danlos syndrome Type IX and the Menkes 
syndrome. 221 Some patients with these disorders were previously classified as having 
X-linked cutis laxa, others as having an X-linked subtype of the Ehlers-Danlos 
syndrome. Because of all the similarities of the clinical and biochemical 
manifestations, it has been proposed that aU these disorders be classified as Ehlers -
Danlos syndrome Type IX 36, although it has later been suggested that this entity be 
excluded from the EDS groups. 3i 
The connective tissue abnormalities are caused by a secondary reduction in the 
activity of Iysyl oxidase, the copper enzyme that initiates the cross-linking of both 
collagen and elastin.3i As a consequence, collagen from skin or produced by fibroblasts 
has been reported abnormally soluble. 159 
Type X 
A disturbance of platelet aggregation is found in these patients and a defect in 
the synthesis of fibronectin is suspected liS The existence of EDS X as a separate 
entity is questioned. 
2.8. Diagnosis of the Marran Syndrome 
Diagnosis may be difficult because of the variability of the clinical expression. 
In its classic form the Marfan syndrome is associated with ocular, musculoskeletal, and 
cardiovascular abnormalities. In 85 % of cases a positive family history is present. 
Besides these major abnOlmalities additional features may be present to support the 
diagnosis.72 
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Ocular manifestations 
Subluxation or luxation of the ocular lenses occurs in 50-80% of patients l87 and 
for that reason the ophtahnologist is the first to make the diagnosis of Marfan in about 
30% of cases. Most often the (sub)luxation is bilateral and the lenses are displaced 
upward and sideward. ls7 The zonulas remain intact, permitting normal accommodation, 
a sign that is of help in differentiating Marfan syndrome from homocystinuria. In 
homocystinuria the lenses are subluxated downwards, the zonulas disintegrate, and the 
eye cannot accommodate. '" The axial length of the globe is increased, contributing 
to the tendency to myopia and an increased risk of retinal detachement. 181 The iris may 
be very thin and, as a consequence, may vibrate. Glaucoma has been described in 3% 
of cases.M 
Cardiovascular manifestatiollS 
Up to 60% of individuals affected by the Marfan syndrome show evidence of 
atrioventricular valve prolapse and regurgitation. 191 ,19J,254 Auscultation of the heart is 
relatively insensitive to detect these abnormalities, and echocardiography has become 
the tool of choice for the evaluation of cardiac morphology and function. More than 
80% of patients have prolapse of at least the posterior mitral leaflet, irrespective of age 
or sex. Aortic dilatation is a later sign and may be present if aortic regurgitation or 
dissection has developed. Dissection usually begins in the ascending aorta and any 
region of a dissected aorta may dilate over time. Also abnormalities of the puhnonary 
artery, tricuspidal prolapse, and regurgitation, have been reported. When the cause of 
death is known in Marfan patients, the cardiovascular system appears to be the culprit 
in over 90% of cases. 21Q,287 
MllscllioskeietalmGllifestatioJls 
The increased relative length of the linlbs as compared with that of the trunk is 
best estinlated by dividing the lower segment length (top of the pubic ramus to floor) 
by the upper segment length (height minus lower segment). This ratio varies with age 
during normal growth and development but, in the person affected by the classic 
Marfan syndrome, is usually at least two standard deviations below the mean for age, 
race, and sex.249 ,25J The ratio of upper to lower segment may be further reduced and 
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the increased ann span/height ratio may be exaggerated by scoliosis. Arachnodactyly 
remains a subjective diagnostic feature. The thumb sign and the wrist sign are 
sometimes useful, but are also subject to differences in observer interpretation. Pectus 
excavatum, sacrodynia, scoliosis, and joint laxity may he present. 
Additional fealllres 
Inguinal hernia, usually bilateral, may occur at a young age.'" Striae of the 
skin in unusual places like the shoulder, and umbilical hernia are also reported. W A 
number of case reports document the occurrence of spontaneous pneumothorax and 
cougenital lung abnormalities: but the prevalence of pneumothorax, bullous 
emphysema and other pulmonary problems in the Marfan syndrome is unknown."4,177 
Some patients show marked reduction in total lung capacity and residual volume in 
association with deforming kyphoscoliosis or pectus excavatum. In 60% of cases dural 
ectasia is present. S9,305,J(kS Neurovascular manifestations may be present in 10% of cases 
273.274 , due to spontaneous dissection of the carotid artery, aneurysms or atrophic 
changes in intracranial vessels. 
Requirements for diagnosis 
The diagnosis is based on criteria of characteristic familial, ocular, 
cardiovascular and musculo·skeletal features. From 1986 to 1996, the diagnosis was 
made with the help of the diagnostic criteria list of the Berlin nosology meeting (1986, 
see appendix 1).31 In 1996 revised diagnostic criteria for the Marfan syndrome were 
published (see appendix 2). The revised criteria were needed because with the previous 
criteria several shortcomings remained and others emerged and because of the advent 
of molecular analysis. In more recent studies these classification differences are not 
relevant as patients were only included when the diagnosis of Marfan syndrome was 
confIrmed in a center for clinical genetics. 
To decide whether or not an individual is indeed affected by a connective tissue 
disorder, Illore diagnostic reliance is placed on the presence of "major" manifestations 
(subluxated lenses, aortic dilatations, severe kyphoscoliosis, and deformily of the 
anterior thorax) than of "minor" features (myopia, mitral prolapse, tall stature, joint 
laxity, and arachnodactyly). 
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In the absence of an unequivocally affected first degree relative the following 
criteria are to be met according to the Berlin nosology of 198631 : 
Involvement of the skeleton and at least two other systems; at least one majar 
manifestation. 
In the presence of at least one unequivocally affected first degree relative: 
Involvement of at least two systems; at least one major manifestation preferred, but 
this will depend on the family's phenotype. 
In the revised criteria that were accepted in 1996 the following points were 
modified or emphasized : 
More stringent requirements for diagnosis of the Marfan syndrome in relatives of an 
unequivocally affected individual. 
Skeletal involvement as a major criterion if at least 4 of 8 typical skeletal 
manifestations are present. 
Potential contribution of molecular analysis to the diagnosis of Marfan syndrome. 
Delineation of initial criteria for diagnosis of other inheritable conditions with 
partially overlapping phenotypes. 
At present no histopathological test is available. 
The differential diagnosis includes homocystinuria, familial or isolated mitral 
valve prolapse syndrome, MASS, familial or isolated annuloaartic ectasia (Erdheim 
disease), congenital contractural arachnodactyly, and Stickler syndrome. 
In order to establish the diagnosis the following investigations are obligatory: 
An extensive personal and family history. 
A careful physical and ophthalmologic examination. 
An echocardiogram and Doppler-ultrasound examination. 
An electrocardiogram. 
A chest X-ray. 
An aminoacid analysis for homocystinuria. 
A thoracic and abdominal CT -scan. 
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2.9. Diagnosis of the Ehlers-Danios syndrome 
The diagnosis and classification of EDS is made on clinical grounds, supported 
by considering the most likely inheritance pattern, and confirmed by biochemical and 
molecular analysis when possible. 31.)).305 A few clinical signs, the so-called cardinal 
signs, are present in each type of EDS: hyperextensible, soft skin, dystrophic scarring, 
easy bruising, joint hypermobility, and symptoms related to connective tissue fragility. 
A detailed overview of the cardinal and additional features is presented in appendix 3. 
The combination of the extent and severity of the cardinal features, with coexistent 
abnormalities and probable mode of inheritance, allows a presumptive classification. 
A simple screening test based on clinical signs and symptoms, is described in 
appendix 4.12! A patient with a score of 7 or more has a 99% chance of having EDS. 
For EDS types I, II, Ill, V, and VIll there is no biochemical or histological marker and 
the syndrome remains based on signs and symptoms. For EDS types IV, VI, VII and 
X, there are laboratory tests which may confirm or exclude the diagnosis, or at least 
uncover genetic heterogeneity. 233 
Diagllosis oJlypes /, II, III, V, alld VIII. 
In EDS type I there is marked skin, joint, and musculoskeletal involvement. It 
is in this type, and in type IV, that complications such as aortic and bowel rupture may 
occur. The diagnosis is mainly based on clinical signs and symptoms, although new 
techniques with exarnination of skin biopsies have proved to be useful. 2JJ With 
transmission electron microscopy abnormalities in collagen structure can be recognized 
in type I and 11. 118•233 
Mutations in type V collagen genes COL5Al and COL5A2 have been 
demonstrated in some families with EDS type I, II, and Ill, and could be used for 
establishing the diagnosis in relatives of these families. Type II shows the same signs as 
type I, only to a lesser extent. In type III the joint laxity and dislocations prevail. 305 
EDS Type V is an extremely rare type, demonstrated in only eight members of 
two families, and with an apparent X-linked inheritance pattern. 23•lO There is no 
biochemical marker for this type, diagnosis depends solely on tile mode of inheritance. 
In EDS type VIll the general manifestations are present in a moderate degree."" 
Dental disease begins with extensive caries of the deciduous teeth; the permanent 
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dentation erupts at the usual time. The onset of gingival inflammation in the second 
decade and the following progression of periodontal disease lead to generalized 
alveolar bone loss around all teeth, which results in the premature loss of all permanent 
teeth during the third decade. The teeth are morphologically normal. 291 
Diagnosis Off)1leS IV, VI, VII, and X. 
The hallmarks of EDS type IV are the severe, life-threatening internal 
complications, which usually occur after puberty and include spontaneous rupture of 
arteries, of the colon and the gravid uterus, and pneumothorax. Arterial bleeding may 
occur at virtually every site and lead to sudden death, cerebral stroke, hematemesis, 
hematuria, and retroperitoneal bleeding. Common locations of arterial bleeding are in 
the abdominal cavity and involve small vessels rather thau the aorta. In the classic 
form of EDS IV, the mean age of death is between 35 and 40 years, with survival 
beyond 50 years being rare.'" 
The diagnosis of EDS type IV is made by demonstration of reduced collagen III 
in pepsin or cyanogen bromide extracts of skin, or reduced synthesis and/or secretion 
of radiolabeled procollagen III in ascorbate stimulated fibroblast cultures. 23o The 
collagen fibrils show disorganisation with irregularity and a bimodal size distribution 
on transmission electron microscopy. 118,233 Mutations in the type III coHagen gene 
(CQL3Al) are involved in EDS type IV and can sometimes be demonstrated and used 
for establishing the diagnosis,J15 
EDS type VI is the ocular and the ocular-scoliotic type. Patients with Iysyl 
hydroxylase deficiency are now classified as EDS VIA, and those with normal activity 
as EDS VIE." The eyes are very vulnerable, corneal perforations develop in 70% of 
cases after minimal eye trauma,305 The severe kyphoscoliosis may be resistant to 
bracing. 
The hallmark of EDS type VII is the involvement of ligaments and joint 
capsules. The disorder is characterized by multiple joint hypermobility and recurrent 
subluxations and luxations of small and large joints and ligamentous tears.m,m 
Congenital bilateral hip dislocation is the rule, and muscular hypotonia is prominent; 
both factors are said to cause a high incidence of breech presentation of an affected 
fetus, and delayed gross motor development. JOj The clinical diagnosis is supported by 
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protein data pertaining to collagen extracted from skin or produced by fibroblasts. This 
type is subdivided depending subtle enzym differences concerning the collagen 
synthesis (pro-alpha I and 2).31 On transmision microscopy "angular and hieroglyphic" 
fibrils are seen. 145,23) 
EDS type IX is "vacant" (see nosology). This type was originally called X-
linked cutis laxa, but has been reclassified as a disorder of metal transport. 
In EDS type X joint and skin abnormalities are present, and a platelet 
aggregation defect can be demonstrated that is correctable in vitro by the addition of 
human fibronectin. 9 The causal association between EDS, dysfibronectinemia,and 
platelet dysfunction remains to be established. Therefore, some authors question the 
existence of EDS X as a separate entity. 
In 1997, a new classification of the EDS in six major types was proposed (see 
Appendix 7)33 , because the earlier established diagnostic criteria did not discriminate 
adequately between the different types of EDS or between Ehlers-Danlos syndromes 
and other phenotypically related conditions. In addition, elucidation of the molecular 
basis of several Ehlers-Danlos syndromes has added a new dimension to the 
characterization of this group of disorders. For each type major and minor diagnostic 
criteria were defmed. The presence of one or two major criteria is either necessary or 
highly indicative for clinical diagnosis and warrants laboratory confirmation when 
possible. The presence of minor criteria contributes to the diagnosis, but, in the 
absence of major criteria, they are considered insufficient to establish the diagnosis of 
EDS. 
The diagnosis depends on examination by physicians trained in recognizing the 
syndrome. An established diagnosis and counseling make the patient and their family 
understand the clinical signs and symptoms, and complications may be recoguized 
earlier. 
In this study the classification of EDS in nine types, as used before 1997, lVas 
applied, because all patients recruited were diagnosed before 1997, and comparison 
with literature data was possible. 
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Chapter 3 
THE MARFAN SYNDROME AND PREGNANCY: 
AN ANALYSIS OF THE LITERATURE 
3.1. Introduction 
Pregnancy is characterized by marked adaptationa! changes in ahuost all 
maternal systems, organs, and tissues,326 These changes may influence the signs and 
symptoms of Marfan's syndrome and, vice versa, the pathophysiology of the disorder 
may modulate the maternal adaptational responses to pregnancy. During pregnancy 
qualitative and quantitative changes occur in the composition of collagen, most likely 
due to hormonal influences. 66,135 The increase in body weight and circulating blood 
volume have an inlpact on the supporting structures and the cardiovascular system.",l" 
Most reports on the relationship between pregnancy and the Marfan syndrome focus 
on cardiovascular effects, in particular dilatation and dissection of the aorta, the most 
severe complication.87,\16,203,205.2H,246,203 Only few authors report other problems during 
pregnancy and delivery.I14,,,S In addition, the Marfan syndrome is an inheritable 
disorder that Illay affect the fetus,l9J 
In this chapter the literature on the effects of pregnaocy on the signs, 
symptoms, and complications of the Marfan syndrome will be reviewed, with 
emphasis on the cardiovascular complications. The incidence, prevention and treatment 
of aortic dissection in pregnancy will be discussed, The significance of the Marfan 
syndrome with regard to the course and outcome of pregnancy, and the possibilities 
and limitations of antenatal diagnosis will be assessed. 
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3.2. Pregnallcy and the manifestations of the Marfan syndrome 
Cardiovascular complications are often described in articles reporting on 
pregnancy and the Marfan syndrome. Women with preexisting cardiovascular disease 
are subject to further stress due to the physiologic changes of pregnancy .'26.\01 In the 
first and early second trimester of pregnancy cardiac output shows a steady rise due to 
an increase in heart rate as well as in stroke volume and is maintained thereafter at 
30% to 40% above nonpregnant levels.133,326 There is an additional 20% increase in 
cardiac output with each contraction during labor and a brief rise immediately after 
delivery.IW,326 
The elevated cardiac output in pregnancy may be expected to increase the shear 
force on the aortic wall and to increase aortic wall tension. The risk of aortic dissection 
depends on the rate of change in pressure on the aortic wall, as well as on the peak 
pressure in the aorta, since aortic wall tension is proportional to pressure. For that 
reason, reduction of myocardial contractility will reduce the rate of ventricular 
ejection, which in turn will decrease the shear force. During the second stage of labor 
the Valsalva maneuver may contribute to the development of aortic dissection. During 
the late Valsalva maneuver aortic tracings show a steep anacrotic rise that subsequently 
decreases to a low incisura. At the end of the Valsalva maneuver blood pressure 
decreases, foHowed by an overshoot with an associated increase in systolic and 
diastolic pressure and an increase in pulse pressure. 167 
In pregnancy, the collagen of the vessel walls shows marked changes in 
architecture and may be more prone to aneurysmatic malformations and 
dissections. 2JJ•B1 In pregnant rabbits Danforth et al. (1964) showed the occurrence of 
fragmentation of the reticulum, a loss of resilience of the elastic fibers, and a 
diminution of the amount of collagen and of the concentration of acid 
mucopolysaccharide in the aorta and peripheral vessels. 66 Similar changes were found 
in nonpregnant rabbits treated with norethynodrel (prostagens). Wolinsky (1972), using 
a hypertensive male rat model, found that estrogen treatment inhibited the increase in 
collagen and elastin deposition in the aorta, and that gestagens slightly accelerated the 
deposition of noncollagenous proteins. 339 These observations suggest that the 
pregnancy-induced arterial changes in the vasculature are a result of hormonal 
influences on the connective tissue structure of the arterial walls. 
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In addition to the cardiovascular complications, a few rare complications which 
may be related to the connective tissue defect were observed like spondylolisthesis, 
inversio uteri255 , and a rectovaginal rupture. 174 Complications resulting from other 
manifestations of the Marfan syndrome, such as coagulopathy, or ocular and skeletal 
abnormalities, were not reported. 
3.3. Incidence, prevention, and treatment of aortic dilatation and dissection in 
pregnancy 
3.3.1. II/cidel/ce. 
In a study in Sweden, the overall incidence of dissection of the thoracic aorta 
was found to be 3.2 per 100.000 autopies in both men and women. J13 Hypertension 
appeared to be the most important risk factor. Other risk factors included Marfan's 
syndrome and disorders of cOlUlective tissue, and also cystic medial degeneration of 
the aorta, a bicuspid aortic valve, aortic coarctation, blunt trauma, pregnancy, and 
manipulations of and operations on the thoracic aorta. According to large older and 
more recent epidemiologic studies, about half the number of the dissections in women 
under the age of 40 occurred during pregnancy (781168)."1.114.181.275 In one of these 
series, 17 percent of the aortic dissections were associated with the Marfan 
syndrome. 124 Zeebregts et al. (1997) reported on six acute aortic dissections in 
pregnancy, out of a total of 56 cases of aortic dissection in women; two of the six 
pregnant patients had the Marfan syndrome. '17 At present over 200 cases of 
pregnancy-related cases of aortic dissection have been reported in the accessible 
literature. None of the risk factors mentioned above were found in 63% of dissections 
that occurred during pregnancy, except pregnancy itself. 131,15-1,295,34Q 
The mean age at which a dissection occurs in male or female patients with the 
Marfan syndrome is reported to be about 30·32 years.'IO.287 In pregnant women with 
the Marfan syndrome, dissection of the aorta may occur at any time in gestation, with 
a slight preference for the third trinlester, until three months postpartum. 253,26-1 
Rusebeye et al. (1958) reviewed 57 cases; three dissections occurred in the first 
trimester, 12 in the second, and 35 in the third trimester, \ViOl 17 around term, while 
seven occurred during the postpartum period. Only four dissections occurred during 
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labor and delivery.m Konishi et at. (1980) collected 51 cases of aortic dissection: 6% 
were found in the first trimester, 10% in the second, and 51 % in the third trimester; 
14% occurred during labor and 20% in the puerperium. Marfan's syndrome was 
present in three of 51 cases. IS' In 1961, Wolff reviewed 73 cases of spontaneous aortic 
rupture during pregnancy, parturition, and puerperium published in the literature at 
that time. "" Two cases were from the University Hospital of Amsterdam. 175 In 76% of 
the cases the aneurysm was found in the ascending part of the aorta; 19 patients died 
within one hour, 29 died within 48 hours, and 19 died within 10 weeks. The author 
suggested a relationship with the Marfan syndrome and discussed other possible 
contributing factors, like hypertension and trauma. 
3.3.2. Preventioll allli trealmelli. 
Successful conservative treatment of aortic dilatation with support of beta-
blockers has been reported. I".263 In 1994 Shores et at. reported a randomized 
controlled trial in which 32 patients with the Marfan syndrome were prophylactically 
treated with propranolol and 38 were not,2Sl After 10 years the aorta ascendens of the 
patients in the beta-blocker group showed less increase in diameter and survival was 
better than that in the untreated group. However, the number of patients who 
developed dissections or ruptures did not differ significantly between groups, which 
could be due to the number of patients, selection of the groups, the mean age at which 
time the study was started, and the limited time of follow-up. 
The putative beneficial effect of beta-blockers on the aortic wall is thought to 
be caused by their negative inotropic effect through reduction of the ventricular 
ejection fraction. In addition, an experimental study showed that turkeys, which are 
known to be prone to spontaneous aortic rupture, had improved survival rates when 
the beta-blocker propranolol was added to their feed.""·2°O Propranolol was shown to 
increase cross-linking of collagen in these animals." Propanolol also appears to reduce 
urinary levels of hydroxyproline in patients with hyperthyroidism47 , and it increases 
deposition of collagen in the hmg.211 In conclusion, beta-blockers may be useful in 
patients in which an operation is not yet indicated. 
According to the Stanford classification, dissections can be divided in type A 
(involving the ascending aorta) and type B (involving the descending aorta). Aortic 
42 
dissection type A is an indication for emergency operation; in type B medical treatment 
with strict management of hypertension is the first choice of treatment. 21,m 
Progression of the dissection or progressive cardiovascular failure are indications for 
surgery."'''. In recent years the results of cardiovascular operations have improved 
considerably.75,105,107,103,I00,152 In 1995, Gatt et aI. reported immediate postoperative 
survival rates for patients with acute or chronic type A aortic dissection to be 60% and 
90%, respectively.IO> The major causes of perioperative mortality and morbidity are 
hemorrhage. myocardial infarction, cardiac tamponade, sepsis, and renal 
failure. IOS•I&9.200.l34 In 1999, the results of aortic root replacement in 675 patients in ten 
surgical centers were published.IO> The 3~-day mortality rate was 1,5 percent among 
patients with elective repair and 11,7 percent among patients who underwent 
emergency repair. Late deaths (more than 30 days after surgery) occurred in 17% of 
cases (n= 114); dissection or rupture of the residual aorta and arrhythmia were the 
principal causes of late death, each in 20% of cases. 
Paraplegia, one of the serious complications after repair of distal dissections, 
occurs in about 5-15 % of patients, and is especially likely in patients with aortic cross-
clamp times of more than 45 minutes in whom a partial cardiopulmonary bypass or a 
shunt are not used to maintain perfusion beyond the cIamp.IC6,I07 Aneurysms that are 5 
to 6 em in diameter have a faster rate of growth and a greater propensity for rupture 
than smaller aneurysms, and in these cases an elective resection is advisable. 103,IW With 
proper peri- and postoperative management approximately 50% of all patients with 
aortic dissection will survive for 10 years.108,189 A recent literature survey 
demonstrated that pregnancy and the postpartum period per se increase the maternal 
mortality risk of an aortic procedure by up to five fold. JJO 
Most authors recommend that obstetric management of patients with an aortic 
dissection hematoma in the third trimester should include cesarean section prior to 
repair of the aorta. 200,203.243,29),334 The surgical correction of an aortic dissection takes 
place with supercooling, hemodilution and hypotension of tlle patient. Not only the 
reduced uteroplacental perfusion but also the cooling may affect tlle survival of the 
fetus if such surgery is performed during pregnancy 21.56.316 Although cardiopulmonary 
bypass for replacement of heart valves and correction of cardiac malformations during 
the fIrst and second trimester have resulted in good pregnancy outcome in some 
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cases21 ,34,62.56.5-1,31O,319, one article reports a 19% fetal mortality rate in 16 patients with 
surgery and maternal cardiopulmonary bypass.'" Only a few reports could be found 
of aortic repair during pregnancy with survival of the fetus. 21,144,162,26S A few reports 
have been published on survival of the fetus in cases of surgery under hypotension and 
hypothermia. %,203,316,34 7 
During and after the cardiovascular operation the patient is heparinized because 
of the extracorporeal circulation and the increased risk of thrombosis; for that reason 
some authors recommend prophylactic ligation of the internal iliac arteries prior to 
cesarean section to reduce the risk of intractable bleeding.56 
According to one study vascular changes do not nonnalize after pregnancy, and 
the authors conclude that patients who have had aortic surgery for dissection may 
better refrain from pregnancy. 155 The aorta has proven to be weak, and dissection may 
take place in other parts of the aortic tract. 
3.4. Complications and outcome of pregnancy in women "ith the Marfan 
syudrome 
3.4.1. Alltella/al diagllosis 
The Marfan syndrome is due to an inheritable, autosomal dominant disorder of 
the connective tissue (see Chapter 2.3), with a 50% risk for the fetus to be affected. 327 
The underlying defect is due to a defective fibrillin gene (FBN-I)."·'" An antenatal 
diagnosis can be made by linkage analysis or, preferably, by mutation analysis if 
possible. Fetal cells for analysis may be obtained by means of chorion villus sampling 
or amniocentesis. i01,2'i7 Over 30 mutations in the FBN-l gene have been identified. 
With a single exception, each mutation has been proven to be specific for an 
individual family. 78,79,SO,81,101,120,141,142.2'i7,m Linkage analysis requires the DNA and 
family data of affected and unaffected relatives. Mutation analysis is limited by the fact 
that the fibrillin gene is very large. Preimplantation diagnosis of the Marfan syndrome 
has been reported in a few cases. I17,147,276 
Three case histories were found of antenatal detection of Marfan syndrome by 
ultrasound. In one case it concerned cardiac abnormalities, in the second case long 
extremities were noted, and in the third case cardiomegaly and cerebral abnonnalities 
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were observed.123.153.179 Two pregnancies were terminated in the second trimester and, 
according to the authors, the abnormalities were confirmed and the fetuses were 
considered to be affected. In the third case intrauterine death occurred at 35 weeks 
gestation, and autopsy revealed findings consistent with the Marfan syndrome. In 
general, the fetal abnormalities associated with the Marfan syndrome are aspecific, and 
although sonographic findings of long fetal extremities with cardiomegaly and 
atrioventricular valve regurgitations are suspicious for Marfan's syndrome in patients 
with a positive family history, the diagnostic usefulness of ultrasound examination 
seems to be limited. 
3.4.2. Review of the lite/'{/Il/I'e 
A literature search for articles published between 1967 and 1999 concerning 
Marfan syndrome and pregnancy yielded 144 publications. The references of these 
publications were scrutinized for articles not included in the Medline system (n=7). 
In the following paragraphs a review of all reports with a full description of 
pregnancy, delivery and outcome is presented. Articles written in English, French, 
German, Italian and Spanish or articles in another language with an extensive 
English abstract were included. Articles or groups of patients reported in articles 
with missing or obscure data, or articles reporting in general about pregnancy 
and/or the Marfan syndrome were considered nonevaluable, and were omitted from 
analysis (11=57). Nineteen articles were written in other languages (Hebrew, 
Danish, Japanese, Russian) without an abstract in English and could not be 
evaluated, and 15 articles concerning research and prenatal diagnosis of collagen 
disorders were omitted. 
Three articles of the 60 publications included in the final review and analysis 
described patient series of pregnant women with the Marfan syndrome176,247,265 , 
including 83 patients and a total of 241 pregnancies; these reports contained complete 
data and were fully evaluable. Fifty-seven articles dealt with anecdotal reports 
describing 75 Marfan mothers, with 146 pregnancies; sufficient data for evaluation 
were available from 99 of these pregnancies. 
Early Of first trimester spontaneous or induced abortion was defined as 
termination of pregnancy before 16 weeks' gestation. Delivery between 16-24 weeks 
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gestational age was considered late or second trimester abortion. Preterm delivery 
was defmed as delivery between 25 and 37 weeks t gestation. Neonatal mortality was 
defmed as death within 7 days after birth. Cases of maternal death were included 
until 6 weeks postpartum. 
Mate17lal complications and outcome 
The pregnancy complications and perinatal outcomes of the three patient series 
and case reports are summarized in table 3.1. 
Twelve of the 26 women in the study of Pyeritz had a cardiovascular problem 
before their fIrst pregnancy.2A7 Of these 12, three had a degree of aortic dilatation, one 
had mitral regurgitation causing congestive heart failure, one had aortic regurgitation, 
and the remaining cases had heart murmurs or some degree of valve prolapse; none of 
these women had an aortic diameter of 40 mm or more. Only the woman with conge-
stive heart failure and preconceptionai cardiac impairment developed endocarditis near 
term and died several weeks later of intractable congestive heart failure. One woman 
experienced preeclampsia. Pyeritz concluded, therefore, that an aortic root diameter of 
less than 40 mIll and minor cardiovascular involvement appeared to be associated with 
favorable maternal outcome. 
The second serial study is a prospective longitudinal investigation published 
more recently by thc group ofPyeritz.265 Forty-five pregnancies in 21 patients wcre 
analyzed. Of thc 28 prcgnancies carried to tcnn beta-blockcrs were used in ten. 
Preeclampsia developed in three pregnancies (two women). A0l1ic dissection 
occurred in two patients, both with an increased risk for dissection established before 
pregnancy. The first woman had a preconceptional aortic diameter of 42 mm and 
moderate cardiovascular impainncnt; thc second woman had a postgraft status. In 
eight pregnancies an aortic diameter of 40 mm or more was present before 
conception. In one case hysterotomy was perfonned at 17 weeks, prior to an aortic 
repair; in one case (aorta diameter 48 mm) abortion was induced. In the other six 
cases the aorta diameter varied between 40 to 45 11Ull and matemal and fetal outcomes 
were good. 
The third and most recent study by Lipscomb et al . (1997) is a retrospective 
analysis of the outcome of 91 pregnancies in 36 women with the Marfan syndrome. 176 
The study describes six cases of aortic dissection or progressive dilatation leading to 
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aortic surgery. In all four of the cases with dissection, progressive dilatation of the 
aorta or an aortic diameter of 40 rum or more was observed. One woman died 14 days 
postpartum; a postmortem diagnosis of Marfan's syndrome was made. Of the 36 
women in this study, one woman had preexistent essential hypertension, one woman 
developed preeclampsia, and one woman developed uncontrolled hypertension at 25 
weeks and was found to have an aortic dissection at 14 days postpartum. Two twin 
pregnancies were reported resulting in second trimester abortion at 22 weeks of 
gestation and pretenn delivery at 32 weeks of gestation, respectively; both 
pregnancies did not lead to maternal cardiovascular complications. 
The complications and outcomes of 99 pregnancies in women with the Marfan 
syndrome collected from 57 case reports are presented in Table 3.1, as well as in 
appendix 6. Quite contrasting are the relatively high incidence of maternal 
cardiovascular events and of unfavorable fetal outcome. 
A severe cardiovascular event occurred in 48 women; in 4 % it occurred in 
the first trimester, in 13% in the second trimester, in 60% in the third trimester, in 
4% during delivery and in 17% in the postpartum period (Table 3.2 ). In three 
women progression of aortic dilatation led to hemodynamic instability and 
necessitated aortic surgery in the third trimester. One woman developed congestive 
heart failure in the second trimester, in one woman aortic insufficiency led to aortic 
repair in the third trimester, and one case of postpartum cardiac failure was reported. 
In one patient myocardial infarction occurred peripartum after a distal aortic dissection 
that was medically treated."1 All other cases involved aortic dissections (n=41). 
Hypertension is a recognized risk factor for aortic dilatation and dissection, and 
reported in 5-7% in the serial studies and in the case reports. 
In 46 % of cases the cardiovascular event resulted in maternal death, in 46 % 
mother and fetus survived; in three cases only the fetus died. Postpartum aortic 
dissection occurred mainly in women with vaginal delivery or cases with a cesarean 
section in whom aortic pathology was already present. 
Other complications of pregnancy and delivery related to the Marfan 
syndrome, such as rectovaginal rupture, uterine inversion, and spondylolisthesis are 
reported, but appear to be extremely rare.174.255 
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Table 3.1 Complications and outcome of pregnancy in patients with the Marfan 
syndrome 
Pyeritz Rossiter Lipscomb Case reports l 
(1981) et a!. (1995) et a!. (1997) n=57 
Number of patients 26 21 36 75 
Age/mean (yrs)-range 25,5/16-40 24-28 27,2118-53 
Primiparous 6 21 NR 45 
Total number of pregnancies 105 45 91' 146 
-of which evaluable 105 44 91' 99 
Obstetric complications 
-First trimester abortion 23) 17} 2 4 
-Second trimester abortion o } o } 6' 2 
-Termination of pregnancy 0 10 7' 4 
-Pretenn labor NR 2 5 8 
-Preeclampsia 1 3 1 6 
Severe maternal complications 
-Cardiovascular events 2 6 48 
-Maternal death 0 1 22 
Delivery 
-Preterm 7 1 5' 35 
-Term 75 26 70 54 
-Spontaneous vaginal NR 13 62 43 
-Forceps NR 8 5 6 
-Vacuum NR 0 1 0 
-Cesarean section 2 6 7 34' 
-Breech 1 0 1 4 
Postpartum complications 
-Hemorrhage 4 2 7 2 
Neonatal outcome 
-Liycbirth 80 26 75 79 
-Stillbirth 1 1 1 9 
-Neonatal death 0 0 1 6 
-Small-for-gestational-age 10 0 0 1 
I In six cases the mode of deliver}' was not relevant because of maternal and fetal death and in one case 
the neonatal outcome was not reported 
2 Two twin pregnancies 
3 Two twin pregnancies 
4 One twin pregnancy (22 weeks) 
5 Four times because of neural tube defect in one patient, once because of cardiac complications 
6 One twin pregnancy (32 weeks) 
7 Two limes sectio parva, 2 times post mortem, 25 times because of cardiovascular compromise of the 
mother 
NR : not reported 
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Obstetric complications and pregnancy outcome 
The incidence of first trimester abortion appears rather high in Pyeritz and 
Rossiter's series, 22% and 38% respectively, but it is only 2% in the report by 
Lipscomb et al . However, in the study by Rossiter et al. 59% of all abortions were 
artificial. Other obstetric complications and pregnancy outcomes are not markedly 
different between the three reports. The incidence of obstetric complications cannot be 
reliably assessed because of lack of controls, but it does not seem to exceed that in the 
general population. The incidence of preterm delivery varies between 3%176 and 
8,5%.'" In the study of Pyeritz a slightly increased incidence of small-for-gestational 
age infants was reported (12,5%), in the other studies no special features concerning 
neonatal outcome were noted. 
As in the patient series, the overall incidence of obstetric complications in the 
case reports seems comparable to that in the general population, except for a 39% 
incidence of preterIn delivery. Hemorrhage postpartum was found in 2-7 % of cases in 
this review; in one case hysterectomy had to be performed. 136 No cases of surgical 
complications during cesareaL: section or complicated perineal or abdominal wound 
healing in women with the Marfan syndrome were found in this study. 
Seventy-nine live births were reported (80%) in the collected case reports. In 
thirteen cases intrauterine death had occurred, in nine of these cases between 24 weeks 
and terIn. In all cases, except one, perinatal death coincided with maternal aortic 
dissection. No special features or factors concerning neonatal outcome were found to 
be relevant, except the maternal condition. 
3.5. Comment 
This review summarizes all evaluable case reports and three serial studies. A 
33 % risk of dissection in pregnant patients with Marfan syndrome can be calculated 
from the collective case reports. Usually the reason for publication of a case report was 
a dramatic event in a pregnancy of a Marfan patient. This means that reported cases 
are subject to selection and publication bias and may tend to suggest a higher incidence 
of complications than in fact occurs in the population. In the serial studies of Pyeritz 
and Rossiter et a1. 247,265, only three serious cardiovascular accidents occurred in 47 
patients, and all three had either major cardiovascular abnormalities andlor an aortic 
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diameter of 40 mm or more before pregnancy. The study of Rossiter et al. 265 is the first 
prospective evaluation of the outcome of pregnancy and the long-term cardiovascular 
course in Marfan syndrome patients. However, there is also a potential bias in this 
study because patients who after counseling with regard to their pregnancy-related 
risks chose to become pregnant or to proceed with pregnancy. may represent a subset 
of the Marfan syndrome population at lower risk for cardiovascular complications. 
Table 3.2 Cardiovascular events in pregnant patients with the Marfan syndrome 
Case reports 
Total number of patients 
Agel1\1can (yrs.lmeanlrange) 
Nulliparous 
Type of event: 
- Aortic dissection 
- Other events3 
Time of event: 
-First trimester 
-Second trimester 
-Third trimester 
-Delivery 
-Postpartum 
-Not reported 
AU maternal deaths 
-Maternal and fetal death 
Survival of mother and fetus 
I Age not reported in 2 cases 
2 Parity not reported in 5 cases 
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27.8 (19-42)' 
20' 
42 
6 
2 
6 
29 
2 
8 
I 
22 
9 
22 
.3 Including progression of dilatation (3x in third trimester), myocardial infarction postpartum, aortic 
insufficiency third trimester, congestive heart failure second trimester 
With a preconceptional aortic diameter of 40 nml or more, a woman is 
considered to be at increased risk of a cardiovascular event during pregnancy.226 In the 
literature review, 16 pregnancies were found of women with a documented 
preconceptional aortic diameter of 40 mm or moreJ2·15,105,186,1S8,265 ; in three of these 
cases an aortic event occurred (19%). Dissections may occur in each trimester of 
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pregnancy, but most appear to happen in the third trimester, at delivery, and in Ule 
postpartum period (83 %). 
The prophylactic use of beta-blockers in pregnancy is reported by Rossiter et 
al. 265 and Lipscomb et al. 176 A recent prospective randomized trial showed that 
prophylactic beta-adrenergic receptor blockade is effective in slowing the rate of aortic 
dilatation in patients with the Marfan syndrome.251 In about half of the patients of the 
study of Rossiter et al. 265 a beta-blocker was prescribed, whereas only a few patients in 
the study of Lipscomb et al. 176 received a beta-blocker. Considering the lack of 
demonstrated teratogenicity, and the known increase in cardiovascular stress during 
pregnancy, authors of recent articles recommend the prophylactic use of beta-
adrenergic receptor blockers in pregnant Marfan syndrome patients, at least from 
midtrimester onward, despite the fact that at present there is no convincing evidence 
that such treatment may indeed reduce the frequency of acute dissection.265,2&4 
In contrast to the three serial studies. the case reports showed a high incidence 
of preterm delivery (39%). This is most likely due to selection and to the fact that 
deterioration of the condition of the mother necessitated preterm termination of 
pregnancy in 66% of these cases. 
Only two articles were found reporting on twin pregnancies l2S ,186 • but the 
condition of the infants rather than the course and outcome of the pregnancies is 
described and no conclusions can be drawn on the basis of these data. 
Complications such as rectovaginal rupture, uterine inversion and 
spondylolisthesis lllay be related to the connective tissue defect, but they seem to be 
extremely rare and publication bias may also be involved here. Although hemostatic 
disorders are known to occur in patients with connective tissue disorders, caused by 
abnormal perivascular tissue and platelet dysfunction6S·143.178, no evidence was found 
that the incidence of postpartum hemorrhage is increased. 
In the case reports the possible presence or absence of the syndrome of Marfan 
in the newborn was reported in only 13 cases, and no conclusions can be drawn on the 
basis of this small number. In the serial studies only pyeritz247 reported a slightly 
increased incidence of small-for-gestational age infants frOlll Marfan mothers. Other 
obstetric complications were not observed more frequently than in the general 
population of pregnant women. 
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The general conclusion is that patients with Marfan syndrome in whom 
preconceptional cardiovascular involvement is minor and the aortic root diameter is 
less than 40 mm, with no abnormal progression of the aortic diameter over time, 
appear to tolerate pregnancy well, with favorable maternal and fetal outcomes and 
without subsequent evidence of an increased risk of aortic root dilatation over time. 
However. it should be realized that these conclusions are based on retrospective data, 
no prospective studies concerning these criteria are known. All reports indicate that 
preconceptional diagnosis of the Marfan syndrome is essential in order to be able to 
assess risk factors for cardiovascular events during pregnancy and delivery, and to 
adapt antenatal and perinatal care. 
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Chapter 4 
THE EHLERS-DANLOS SYNDROME AND 
PREGNANCY: AN ANALYSIS OF THE 
LITERATURE 
4.1. Introduction 
In patients with the Ehlers-Danlos syndrome various complications during 
pregnancy and delivery have been described, ranging from minor problems like 
increased bruising to maternal death. 27,217,2M,297,298 The likelihood and severity of 
pregnancy complications appear to vary with the type of EDS. 
The Ehlers-Danlos syndrome shows autosomal dominant or autosomal 
recessive inheritance and parent-ta-offspring transmission is accordingly frequent. 126,193 
In this chapter the literature on the effects of pregnancy on the signs, symptoms and 
complications of the Ehlers-Danlos syndrome will be reviewed. The significance of the 
Ehlers-Danlos syndrome with regard to the course and outcome of pregnancy will be 
assessed and the possibilities and limitations of antenatal diagnosis in certain types will 
be discussed . 
4.2. Pregnancy and the manifestations of the Ehlers-Danlos syndrome 
Pregnancy is associated with marked changes in the composition of collagen 
and structure of connective tissue.66,m In healthy women these changes become 
apparent in an increased mobility of the joints, structural changes of the vascular walls 
(see chapter 3.2), adaptations of the skin, and of the tissues involved in the birth canal. 
The changes may be expected to lead to complications in pregnant women with the 
Ehlers-Danlos syndrome, in particular with the types associated with excessive joint 
hypermobility, (sub)Iuxations (type I, II, Ill), and vascular manifestations (type IV). 
Also the often encountered coagulopathy in patients with the Ehlers-Danlos syndrome 
may lead to complications. 
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4.3. Complications and outcome of pregnancy in women "ith the EWel's-Danlos 
syndrome. 
4.3.1. Alltellatal diagllosis 
Most types of EDS are autosomal dominant (Table 2.2, Chapter 2), with a 
50% risk for the fetus to be affected. For type I, II, and III antenatal diagnosis has not 
yet been reported. In some families the mutations in the collagen gene defect 
(COL5AI,COL5A2) have been unraveled and in the near future antenatal diagnosis 
may be posssible in these farnilies.73.197.315 Predictive DNA analysis by linkage can be 
performed if several affected members in successive generations are available for 
investigation, and when the genotype is relevant, as in types IV, VI A, and VlI.23J·305 In 
such families DNA analysis should allow prenatal detection of the disease. 
EDS IV is caused by a deficiency in type III collagen. The structural gene for 
collagen type III is located on chromosome 288 and a deletion in that gene (COL3AI) 
has been identified.99,IOO,233 Antenatal diagnosis has indeed been reported. 71 ,233.305 
However. the procedures of amniocentesis or chorionic villus biopsy may be 
potentially hazardous in patients with type IV EDS because of the inherent fragility of 
the tissues involved.231 
EDS VI A has a Iysyl hydroxylase deficiency. Antenatal diagnosis should be 
possible, but has so far not been successful. 233,3{l5 
EDS VII may be detected in fetal cells by DNA or protein studies when the 
defect in the index patient has been characterized, but antenatal diagnosis has not yet 
been reported. 303·,," 
The types VIII and X are very rare, and no reports on antenatal diagnosis were 
found in the accessible literature. 
4.3.2. Review of the literalllre 
A search for articles concerning the relationship between Ehlers-Danlos 
syndrome and pregnancy published between 1967 and 1999 yielded 104 publications. 
The references of these publications were scrutinized for articles not included in the 
Medline system (n=I). In the following paragraphs a review of all reports with a full 
description of pregnancy, delivery, and outcome is presented. Articles written in 
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English, French, German, Italian, and Spanish or articles in another language with an 
extensive English abstract were included. Articles or groups of patients reported in 
articles with missing or obscure data or reports on the Ehlers-Danlos syndrome and 
pregnancy in general, were considered nonevaluable, and were omitted from analysis 
(n=39). Five articles written in other langnages (Russian, Danish, Hebrew, Japanese) 
without an English abstract and 12 articles that concerned research related to the 
prenatal diagnosis of collagen disorders in general were omitted from analysis. 
Five articles of the 49 publications included in the final review and analysis 
reported studies describing groups of patients. J,27,225,267,293 Only in the studies of Sorokin 
et a1. 2" and Rudd et a1.267 sufficient data were available for evaluation. In the other 
studies (Beighton27, 27 patients, Ainsworth and Aulicio', 98 patients, Pepin et al. 225 , 27 
patients) obstetric data were found to be incomplete and they are therefore discussed 
only briefly. In the study of Beighton (1970) a general survey of the Ehlers-Danlos 
syndrome is presented, which also includes a chapter concerning pregnancy-related 
complications. A variety of complications is reported, but specific numbers or 
incidences of complications could not be extracted from this publication. The study of 
Ainsworth and Aulicino was published in an orthopedic journal and describes all kinds 
of complications in Ehlers-Danlos patients, but only a selection of obstetric 
complications with percentages of incidence is reported. In a brief survey Pepin et al. 
(1992) report results of the natural history of a group of EDS type IV patients, and 
specific obstetric results are not presented. The results from the articles of Rudd et 
al.261 and Sorokin et a1. 293 are summarized, with the case reports, in Table 4.1. 
Forty-four case reports are included in the review, describing 48 patients with 
73 pregnancies. An overview of these case reports is presented in appendix 7. EDS 
Type I was found in three patients (6%, 3 pregnancies); type II in seven patients (15 %, 
14 pregnancies); type III in six patients (11.0%, 10 pregnancies), type IV in 12 patients 
(26%, 17 pregnancies); types V, VIll, and X each in one patient, and type unknown in 
17 patients (36%, 26 pregnancies). Of70 pregnancies the course and outcome could be 
evaluated (see Table 4.1). 
Early or flrst trimester spontaneous or induced abortion was defIned as 
termination of pregnancy before 16 weeks' gestation. Delivery between 16-24 weeks 
gestational age was considered late or second trimester abortion. Preterm delivery 
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was defined as delivery between 25 and 37 weeks' gestation. Neonatal mortality was 
defined as death within 7 days after birlh. Cases of malernal dealh were included 
until 6 weeks postpartum. 
Maternal complications alld outcome 
Rudd et a1. 267 describe 10 women who had 20 pregnancies. A II patients had 
Iype IV EDS. Two pregnancies were terminated, one because of bowel rupture. The 
observed complications were: bowel rupture, uterine ruplure (2x), aorlic rupture (3x), 
vena cava rupture rupture, rupture of the pulmonary artery, severe bleeding (2x) , 
severe vaginal laceration, termination by hysterotomy at 14 weeks gestation. Five 
patients died; OIlC from uterine rupture during labor at term; one from uterine rupture 
and arterial rupture during preterm labor. hvo from vascular mpturc in the inmlediate 
postpartum period, and the death of the fifth patient was probably caused by uterine 
ruplure during labor. Based on this study, Rudd et a1. 267 conclude that pregnancy in 
patients with type IV EDS is associated with a 25 % risk of maternal mortality. 
Sorokin et a1. 298 report the results of a questionnaire sent to the newly formed 
Ehlers-DanIos National Fouudation in the U.S.A. One of 43 patients suffered from 
heart failure (Iype IV), and no malernal deaths were reporled. 
The sludy of Beighton" covers 27 women with the EDS, but the type of EDS is 
not mentioned. A variety of incidental complications is reported in this study, some of 
which may be related to the EDS, and no maternal deaths were recorded. 
Ainsworth and Aulicino' describe 98 pregnant women with the Ehlers-Danlos 
syndrome. Only percentages of complications are presented in this article and types are 
not specified. Joint laxity was a common complaint. and "postparnml complications!i 
were seen in 20-58% of the women. The postpartum complications included excessive 
bleeding, cervical tears, fourth degree perineal tears, and uterine prolapse. 
In an abstract of a survey on 137 individuals with the Ehlers-DanIos syndrome 
lype IV, Pepin el a1. 225 report aboul 59 women, of which 27 had been pregnant, 
togetller comprising 59 term pregnancies. Of the 59 women, 16 died (mean age 28 
years); seven deaths were related to pregnancy, and in four cases uterine rupture 
occurred. 
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Table 4.1 Complications and outcome of pregnancy of patients with the Ehlers-
Danlas syndrome 
Sorokin Rudd Case reports 
cl al. (1994)' ,I al (1983), 0=443 
Number of patients 43 10 48 
Age/Mcan (yrs)-range NR' NR 26117-38 
Primiparous NR 10 41 
Total number of pregnancies 138 20 73 
-of which evaluable 138 20 70 
Obstetric complications 
-First trimester abortion 33 NR 7 
-Second trimester abortion 7 NR I 
-Preterm labor NR NR 5 
-Preeclampsia I NR 4 
Severe maternal complications 
-Vascular rupture 0 5 6 
-Bowel rupture 0 I 0 
-Uterine rupture 0 2 4 
-I\-£yocardiaJ infarct 0 0 I 
-Maternal death 0 5 7 
Delivery 
-Preterm 22 NR 19 
-Tenll 74 NR 43 
-Spontaneous vaginal 90% NR 25 
-Forceps I NR 5 
-Vacuum NR NR 4 
-Cesarean section 8,4% NR 27 
-Breech 1 NR 3' 
Postpartum complications 
-Hemorrhage 0 2 9 
-Retained placenta I NR I 
-4th degree tear/Lacerations/Hemalollla 0 1 8 
Neonatal outcome 
-Livcbirth 95 16 58 
-Stillbirth 3 2 4 
-Neonatal death 0 0 0 
-Small-for-gestational age 15 NR 2 
1 Data presented as reported in article: '[he stillbirths are not included in the pretermlterm delivery 
figures (n=96), and the number of reported livebirths is 95 
2 Only type rv patients 
3 In one case delivery is not relevant because of maternal death at 7 months 
4 Only age at time of interview reported 
5 All delivered by cesarean section 
NR: not reported 
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The complications and outcomes of 70 evaluable pregnancies in women with 
the Ehlers-Danlos syndrome collected from 44 case reports are also summarized in 
Table 4.1. 
One case of myocardial infarction was described in a patient at 30 weeks' 
gestationJO , and vascular rupture occurred in three pregnant women with EWers-Danlos 
syndrome type IV (29 weeks, 7 months, third trimester)2l.45.221 Joint pains, 
dislocations and symphysiodyny were observed in seven cases (12%). Increased joint 
laxity with subluxation or dislocations, low back pain, pubic symphysis separation 
during pregnancy or labor and prolonged symphyseal pain are described or indicated in 
various case reports,lI·4(j,315 In some cases, general joint laxity. pain in the hip joints, 
or severe pelvic pain/symphysiolysis induced the obstetrician to perform an (elective) 
cesarean section.46,315 A prolapsed intervertebral disc causing severe pain and retinal 
pathology formed an indication for cesarean section in two women wilh EDS type 
1I1. 11 •1l Prominent varicosis and increased bruising are described depending on the type 
of EDS. I'.27•m Ocular manifestations (orbital bleeding, amaurosis fugax) occurred in 
Iwo type IV patients during pregnancy.,,·m Seven maternal deaths are repor-
ted. IO,45,81,2lJ.220,221.297 In six cases death was caused by rupture of major blood 
vessels45,Sl,2I1,220,221,297. and in one case because of myocardial infarction. 1O Three deaths 
occurred in the third trimester, one during delivery, and three in the postpartum 
period. In five cases EDS Iype IV was involved, in Iwo cases the type was unknown. 
In case of EDS type IV Ihe reported maternal mortality rate was 42% of the patients, 
or 29% when calculated on the number of pregnancies beyond 24 weeks' duralion. 
The tolal maternal mortality rale in the case reports is 17 %, or 13 % calculaled on Ihe 
number of pregnancies beyond 24 weeks' duration. 
Obstetric complications and pregnancy outcome 
In Ihe study by Rudd el al. 267 no mention is made of complications of 
pregnancy and delivery; only postpartum complications are reported, one 41h degree 
perineal tear and two cases of postpartum hemorrhage. 
Sorokin et a1.298 reported a spontaneous abortion rale of 30% in 138 
pregnancies, and a preterm delivery rale of23%. Small-far-gestational age was found 
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in 15,7% of pregnancies and the stillbirth rate was 3%. In 15% of cases hemorrhage 
occurred in the peripartum period. 
In the study of Ainsworth and Aulicino' the obstetric complications include: an 
abortion rate of 14-60%, depending on the type of EDS; preterm rupture of 
membranes in 26-75%, and a cesarean section rate of 4-25%. 
The obstetric complications and outcome of pregnancy reported in the 44 case 
reports are summarized in Table 4.1. The total nrst trimester abortion rate was 10%. 
Nineteen of the 62 evaluable pregnancies cnrried beyond 24 weeks gestation ended 
preterm (31 %). In ten of these cases pregnancy was terminated because of worsening 
of the maternal condition, and in one case it concerned a maternal death at 7 months 
gestational age. 21I In three cases a prophylactic cervical cerclage was performedl69,227 
and in another case a Smith-Hodge pessary was placed at 29 weeks' gestation in a 
attempt to prevent pretenn delivery. 165 
In nine cases a forceps or vacuum extraction was performed and in four of 
these cases severe lacerations of vagina and/or cervix, or parametrial/perineal 
hematoma occurred. 212,22O,2&),292 Cesarean section was performed in 27 cases (42%), in 
nine of those indicated by deterioration of the maternal condition. In four cases, two 
type IV and two of unknown type, a uterine rupture occurred.70•212.)()S.J41 In several 
cases surgical complications occurred, attributed to the underlying connective tissue 
disorder and resulting in (re)laparotomies, vessel ruptures, bowel ruptures and 
complicated wound healing. 45,83,267 
In three cases major bleeding occurred postpnrtum (type IV: 2, unknown 
type: 1). 17.8J.2lO The incidence of postpartum hemorrhage seelll5 quite high (14 %) and is 
attributed to uterine atonia, abnonnal hemostasis, and trauma. Other complications 
consisted of third and fourth degree perineal tears, vaginal and cervical lacerations, 
large hematomas, and secondary healing of perineal wounds (13 %). Three reports 
point out that local analgesia may be difficult to accomplish because of the abnormal 
subcutaneous structure.7,8,331 
An antepartum fetal death rate of 6% can be calculated from these case reports. 
Fetal death because of maternal death (type IV) occurred in two patients of 30 weeks 
and 7 months gestational age, respectivelylO,m ; in one case intrauterine death occurred 
at 26 weeks in a type 11 EDS patient; one fetal death occurred during delivery. A 
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small-far-gestational age infant was reported only twice. Congenital deformities 
consisted of pes equmovams, congenital hip luxation, and hamartoma of the liver. 
Only one study was found in which the influence of a fetus with EDS on the 
course of pregnancy was analyzed.'70 In this study all available cases of EDS in New 
Zealand were investigated. In three families with an EDS father 16 pregnancies were 
evaluated. There were eight liveborn children and five first trimester abortions, two 
second trimester abortions, and two stillbirths at 30 weeks gestational age. 
Unfortunately, the types of EDS are not mentioned in the report. 
4.4. Comment 
In 36% of the case reports the EDS type was not mentioned, but usually a 
tragic incident in pregnancy or the peripartum period was the reason to publish the 
case report. Molecular studies are only rarely available and most authors used one of 
the "classical" clinical definitions. The tragic complications appear to occur mainly in 
patients with Ehlers-Danlos type IV, and consist of mpture of major vessels, bleedings, 
and ruptures of the bowel or the utems' The study of Rudd et al. 267 reported a 25 % 
maternal mortality rate in 10 type IV patients. Because of publication bias the reported 
complication rates are most likely much higher than is to be expected in the general 
population of patients. Indeed, in the study of Sorokin et a1. 298, which contains five 
patients with type IV EDS having 15 pregnancies, no maternal deaths occurred, which 
may be due to the method of data collection. In this study, a questionnaire was sent to 
members of the Ewers-DanIos Foundation, whereas in the study by Rudd et al. 267 14 
families were identified in a diagnostic center for inherited connective tissue disorders, 
from only eleven of which all medical data were available. Another explanation for the 
different reported complication rates may be the distribution in the world of the 
responsible different point mutations in the COL3A I gene in some families with EDS 
type IV. One article reported that in some families with a certain point mutation 
(G571S) less pregnancy-morbidity was found." 
The study of Sorokin et al. 298 is the largest study and it probably gives the best 
available estimate of the risk of complications in pregnant women with EDS. Rare 
complications such as orbita bleeding, amaurosis fugax, prolapsed intervertebral disc, 
symphysiolysis, and joint pain may be related to the connective tissue abnormality. 
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Also, the reported prolonged or secondary healing of tears and lacerations of the birth 
canal may be explained by the underlying collagen defect. During pregnancy the signs 
and symptoms of the EDS may become worse because of connective tissue changes 
under the influence of the gestational endocrine environment (Chapter 3.2)3)9 
The preterm delivery rate in the collected case reporls was 31 %, and 23% in 
the study of Sorokin et ai., which seems to be higher than that in the general obstetric 
popUlation. However, preterm delivery appears to be mainly iatrogenic due 10 maternal 
complications. elective induction of labor or elective cesarean section. Specific details 
on the incidence of spontaneous preterm rupture of the membranes Of cervical 
incompetence were not found. 
Vaginal delivery is said to be preferable in pregnanl women with all types of 
EDS, excepl for type IV; there seems to be agreement in the literature to perform a 
primary cesarean section in women with EDS type lV."'''')!' Both modes of delivery 
have advantages and disadvantages for the mother. The lilerature shows that vaginal 
delivery in EDS IV women may be complicated by uterine, vessel or bowel rupture, 
but on the other hand a cesarean section may be hazardous because of bleeding, 
anesthetic complications. and tissue vulnerability. 
Extensive perineal and vaginal tears, hematoma formation, and secondary 
healing of tears or episiotomy are reported as frequent complications of vaginal 
delivery in women with EDS, in parlicular in type IV. Surgical repair may be difficult 
because of pronounced tissue fragility and tearing of sutures, and wound dehiscence is 
reported to be conUllOll. 
If assisted vaginal delivery is indicated, the use of a vacuum extractor is said to 
carry a smaller risk with regard to the perineum than forceps, 129,139,158,281 Although the 
risk of the felus being affected by EDS is 50%, which may carry a risk of neonatal 
hematoma and skin lacerations when vacuum extraction is applied, such complications 
have not been reported in affected infants. 
Local analgesia lVas found to be less effective and less long lasting in patients 
with EDS than in heaW1Y women, and it has been suggested that this could be used as a 
test for diagnosing EDS.7,8 
Neonatal outcome is mainly determined by the preterm delivery rate, No 
conclusions can be drawn on the basis of the data collected from the literature with 
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regard to the question if preterm delivery and preterm rupture of membranes occur 
Illore frequently if the fetus is affected. 
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Chapter 5 
PREGNANCY AND THE MARFAN SYNDROME: 
A DUTCH STUDY 
5.1. Introduction 
The Marfan syndrome is an inheritable connective tissue disorder, with 
multisystem involvement and variable expression of signs and symptoms,193 It is 
caused by mutations within the fibrillin gene on chromosome 15q21."·140 A positive 
family history can be traced in about 85% of the cases, whereas approximately 15% 
appears to be due to a new mutation.12,193,244 The prevalence of the Marfan syndrome 
is estimated at I : 5.000 in a general population.12 .m In the Netherlands, with about 
15 million inhabitants, one may expect approximately 3.000 individuals with the 
Marfan syndrome. There are about 200.000 deliveries per year in the Netherlands. 
If the birth rate in the population of Marfan patients and the reproductive fitness of 
males is similar to that in the general population, and taking into account the 15 % 
mutation rate, approximately 40 Marfan mothers may be expected to give birth each 
year, and about 46 babies with the Marfan syndrome will be born. 
The most severe complication of the syndrome, also in pregnancy. is aortic 
dissection. A review of the literature revealed an incidence of aortic dissection in 
pregnant patients with the Marfan syndrome of approximately 50% based on case 
histories, and a 4% incidence of dissection or serious cardiovascular complications 
in larger series of patients (Chapter 3). Limited data are available with regard to 
other maternal and perinatal complications in pregnant women with the Marfan 
syndrome, which hampers preconceptionai assessment of risk and counseling, and 
appropiate antenatal and perinatal care. 
We designed a retrospective study based on data collected from members of 
the Dutch Association of Marfan patients with the aim of developing guidelines for 
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assessment of risk and counseling of women with the Marfan syndrome 
contemplating pregnancy, and for providing optimum medical and obstetric care 
during pregnancy. This chapter deals mainly with maternal aspects of pregnancy, 
the neonatal aspects will be dealt with in Chapter 7. 
5.2. Subjects and methods 
In 1995, a letter was sent to the 170 members of the Dutch Marfan 
Association with the request for them and their family to participate in the study. 
Members are individuals who are registered with the Dutch Marfan Association and 
they include: 1) individuals with the Marfan syndrome; 2) individuals belonging to a 
family in which the Marfan syndrome occurs; 3) individuals with professional or 
emotional interests in the Marfan syndrome. Response was obtained from 69 
families, three of which refused to participate. The participating 66 families 
comprised 126 affected individuals. All these individuals were approached again by 
means of a letter andlor by telephone, and the objectives of the study and the 
information required were explained in detail. After informed consent had been 
obtained, general data, clinical data with respect to the Marfan syndrome, and data 
regarding the course and outcome of pregnancies were collected by means of a 
detailed questionnaire from female Marfan patients who had been pregnant, and 
from nonaffected women with one or more Marfan children (Table 5.1). Hospital 
records were called in when available and needed. Data on pregnancies and 
deliveries that took place more than 20 years ago could not be reliably assessed, and 
were not included. 
Defillitiolls 
Dllratioll of pregllallcy. Calculated from the fIrst day of the last menstrual period 
and expressed in completed weeks. 
Early or first trimester abortioll. Termination of pregnancy before 16 completed 
weeks. 
Late 01' secolld trimester abortioll. Termination of pregnancy between 16-24 
completed weeks. 
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Table 5.1 Data recorded from women with the Marfan syndrome and from 
nonaffected women with one or more infants with the Marfan syndrome included in 
the study 
General data 
family history/pedigree 
confirmation diagnosis Marfan 
number of affected Marfan patients in the family 
congenital deformities 
relevant illnesses or medication, present or in the past 
History related to Marfan syndrome 
aortic diameter 
aortic dissection or dilatation 
other cardiovascular pathology 
coagulopathy 
ocular manifestations 
joint pains 
severe back pain 
pelvic instability 
medication 
preconceptional counseling 
Obstetric history 
gravidity 
parity 
age at first pregnancy 
abortion 
gestational age at delivery 
maternal death 
perinatal death 
Pregnancy related pathology 
abortion 
pregnancy-induced hypertension /preeclampsia 
gestational diabetes 
blood loss in pregnancy 
preterm labor with hospital admission 
preterm rupture of membranes 
cervical incompetence/cerclage 
other pathology 
Delivery 
duration of labor 
mode of delivery (spontaneous vaginal; assisted vaginal; cesarean section) 
presentation at birth 
PostpartuIll 
hemorrhage 
lacerations of birth canal 
retained placenta 
Newborn 
birthweight/gestalional age 
neonatal outcome 
congenital deformities 
defects related to delivery or pregnancy 
affected with 1hrfan syndrome 
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PreteI'm delivery. Delivery after 24 and before 37 completed weeks' gestation (259 
days). 
Preterm mph,re of membral/es (PROM). Spontaneous rupture of membranes after 
24 and before 37 completed weeks of gestation. 
Cervical il/competel/ce. Diagnosed on the basis of a history of (repeated) painless 
cervical dilatation before 24 weeks gestation. resulting in second trimester abortion. 
Pregl/al/cy-il/dl/ced hypertel/siol/ (PIH). A diastolic blood pressure of 90 mm Hg or 
morc developing after 20 weeks gestation in a woman without known preexisting 
hypertension. 
Preeclampsia. PfH with proteinuria + as determined by dipstick or 0.3 giL or 
more. 
Protracted labor. Labor in which stimulation of uterine activity with oxytocin was 
considered necessary, or in which the first phase lasted more than 12 hours. 
Pelvic pail/IiI/stability. Considered to be present if a pelvic belt or crutches were 
needed for normal daily activities. 
Postpartllm hemorrhage. Blood loss of more than 1000 ml, or any blood loss 
necessitating blood transfusion. 
Neol/atal olltcome was assessed by means of Apgar scores available from the 
records or estimated based on the questionnaire, birthweight, congenital defects, and 
birth traumas. A birthweight below the 10th percentile of the Dutch reference 
curve lSO of weight for gestational age, corrected for parity and sex, was considered 
small-for-gestational age (SGA). 
The occurrence of maternal death in women with the Marfan syndrome was 
checked against data obtained from the Dutch National Registry of Maternal Deaths, 
available since 1981. 
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Women with 
Marfan who 
refrained from 
pregnancy 
n=5 
Letter of recruitment to 
members of the Marfan 
Association, n = 170 
Families that responded, 
n=69 
t 
Families that participated 
n=66 
Number of ~'farfan patients in 
these families. 
n~126 
1 
Women with 
Marfan and one 
or more 
pregnancies 
n=45 
L.j Refused participation, 
n=3 
1 
Women without Marfan 
and one or more 
pregnancies with affected 
infant 
n~44 
Figure 5.1 Diagram of design and results of data collection 
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I 
Unknown if 
affected infant 
0=11 
All pregnancies of 45 women 
with the Marfan syndrome 
> 24 wks, 
n=95 
1 
Evaluable pregnancies 
of 38 affected women 
> 24 weeks, 
n=78* 
Affected 
infant 
n=53 
Nonaffected 
infant 
n=15 
Figmc5.2 Pregnancies of women with the Marfan syndrome 
* One twin pregnancy. one infant was affected 
Statistical allalysis. 
The X'-test was used where appropriate to test differences between relative 
frequencies of occurrence in study and control groups. A p-value of < 0,05 was 
taken to represent statistical significance. 
5.3. Results 
5.3.1. Patiellt data. 
A diagrammatic summary of the design and results of the data collection is 
presented in figures 5.1-5.3. Of the female affected members of the Marfan 
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Association 45 women had been pregnant, with a total of 117 pregnancies, 95 of 
which were carried on beyond 24 weeks. 
Total number of pregnancies of 
44 nonaffected women, 
n ~t65 
Number of pregnancies 
> 24 weeks. 
0=147 
Evaluable pregnancies > 24 weeks 
of 44 nonaffected women with a 
Marfan infant. 
0=51 
I 
~ ~ 
Pregnancies of 16 nonaffected Pregnancies of 28 nonaffectcd 
women resulting in tbe birth women resulting in the birth of 
of an affected infant an affected infant. Father also 
(mutations), affected, 
0=16* 0=35* 
Figure 5.3 Pregnancies of nonaffected women 
* One twin pregnancy. one infant affected 
Five women with the Marfan syndrome stated that they had refrained from 
pregnancy after preconceptional counseling; three women had had a cardiovascular 
event and two women did not want to take the risk of getting an affected infant. In 
each case the Marfan syndrome had been confirmed in a center for clinical genetics. 
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These 45 affected women with one or more pregnancies form the study group (A). 
Of the 95 gestations in the study group, 78 had occurred in 38 women in the past 20 
years; of these evaluable pregnancies detailed clinical data on the course of 
pregnancy, labor. delivery. and neonatal outcome were available. Of the women in 
this group six conceived after antenatal counseling, indicating an increased risk of 
cardiovascular events. 
Of the nonaffected members of the Association, 44 women had had 165 
pregnancies; 147 were carried beyond 24 weeks. These nonaffected women form 
the control group (B). Fifty-one pregnancies in the control group had occurred in 
the past 20 years and were evaluable. These pregnancies resulted in the birth of at 
least DOC affected infant. In 31 % of cases it concerned a new mutation and in 69% 
the father was affected. 
General characteristics of pregnancies in groups A and B arc summarized in 
Table 5.2. The mean age at first pregnancy was 3 years less in the unaffected than 
in the affected women, and on average the unaffected women had had one 
pregnancy more. In the group of unaffected women evaluable pregnancies 
comprised only 35 % of all gestations carried beyond 24 weeks, significantly less 
than 82% in the group of Marfan patients (p < 0.001 ). 
In about 75 % of the cases preconceptional counseling was not performed; 
in 25 % counseling had taken place before pregnancy and in a few cases in the first 
trimester. 
5.3.2. COllrse alld oll(come o!pregllallcy. 
Abortion rates were not different between pregnancies in Marfan patients 
(15%) and unaffected women (11 %). Late abortion occurred in 3,4% of cases in 
group A, and was not recorded in group B (Table 5.2). Three of the four cases of 
latc abortion concerned the same woman; the course of these pregnancies was 
characteristic of cervical incompetence. She had five subsequent pregnancies with an 
uncomplicated course following prophylactic cervical cerclage. 
The course and outcome of pregnancies carried beyond 24 weeks in both 
groups are presented in Table 5.3. Rates ofpreeciampsia, preterm delivery, PROM, 
and bleeding during the second half of pregnancy were sinlilar in both groups. One 
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twin pregnancy was found in group A (32 weeks) and two in group B (33 and 36 
weeks). In all three cases one of the newborns was affected. 
The incidence of protracted labor was similar (8-10%) in both groups. 
Abnormal presentation at birth occurred in II % of pregnancies of affected women 
compared with 6% in unaffected women, a nonsignificant difference. It is of note 
that it concerned an affected infant in eight of 11 cases. Regional analgesia was not 
used in any patient with a vaginal delivery. A cesarean section was performed in 
five pregnancies, three of which in the same patient due to rachitic pelvic 
abnormalities. The other two cesarean sections concerned a "bad general condition", 
and a nonspecified increase in the aortic root diameter near term. In group B only 
one cesarean section was performed, because of abnormal presentation. 
Table 5.2 General characteristics of pregnancies of Marfan patients (Group A) and 
unaffected women (Group B). Values are presented as n, mean, and (range). 
Group A Group B 
Number of women 4S 44 
Mean age at first pregancy (yrs) 26 (20-32) 23 (19-29) 
Mean age at last pregnancy (yrs) 28 (23-41) 27 (24-39) 
Pregnancies per woman 2,6 (1-9) 3,8(2-8) 
Total number of pregnancies II7 165 
Total number of pregnancies> 24 wks 95 147 
Early abortions 18 18 
Late abortions 4 0 
Postpartum hemorrhage occurred in five affected women (6%) and was 
recorded in one unaffected woman, a nonsignificant difference. Manual removal of 
the placenta was performed in 5 % of women in group A and did not occur in group 
B, but the difference is not statistically significant. In one case a large rectovaginal 
rupture occurred, following an uncomplicated delivery. 
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Table 5.3 Course and outcome of evaluable pregnancies > 24 weeks of Marfan 
mothers (Group A) and unaffected mothers (Group B). Values are numbers. 
Group A Group B 
Number of women 38 44 
Evaluable pregnancies> 24 wks 78 51 
Number of pregnancies 
with Marfan infant 53 51 
Number of pregnancies 
with unknown or unaffected infant 25 96 
Obstetric complications 
-Preeclampsia 6 2 
-Blood loss during pregnancy 6 2 
-PROM'" 2 2 
-Fetal death 2 I 
Delivery 
-Preterm 4 4 
-Term 74 47 
-Protracted labor 6 5 
-Spontaneous vaginal 70 49 
-Forceps 3 0 
-Vacuum 0 I 
-Cesarean section 5 I 
-Abnormal presentation 9 3 
Postpartum complications 
-Hemorrhage 5 I 
-rVfanual removal of placenta 4 0 
Maternal complications 
Maternal death 0 0 
Aortic dissection 
-during pregnancy 3 0 
-postpartum 2 0 
Cerebral vascular accident 2 0 
Severe back pain 3 I 
Pelvic pain/instability 3 0 
'" Pretcml rupture of membranes 
72 
Fetal death occurred in two patients with the Marfan syndrome, and in one 
woman in the control group; no specific causes could be determined in any of these 
cases. Detailed neonatal outcomes are presented and discussed in Chapter 7 . 
Concomitant maternal pathology consisted of von Willebrandt disease in two 
Marfan mothers, without clinical consequences. 
5.3.3. Effects ofpregllallcy 011 the Malfall sYlldrome 
No maternal deaths were reported. None of the patients was treated with 
beta-blockers during pregnancy. Aortic dissection occurred in five women with the 
Marfan syndrome, in three during pregnancy, and in two in the postpartum period; 
type A (involving the ascending aorta) in four women and type B (involving the 
descending aorta) in one case. A cerebral vascular incident occurred in two women 
postpartum. The case histories are presented below. 
Aortic dissection 
Case I. An apparently healthy 28-year old gravida 4, para 2 had an uncomplicated pregnancy until 
she was admitted at 24 weeks' gestation because of general discomfort and severe pain between the 
scapulae. No inmlediate diagnosis was made and she was kept under observation. One day after 
admission she collapsed and developed anuria and hypotension. Transesophageal echocardiography 
revealed aortic dissection type A and she was transferred to a tertiary center with cardiovascular 
surgical facilities, where she was successfully operated. The postoperative course was uncomplicated 
and the pregnancy proceeded normally. At term an elective cesarean section was performed, and a 
girl of 2170 gram was born. TIle diagnosis of Marfan's syndrome was suspected at operation and 
later confirmed on the basis of other clinical signs related to the Mart"an syndrome (arachnodactyly, 
skeletal, and ocular manifestations). 
Case 2. A 24-year old primigravida was admitted in labor at term. The diagnosis of Marfan 
syndrome was established at 18 years of age and she had received preconceptional counseling. 
Echocardiography during pregnancy revealed no increase in the aortic root diameter of 40 mill before 
pregnancy. The course of pregnancy was uneventful. Labor started at 39 weeks. After:} hours the 
patient became hypotensive and complained of severe pain in the back. The signs and symptoms of 
aortic dissection were recognized and a type A dissection was confirmed by ultrasound. A cesarean 
section was performed and a 2840 g baby was born in good condition. Aortic repair was successfully 
perfonned in the same session. and the postoperative course was uncomplicated. 
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Case 3. A 28-year old primigravida with the Marfan syndrome had an aortic root diameter of 45 mm 
before conception; otherwise she was in excellent condition. She had received preconceptional 
counseling. Although the increased aortic diameter was considered to be a significant risk factor, the 
patient and her partner insisted on treatment of anovulation. Ovulation induction was performed and 
she became pregnant. The course of pregnancy was unremarkable, and the aortic diameter remained 
stable at approximately 45 mm. She was delivered vaginally at term of a healthy girl. Because of the 
Marfan syndrome and the dilated aorta she stayed in the hospital for observation. On the sixth day 
postpartum, while still in the hospital, she developed acute progressive dilatation of the aorta with 
beginning of dissection (type A), and was successfully operated. 
Case 4. A 23-year old primigravida, not known to have Marfan syndrome, had an uncomplicated 
pregnancy and vaginal delivery. Six ,veeks after delivery she developed severe backpain and 
dyspnea. She was admitted to a hospital and an aortic dissection (type A) was diagnosed and 
confirmed by MRI and transesophageal echocardiography. She was successfully operated. After the 
operation the suspected diagnosis of Marfan syndrome was confmned on the basis of clinical signs. 
Case 5. A 28-year old primigravida was admitted in labor at term. The course of pregnancy had been 
unremarkable. She was known to have the Marfan syndrome, and had received preconceptional 
counseling. Her preconceptional aortic dianleter of 41 rum was assessed regularly during pregnancy 
by ultrasound and showed no increase. Labor and vaginal delivery were uncomplicated and a girl of 
3210 gram was born. Immediately after delivery of the baby, the patient developed signs and 
symptoms of impending dissection and dilatation (severe backpain, dyspnea). Transesophageal 
echocardiography showed an increase of dilatation and signs of dissection (type B). She was treated 
conservatively for two weeks, after which an aortic rcpair was successfully performed. 
Cerebral vasc/llar accidents 
Case 6. An apparently healthy 24-year old primigravida had an uncomplicated pregnancy and was 
delivered vaginally at tenn of a healthy boy of 3100 gram. Thirty minutes postpartum a left half-
sided paralysis occurred with limitation of speech, and a cerebral vascular accident was diagnosed, 
probably due to bleeding. Because of the intracranial location of tbe bleeding and the medical 
facillities at that time and place, she was treated conservatively. The signs subsided, but 15 years 
later she still suffered from left balf-sided paresis. A careful family history aroused suspicion of the 
Marfan syndrome in a few individuals of her family. One year later the diagnosis of Marfan 
syndrome was established in a genetic center as a result of family screening. 
Case 7. A 26-year old gravida 3, para 2 was delivered vaginally of a healthy daughter of 3000 gram. 
TIle course of pregnancy had been unremarkable.The obstetric history showed no abnormalities. She 
was not known to have Marfan syndrome. Six weeks postpartum she had a cerebral vascular accident 
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due to bleeding, with paresis of the left arm and hand. She was treated conservatively and recovered 
completely. TIle typical habitus and clinical findings of Marfan syndrome were recognized by the 
pbysician in charge and confirmed later. 
Other cardiovascular complications were not reported in patients with the 
Marfan syndrome nor in the control group. Data on the prophylactic use of 
antibiotics to prevent endocarditis were not available in the majority of the records. 
No maternal deaths were observed in this study, and one maternal death 
related to the Marfan syndrome was reported to the Dutch National Registry of 
Maternal Deaths out of a total of five fatal dissections of the aortic tract since 1981. 
An increase in the severity of symptoms of the Marfan syndrome such as 
pelvic pain, severe back pain and pelvic instability necessitating the use of a pelvic 
belt or crutches was noted in 8 % of pregnancies of affected women, whereas these 
complaints were not mentioned by any of the women in the control group. 
5.4. Comment 
Dne to the low prevalence of the syndrome, a controlled prospective study of 
the interaction between pregnancy and the clinical signs and symptoms of the 
Marfan syndrome is hardly possible. Even if a controlled study would be feasible it 
would be biased (ascertainment bias) because only counselled women would enter 
the study. Preconceptional counseling either by the clinical geneticist, obstetrician, 
or cardiologist may have an impact on the frequency of complications, because 
women at high risk of cardiovascular complications may decide to refrain from 
pregnancy. In our study approximately 75% of cases analyzed concerned 
pregnancies without any apparent counseling. only 25% of women had received 
some counseling before they became pregnant. Because the degree of 
preconceptional counseling could not be reliably determined, the effect of 
counseling as a possible confounder in this study cannot be assessed. The present 
study, based on data obtained from membership of the Marfan Association, may 
also suffer from selection bias. Selection bias is a known problem in studies on 
patients recruited through patient organisations, as they may focus upon patients 
with severe involvement and a high willingness to participate. The occurrence of a 
complicated pregnancy may well have influenced the decision to join the 
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Association. Moreover, the response to our first case-finding inquiry led to Marfan 
mothers (Group A) with only documented affected infants. Also, a large scale effort 
to obtain all data on pregnancies from unaffected women with affected male partners 
was unfeasible. Based on an estimated 40 pregnancies of Marfan women per year in 
the Netherlands, the period of 20 years covered by this study should include 
approximately 800 pregnancies, whereas only 117 (34%) were collected. Also, the 
age distribution of the women in this study compared to that of all Marfan patients 
or of a general population may be different, and the birth rate in the Marfan 
population may be lower than that in the general population. Even more severely 
biased are single case reports, usually focussing on severe and dramatic 
presentations, and reporting heroic surgical interventions (see Chapter 3). 
The course and outcome of pregnancy in women with the Marfan syndrome 
were compared with those in healthy women who also belonged to the Marfan 
association, because they had one or more affected children. These women were 
chosen as the control group because their pregnancies took place during the same 20 
years' period as those in the affected women, and because they were aware of the 
Marfan syndrome the recall bias in this group may be expected to be comparable to 
that of the study group. A different control group of pregnancies of healthy women 
could not be adequately matched and obtained retrospectively, and the pregnancy 
complications in the nonaffected women with one or more affected children were 
expected to be similar to those in a normal population. 
In 23 families several affected relatives were known to be member of the 
Dutch Marfan Association, which may have affected the number of Marfan patients 
included in tltis study. In some families relatives did not want to participate, because 
they did not want to know that the Marfan syndrome was present or they just were 
not interested. In some cases communication with other relatives was absent. If all 
families of all members would have been included, approximately 375-400 Marfan 
patients would have been found. In 18 % of cases a mutation was present, most of 
them in group B. 
In most cases the underlying reason for membership of the Marfan 
Association was previous disappointment in medical treatment and recognition of the 
fact that the Marfan syndrome is a serious disorder that needs more attention in the 
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(medical) world. In addition, help and understanding from other families was found 
to be supportive. In the Marfan syndrome multiple organ systems are involved, and 
each of them may lead to a certain degree of disability. In the Dutch Marfan 
Association there is no selection for membership concerning severity of signs and 
symptoms of the Marfan syndrome; there are no clues to suspect that particularly 
severe or milder cases are members of the Marfan Association. 
Future results of studies on maternal and fetal outcome of pregnancies of 
women with the Marfan syndrome will also be hampered by selection bias because 
of increased surgical possibilities and use of medical treatment like beta-blockers. 
Unfortunately, the percentage of evaluable pregnancies beyond 24 weeks was 
only 35 % in the group of unaffected women, compared with 82 % in the Marfan 
group. This bias has two explanations. In the group of Marfan mothers, most 
pregnancies were monitored by an obstetrician, and the infant (if affected) carefully 
examined. Less data were available in unaffected infants. Similarly, in healthy 
women with Marfan syndrome-infants, there were more often data on pregnancies 
of their affected children and data on the affected children themselves were more 
often available. 
The 78 pregnancies of the 38 affected women resulted in 53 affected infants, 
15 nonaffected and 11 unknown if affected infants. One would expect that about half 
of the infants in Group A would be affected. The difference may be due to the fact 
that the numbers are relatively small, or that the diagnosis of the Marfan syndrome, 
which may be difficult to assess in children and small infants, was incorrect in some 
cases. 
The only published cases (n=9) in the Netherlands of aortic dissection in 
pregnancy besides the ones reported here, were reported by Wolf (n=2)'40 , 
Zeebregts et al. (n=6)347 , and Mul et al. (n= 1)21", and are discussed in the 
literature survey. In three cases the Marfan syndrome was involved. Since 1981, 
five fatal dissections were recorded the Dutch National Registry of Maternal Deaths 
(about 1 : 720.000 pregnancies); one case was related to the Marfan syndrome. 
Anecdotal reports are notorious for publication bias in that uncomplicated cases are 
underreported. Two studies of the Pyeritz group, one of which is prospective, 
indicate that the risks associated with pregnancy may be much lower in unselected 
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patients (1-4%) than in a selected group of women with the Marfan syndrome as 
reported in the collected case reports (Chapter 3,,,,·'65). Indeed, we found five cases 
of dissection in 117 pregnancies, Oile in the second trimester, two during delivery, 
and two postpartum, a dissection rate of 4.5%. No maternal deaths were recorded. 
The mean age at which aortic dissection occurred in the five patients was 26, 
somewhat younger than the 32 years in the Marfan group reported by Murdoch et 
a1. 210 Two dissections occurred in women who were not aware of having the Marfan 
syndrome, and three of the five dissections occurred in patients who, at the time of 
pregnancy, were known to have the Marfan syndrome. In these three cases the 
aortic root diameter was 40 nun or more before conception. Our findings confirm 
earlier data on pregnancy and the Marfan syndrome of Pyeritzw, Rossiter et al. 26\ 
and Lipscomb et a1. 176. suggesting that in case of minor preconceptional 
cardiovascular involvement and an aortic diameter of less than 40 mm the risk of 
aortic dissection in pregnancy is small (Chapter 3). However, not only the single 
measurement of the diameter of the aorta but also the rate of change in diameter 
appears to be an important predictor of risk. 265,284 In pregnant women with the 
Marfan syndrome serial cardiovascular measurements during pregnancy should be 
performed to detect progression of dilatation during pregnancy, delivery and also in 
the postpartum period, as illustrated by case 3. 
During the last ten to twenty years the life expectancy of Marfan patients has 
improved considerably due to advances in cardiovascular surgery and treatment with 
beta_blockers."s.21o.287.)]4 The reported beneficial effects of the use of beta-blockers 
is most likely due to reduction of the ventricular ejection fraction and the reduction 
of the shear stress on the aortic wall. There may also be a beneficial effect on the 
formation and break-down of connective tissue (Chapter 3.5). However, the 
prophylactic use of beta-blockers was not reported or recorded in any of the patients 
in our study, No other cardiac complications were observed in the patients with 
Marfan syndrome in our study. Prophylactic treatment with antibiotics was not 
reported, but endocarditis did not occur. In the study of Pyeritz'47, the only maternal 
death reported in follow-up was the result of endocarditis. Modern guidelines 
recommend endocarditis prophylaxis in patients with valve abnormalities for other 
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vascular or cardiac defects only in case of a complicated delivery or cesarean 
section.4 
Aneurysmatic changes and ruptures can take place not only in large, but also 
in smaller vessels20 notably in the brain, as shown in the two women with 
cerebrovascular accidents in our study. The occurrence of neurovascular disease in 
the Marfan syndrome, due to aneurysmatic changes in the relevant vessel walls, has 
been observed previously. 273,274 
Clinical symptoms of the Marfan syndrome such as ocular, skeletal, or other 
additional manifestations did not lead to more or particular complications in 
pregnant affected women, except for complaints of severe pelvic pain and 
instability, noted in 8% of the pregnancies of group A, compared to none in group 
B. 
In contrast to observations in some reports315 , no difference was found 
between the frequency of occurrence of early and late abortions in the study and 
control group. The preterm delivery rate in women with Marfan syndrome could be 
expected to be higher than in a nonaffected population because of the underlying 
connective tissue disorder. However, the observed 3,4 % preterm delivery rate in 
Group A was even less than that in Group B (8%), in accordance with the findings 
in serial studies reported earlier .176.247.265 
Hypertensive disorders constitute a risk towards acute aortic dilatation in 
Marfan patients. Preeclampsia occurred slightly more li"equently in affected (8%), 
than in nonaffected mothers (4%), but the difference is not significant. The 
development and treatment of hypertension in pregnant Marfan women should be 
monitored carefully. 
The primary aim of intrapartum management in patients with the Marfan 
syndrome is to reduce the cardiovascular stress of labor and delivery. However, the 
majority of the patients appear to tolerate the process of labor and delivery well. 
Regional analgesia during labor is not widely accepted in the Netherlands, and was 
not used in the patients in the study group. No adverse effects of the use of 
prostaglandin or oxytocin were observed. 
In five pregnancies of affected mothers a cesarean section was performed 
(6%) and in group B only one cesarean section was performed. This is a low 
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cesarean section rate compared to the rate of 10,1 % in 1983 and 14,8% in 1996 in 
the Netherlands (Dutch Perinatal Database (LVR)). This may be due to the long 
period of time covered by the study, many pregnancies having occurred when the 
overall cesarean section rate lVas 10IV, but it may also be related to the quality of the 
connective tissue. No cases of vaginal delivery \vith a previous cesarean section 
were found. The abnormal tissue qualities could, theoretically, form an indication 
for a repeat cesarean section, but no COllUnents could be found in the literature about 
primary repeat cesarean section. 
The occurrence of postpartum hemorrhage and manual removal of the 
placenta was not different between groups. Also in the relevant literature the 
incidence of these complications does not appear to be elevated (Chapter 3.3). 
In conclusion, aortic diameter and progression of aortic dilatation are the 
most important predictors of risk in pregnant women with the Marfan syndrome. 
Diagnosis and evaluation before conception are considered corner stones of 
management. An event-free pregnancy and delivery can never be guaranteed, also 
not in women with the Marfan syndrome, but the risk of aortic dissection appears to 
be small in patients with an aortic root diameter of less than 40 mm that does not 
progress in the course of pregnancy. Optimum care for these patients requires 
adequate preconceptional counseling and a multidisciplinary approach to the 
surveillance and management of pregnancy, delivery, and the postpartum period. 
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Chapter 6 
PREGNANCY AND THE EHLERS-DANLOS 
SYNDROME: A DUTCH STUDY 
6.1. Introdnction 
The Ehlers-Danlos Syndrome (EDS) constitutes a heterogenous collection of 
rare disorders of the connective tissue.27 The syndrome manifests itself in a wide 
range of clinical signs and symptoms, from mild skin laxity and joint hypermobiIity 
to severe disabling luxations, bleeding due to rupture of greater vessels, or rupture 
of the intestine. 27•305 The EDS may be inherited, usually following an autosomal 
dominant pattern, or may be caused by a new mutation. 
Nine different types of EDS are identified according to the classification used 
in this study, based on phenotypic manifestations, specific biochemical 
abnormalities, and mode of inheritance (Chapter 2). Most of the cases concern types 
1, ll, and HI (approximately 30% each); in approximately 10% of the cases type IV 
is concerned, and the remaining types are rare. 305 
The prevalence of the EDS used to be estinlated at 1 : 150.000, but recent 
reports suggest a prevalence of 1 : 5000.""" The prevalence may even be higher, 
because the disorder has become easier to diagnose, and more subtypes are being 
identified. Based on an estimated prevalence of 1: 5000 there will be about 3000 
individuals with the Ehlers-Danlos syndrome in the Netherlands, with a population 
of approximately 15 million. Approximately 200.000 deliveries take place per year 
and, if the birth rate among EDS patients is similar to that in the general popUlation, 
each year about 40 EDS mothers may be expected to give birth, and 40 EDS babies 
may be born. 
In conjullction with the syndrome a variety of obstetric as well as medical 
complications are reported, which are attributed to the fundamental collagen defect 
(Chapter 4). Due to the rare occurrence of EDS it is difficult to estimate the true 
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incidence of the complications. Most articles on EDS and pregnancy are case 
reports, which are notorious for publication bias. As an example, one article gives a 
maternal mortality rate of 25 % for EDS type IV, based on 10 patients having 20 
pregnancies.267 In a survey of clinical aspects of EDS patients Ainsworth and 
Aulicino' report the occurrence of preterm rupture of membranes in 26-75% of 
cases, depending on the type of EDS, and excessive bleeding antepartum was 
"often" observed. Postpartum complications. consisting of severe bleeding. 
lacerations of the birth canal, and uterine prolapse were reported in 20-58% of 
cases. In contrast to these reports, a recent survey of 138 pregnancies in 43 affected 
female members of the American Ehlers-Danlos National Foundation revealed no 
serious complications.298 The scarcity of pertinent data hampers preconceptional 
assessment of risk and counseling, and appropriate antenatal and perinatal care. 
We designed a retrospective study based on data collected from members of 
the Dutch Association of Ehlers-Daulos patients with the aim of developing 
guidelines for assessment of risk and counseling of women with the EDS 
contemplating pregnancy, and for providing optimum medical and obstetric care 
during pregnancy, delivery, and post partum. 
This chapter covers mainly maternal aspects of pregnancy, the neonatal data 
will be presented and discussed in Chapter 7. 
6.2. Subjects aud methods 
In 1995, a letter was sent to the approximately 170 members of the Dutch 
Ehlers-Danlos Association with the request for them and their family to participate 
in the study. Members are individuals who are registered with the Dutch Ehlers-
Danlos Association and include: I) individuals with the Ehlers-Daulos syndrome; 2) 
individuals belonging to a family in which Ehlers-Danlos syndrome occurs; 3) 
individuals with professional or emotional interests in the Ehlers-Danlos syndrome. 
Response was obtained from 74 families, 16 of which refused to participate. The 
participating families comprised 168 individuals with the Ehlers-Danlos syndrome. 
AU these individuals were approached again by means of a letter and I or by 
telephone, and the objectives of the study and the information required were 
explained in detail. After informed consent had been obtained, general data, clinical 
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data with respect to the Ehlers-Danlos syndrome, and data regarding the course and 
outcome of pregnancies were collected by means of a detailed questionnaire from 
women with the Ehlers-Danlos syndrome who had been pregnant, and from 
nonaffected women with one or more children with the Ehlers-Danlos syndrome 
(Table 6.1). Hospital records were called in when available and needed. Data on 
pregnancies that took place longer than 20 years ago could not be reliably assessed 
and were excluded. 
Definitions 
The definitions of obstetric and neonatal outcome variables are identical to 
those applied to the Marfan study (Chapter 5.2). 
The occurrence of maternal death in women with the EDS was checked 
against data obtained from the Dutch National Registry of Maternal Deaths, 
available since 1981. 
Statistical analysis. 
The X 2-test was used where appropiate to test differences between relative 
frequencies of occurrence in study and control groups. A p-value < 0,05 was taken 
to represent statistical significance. 
6.3. Results 
6.3.1. Patiellt data 
A diagrammatic summary of the design and results of the data collection is 
presented in figures 6.1-6.3. 
Of the 168 EDS patients, 66 were women who had been pregnant, with a 
total of 246 pregnancies, 194 of which were carried beyond 24 weeks gestation. 
These women form the study group (A). Of these 194 pregnancies, 128 had 
occurred in 46 women in the past 20 years; of these 128 evaluable pregnancies 
detailed clinical data on the course and outcome of pregnancy, labor, delivery, and 
neonatal outcome were available. 
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Table 6.1 Data recorded from women with the EDS and nonaffected women with 
one or more infants with the Ehlers-Danlos syndrome included in the study 
General data 
family history/pedigree 
confirmation diagnosis EDS and type 
number of affected EDS members in the family 
congenital deformities 
relevant illnesses or medication, prescnt or past 
History related to EDS 
hyperextcnsibility and joint luxalions 
cutaneous hyperexlensibility and fragility 
hematoma and bruising 
coagulopathy 
wound infections/healing problems 
uterine mpture 
pneumothorax 
ocular manifestations 
pelvic instability/pain 
severe back pain 
varices 
cardiovascular pathology 
medication 
preconceptional counseling 
Obstetric history 
parity 
gravidity 
age at first pregnancy 
abortion 
gestational age at delivery 
maternal death 
perinatal death 
Pregnancy-related pathology 
abortion 
pregnancy-induced hypertension/preeclampsia 
gestational diabetes 
blood loss in pregnancy 
pretenn labor with hospital admission 
preterm rupture of membranes 
cervical cerclage 
other pathology 
Delivery 
duration of labor 
mode of delivery (spontaneous vaginal, assisted vaginal; cesarean section) 
presentation at birth 
Postpartum 
hemorrhage 
lacerations of birth canal 
retained placenta 
Newborn 
birthweight/gestational age 
neonatal outcome 
congenital deformities 
defects related to delivery or pregnancy 
affected with EDS 
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Of the nonaffected members of the Association 33 women had had 107 
pregnancies; 93 were carried beyond 24 weeks. These nonaffected women form the 
control group (B). Of the 93 pregnancies in group B, 43 had occurred in the past 20 
years and were evaluable. These pregnancies resulted in the birth of at least one 
affected infant; in 46% it concerned a new mutation, and in 54% the father was 
affected. 
General characteristics of pregnancies in groups A and B are presented in 
Table 6.2. The mean age at first pregnancy was similar in the study and control 
group, and on average the affected women had one pregnancy more than the 
nonaffected women. In the control group of unaffected women the evaluable 
pregnancies comprised 46% of all gestations carried beyond 24 weeks, versus 66% 
in the study group (p < 0,001 ). 
The diagnosis and the type of EDS were confirmed in a center for clinical 
genetics in 82 % of cases; in the remaining cases the diagnosis had been made by a 
pediatrician, a dermatologist, or another specialist involved. The combination of the 
extent and severity of the most important features, together with coexistent 
deviations aud probable mode of heredity, and in recent years by biochemical and 
molecular analysis if possible, allow a reliable classification. 
Of the total of 194 evaluable pregnancies in the 66 women in the study group 
EDS type 1 was found in 11 %, type II in 27%, type III in 31 %, and type IV in 11 %. 
In 18% the type was not known, and in the remaining 2% one of the other types 
(VI, VII, or Vlll) was present. A remarkable finding was the occurrence of 
different types of EDS within one family. Also, the clinical expression of the 
syndrome within a family showed great variability. In one family a baby and the 
grandmother were severely affected, but the mother had only slight joint laxity and 
could not be diagnosed as having EDS. In a few women a combination of 
histologically verified type 1 and type IV EDS was found. One woman had the 
Marfan syndrome combined with type IV EDS. 
In about 20% of cases preconceptional counseling had taken place and two 
women with EDS type IV and two women with EDS type III refrained from 
(further) pregnancies after counseling. Like in the Marfan syndrome, also in this 
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study the extent of preconceptional counseling could not be reliably assessed in the 
majority of cases, and had to be omitted from further analysis. 
6.3.2. COIIl'se alld olllcOllle o!pregllallcy 
The early abortion rate in EDS women (23 %) was almost twice that in 
nonaffected women (13%), but the difference is not statistically significant. The 
highest abortion rate was observed in women with an unspecified type of EDS 
(39%). Late abortions occurred in 8% of pregnant women, and the numbers arc too 
small to distinguish between types (Table 6.2 ). 
The course and outcome of pregnancies carried beyond 24 weeks in both 
groups are presented in Table 6.3. The incidences of blood loss during pregnancy 
and of preeclampsia were not different between the groups. Of the seven cases of 
preeeclampsia in patients with EDS, four occurred in type IV. The preterm delivery 
rate of all affected women was 21 %, compared with twice that in group B (40%), a 
significant difference. However, in affected women with a nonaffected fetus the 
preterm delivery rate was 12,5 %. Preterm delivery in both groups was caused in the 
majority of cases by spontaneous preterm rupture of membranes (PROM), which 
occurred in 20% of affected women and more than twice as often (50%) in the 
control group (p < 0,001 ). A diagnosis of cervical incompetence was not recorded 
in either group. 
A few other complications were reported in group A. On one patient (EDS 
type II) strangulation of a retroverted gravid uterus in the perlvis caused 
hydronephrosis; surgical reposition was performed and further complications did not 
occur. Two cases with spontaneoous deep venous thrombosis during pregnancy 
were found (type I and ill), and one case with pyelitis (type I1I). 
Four women in group A had twin pregnancies. One pregnancy ended in latc 
abortion at 22 weeks gestational age (type unknown). The same mother had 
previously had one full term pregnancy. Two women with a twin pregnancy went 
into spontaneous labor and delivery at 23-24 weeks (type III and type unknown). It 
could not be established whether or not the fetuses were affected. One twin 
pregnancy in a woman with EDS type I or II was complicated by PROM at 28 
weeks; the twins were delivered at 29 weeks, both infants were alive and healthy. 
86 
Figure 6.1 
Letter of recruitment 
to members of the 
Ehlers~Danlos 
Association, n=170 
I Families that responded, I Families that refllsed 
n=74 participation, 
n=16 
Families that participated, 
n=58 
Number ofEDS patients in these families, 
n=168 
Women with EOS and one 
or more pregnancies, 
n=66 
Women without EOS and one 
or more pregnancies with an 
affected infant, n=33 
Diagram of design and result of data collection 
In the control group only one twin pregnancy was recorded that was delivered at 38 weeks' 
gestational age. The first born was a healthy boy of 3000 g, the second infant, also a boy, 
weighed 1500 g, was delivered by breech extraction, and was found to be affected (type II). 
No reliable data on the zygosity of the twins could be found in the records 
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All pregnancies of 66 women with EDS 
> 24 weeks, n = 194 
Evaluable pregnancies of 46 affected 
women> 24 weeks, 
n= 128* 
Unknown if infant 
affected, I Affected infant, I n=26 n=48 
Nonaffected infant , 
n=55 
Figure 6.2 Pregnancies of women with the Ehlers-Danlos syndrome 
• One twin pregnancy, two nonaffectcd infants 
Rates of protracted labor were similar in both groups. An abnormal fetal 
presentation at delivery was observed in 12 % of the pregnancies in affected women, 
compared with 2 % in the controls; the difference is not statistically significant. 
A breech delivery was reported in 10 cases (8%), compared with one case in 
the control group; in five of the 10 cases the newborn was affected. In three cases a 
brow presentation occurred, and twice a face presentation was found; these infants 
were all affected. The incidence of abnormal presentations was highest in women 
with EDS type III (19%), in the other types it occurred only incidentally. 
The incidence of assisted vaginal delivery was similar in both groups (7-
8%). In one woman with EDS type I fundal expression was performed during the 
second stage because of lack of progress. The cervix was torn off and was found 
around the infant's head. In 8% of affected women complicated lesions of the birth 
canal occurred: five deliveries were associated with third degree perineal lacerations 
(4%), and in five cases healing of an episiotomy wound appeared to have been 
complicated. These complications were not reported in the control group. 
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I 
Total number of pregnancies of 33 
nonaffectcd women, 
n=107 
Number of pregnancies > 24 
wceks, n=93 
1 
Evaluable pregnancies> 24 weeks of 33 
nonaffected women with an EDS infant, 
n=43 
1 
Pregnancies of 20 nonaffected 
women resulting in the birth of 
an affected infant (mutations), 
n=20* 
Pregnancies of 13 nonaffcctcd 
womcn resulting in the birth of 
an affected infant. Father also 
affected, 
n-23 
Figure 6.3 Pregnancies of nonaffccted women 
* One twin pregnancy, one infant affected 
In Group A seven women were delivered by cesarean section. The 
indications were cervical dystocia in four cases and fetal distress in three. In three of 
the cases the diagnosis of EDS was known and special measures were taken to 
prevent surgical complications, like gentle tissue handling, meticulous hemostasis 
and attention to skin adaptation. In these cases no postoperative complications 
occurred; in the other four cases wound dehiscence and wound infection occurred 
once. No cesarean sections were reported in the control group. One patient (EDS 
type IV) presented with complications of epidural analgesia, consisting of leakage of 
spinal fluid, and severe headache. 
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Table 6.2 General characteristics of pregnancies of Ehlers-Danlos patients (Group 
A) and unaffected WOIllen (Group B). Values are presented as n, mean, and (range) 
Group A Group B 
Number of women 66 33 
Mean age at first pregnancy(yrs) 23 (19-32) 24 (20-29) 
Mean age at last pregnancy(yrs) 29 (21-37) 28 (25·38) 
Pregnancies per woman 3,7 (1-9) 2,5 (1-4) 
Total number of pregnancies 246 107 
Total number of pregnancies > 24 wks 194 93 
Early abortions 41 14 
Late abortions 11 0 
Hemorrhage postpartum was found almost three times more often in affected 
women (19%) than in controls (7%); Ihe difference is just significant at the 5% 
level. When both the newborn and the mother were affected, postpartum 
hemorrhage occurred in 33% of cases. The highest incidence was observed in 16 
deliveries in women wilh a nonspecified type of EDS (43%), followed by an 
incidence of 33 % in women with type I. 
Fetal death occurred in four patients with EDS. One case concerned a twin 
pregnancy and occurred at 22 weeks r gestational age; the other two cases occurred 
in the early third trimester in women with EDS type II. The possible cause of death 
is not clear from the records, and there is no evidence as to wether or not these 
fetuses were affected. No fetal death was reported in the control group. Detailed 
neonatal outcome is presented in Chapter 7. 
6.3.3. Effects ofpregllallcy Oil tlte Ehlers-Dallios sYlldrome 
No maternal deaths were reporled. One woman with type IV died six years 
after a delivery complicated by bowel rupture. 
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Table 6.3 Course and outcome of evaluable pregnancies > 24 weeks of EWers-
Danlos patients (group A) and unaffected women (group B). Values are numbers. 
Group A Group B 
Number of women 46 33 
Evaluable pregnancies> 24 wks 128 43 
Number of pregnancies with EDS infant 48 43 
Number of pregnancies with 
unknown or unaftccted infant 80 64 
Obstetric complications 
-Preeclampsia 7 1 
-Blood loss during pregnancy 12 2 
-PROM* 25 21 
-Fetal death 2 0 
Delivery 
-Preterm 27 17 
-Term 101 26 
-Protracted labor 12 6 
-Spontaneous vaginal 112 40 
-Forceps 5 I 
-Vacuum 4 2 
-Cesarean section 7 0 
-AbnoffilRl presentation 15 1 
Postpartum complications 
-Hemorrhage 24 3 
-Manual removal of placenta 3 2 
-TIlird degree perineal tear 5 0 
-Complicated healing of episiotomy 5 0 
Maternal complications 
Maternal death 0 0 
Pelvic pain/instability 34 3 
Ruptured bowel 1 0 
*Preterm rupture of membranes 
Case 1. The 21-year old, apparently healthy, primigravida had an uncomplicated pregnancy and was 
delivered at 38 weeks of a healthy boy of 3280 g. A third degree perineal tear occurred. The first 
day postpartum a laparotomy was performed because of a diagnosis of an acute intraabdominal 
condition and septic shock, and a bowel perforation was found. Six operations followed, 
complications included vena cava thrombosis and surgical removal of large hematomas. She 
recovered after three months. The diagnosis Ehlers-Danlos type IV was suspected two months after 
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delivery and later confirmed by means of collagen analysis. She died six years later of complications 
of peritonitis due to spontaneous bowel perforation. 
One case of maternal death involving EDS type IV, caused by rupture of a 
major blood vessel, has been reported to the Dutch National Registry of Maternal 
Deaths. 
Pelvic pains and instability andlor a diagnosis of symphysiolysis were 
reported in 26 % of cases in group A as compared to 9 % in unaffected women; for 
type I, II, Ill, IV, and type unknown, in 0%,22%,28%,23%, and 27% of cases, 
respectively. In some patients complaints of severe pelvic pains. sometimes leading 
to chronic disability, persisted after delivery. In the control group no patients with 
complaints of pelvic pain, instability or symphysiolysis were found. Complaints 
related to varicosis were not reported. One woman with EDS type I had an orbital 
bleeding during delivery, which was treated couservatively. 
6.4. Conmlent 
Only a few series and about 40 case reports are available in the literature 
regarding pregnancy in women with the EWers-Danlos syndrome. Anecdotal reports 
suggest that pregnancy in women with EDS carries a high risk of potentially lethal 
complications, in particular rupture of major blood vessels. The high incidence of 
maternal complications ill case reports may be explained, at least in part, by 
publication bias; often a dramatic cornpJication and outcome forms the reason for 
publication (Chapter 4). A large retrospective study of EDS patients and their 
pregnancies is presented here based on data obtained from the Dutch Ehlers-Danlos 
Association alld to participate in the study. Such a study is likely to suffer from 
selection bias since the occurrence of a complicated pregnancy may well have 
induced the patient and her family to join the Association. Selection bias is also 
suggested by the fact that only about 30% of all approxhnately 800 pregnancies 
estimated to have occurred in the past 20 years in women with the Ehlers-Danlos 
syndrome are included in this study. On the other hand, the birth rate in women 
with EDS may be lower than that in the general population. 
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The course and outcome of pregnancy in women with the Ehlers-Danlos 
syndrome were compared with those in healthy women who delivered one or more 
neonates affected with the Ehlers-Danlos syndrome, and who were also members of 
the Dutch Ehlers-Danlos Association. The motivation for using pregnancies of 
unaffected women giving birth to an affected infant in the control group (B) was the 
same as in the Marfan study described in Chapter 5. The groups match historically 
as the data from this study comprise the same 20 years' period. Because the women 
were aware of the Ehlers-Danlos syndrome, the recall bias in the control group may 
be expected to be comparable to that in the study group. The fact that a significantly 
higher proportion of pregnancies in affected women (66%) than in controls (46%) 
was found to be evaluable may also have introduced bias. Because the extent of 
preconceptional counseling could not be reliably assessed, the possibility of bias 
resulting from counseling cannot be excluded. 
Considering the low prevalence of the syndrome a controlled prospective 
study of the interaction between the Ewers-Danios syndrome and pregnancy is not 
quite feasible and would be heavily biased because at present all EDS patients 
should receive preconceptional counseling. Some counselled women would refrain 
from pregnancy, and only counselled women would become pregnant and enter the 
study, which would influence the frequency and nature of complications. 
In 12 families several relatives were members of the Dutch Ehlers-Danios 
Association, which may have affected the total number of patients included in this 
study. In some families relatives did not want to participate in the study for the same 
reasons as some members of the Dutch Marfan Association (Chapter 5.4). Also the 
reasons for membership were about the same as those in the Marfan group. There 
are no clues to suspect that more severe or milder cases are members of the Dutch 
Ehlers-Danlos Association. For instance, EDS type IV was found in II % of cases, 
which is as much as would be present in EDS patients in a general population and it 
is in this group that severe morbidity is expected. If all families and all members 
would have participated about 500 EDS patients would have been found. 
Serious complications and maternal mortality are reported in the literature 
associated with delivery in women with EDS type IV, such as bowel fuptures, 
ruptures of major blood vessels, and ruptures of the uterus and birth canal. 71,220,261 
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Therefore, most authors reconunend a cesarean section for patients with type 
IV.'20.22I,J15 In our study, which included II patients with type IV, one bowel rupture 
was reported and no cesarean sections \vere performed. It is unlikely that the bowel 
rupture could have been prevented by performing a cesarean section. The incidence 
of complications in women with EDS type IV was not different from that in patients 
with other types of EDS, but the numbers are small. Another explanation for the 
relatively low morbidity in EDS type IV patients in this study may be the fact that 
EDS type IV families have been identified with longer longevity and less pregnancy-
associated morbidity. 99 The distribution and prevalence of the responsible point 
mutation, or other, in the COL3A I gene in these EDS type IV families in the world 
is unknown. Since 1981, only one case involving the EDS (type IV) has been 
reported to the Dutch National Registry of Maternal Deaths. 
The incidence of pelvic pain, instability, and a diagnosis of symphysiolysis 
was high (26 %) in all pregnant women with EDS, except in those with type I. This 
incidence is markedly higher than that found in the control group (7 %) and a 
general obstetric population (I %).163,296 A pelvic belt or crutches may be used 
prophylactically to alleviate the complaints. In some patients severe pains and even 
chronic disability persisted after delivery. It is a matter of discussion if an elective 
cesarean section is indicated in these patients for this reason, there is no evidence 
that abdominal delivery prevents deterioration of signs and symptoms of pelvic 
instability.1I,296 Decisions whether or not a cesarean section should be performed 
must be individualized, and depend on physical condition, possibilities of adequate 
analgesia, and course and outcome of previous pregnancies. Usually a sensible 
decision concerning the mode of delivery can be made in agreement with the 
patient's wishes after she has been fully counselled. 
Previous reports indicate a risk of 20-25 % of preterm delivery in women 
with EDS.'''·31' This is in agreement with the results of this study, with a preterm 
delivery rate of 21 %, independent of whether the fetus was affected or not. 
However, the incidence of preterm delivery in the control group (40%) was 
significantly higher. The observation that the risk of preterm delivery was 12,5 % in 
affected women with a healthy fetus, but 40% in the control group of healthy 
mothers with an affected fetus, and was usually caused by spontaneous rupture of 
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membranes, suggests that the fetal connective tissue disorder may affect the fetal 
membranes, rather than the maternal disorder the uterine tissues. The results of this 
study do not suggest a role of the cervix as a factor of pretenn delivery, as no clear 
cases of cervical incompetence were found. Preterm labor, preterm rupture of 
membranes, and preterm delivery are associated in about 80% of cases with 
chorioamniotic membrane infections. 218 Therefore, repeated cervical, vaginal, and 
urinary cultures should be part of antenatal care in women with EDS or pregnant 
women with an affected spouse. No data are available on the possible benefits of 
longitudinal cervical length measurements or fibronectin determinations in vaginal 
or cervical fluids in these patients. 
In this study, all four twin pregnancies resulted in spontaneous, extremely 
preterm deliveries. Unfortunately, information whether or not the fetuses were 
affected was not available in all cases. In the literature no data are available on the 
course and outcome of twin pregnancies in women with EDS. At present, EDS 
patients may request egg cell donation - embryo transfer procedures, or donor 
sperm if the partner is affected, in order to prevent an affected infant. Ovulation 
induction, in vitro fertilization, and embryo transfer are associated with an increased 
frequency of multiple pregnancies" , and prudence seems to be indicated with the 
use of these techniques when EDS is involved in order to avoid multiple 
pregnancies. 
Although the tissues of the birth canal in women with EDS may be expected 
to be soft and fragile, protracted labor did occur in 10% of the patients. This may 
be due to the fact that patients with EDS are sooner exhausted than nonaffected 
women. Review of the records of cases with protracted labor gave the impression 
that oxytocin could be less effective in EDS women than in nonaffected, perhaps 
caused by less effective uterine contractions, due to lack of (good) collagen." 
We found a higher incidence of abnormal fetal presentations, in particular 
breech, in women with EDS (12%) compared to the control group (2%). The 
highest incidence was found in women with EDS type III (19%). However, the 
numbers are small and the differences were not statistically significant. In the 
literature only one article was found with the suggestion of an increased risk of 
abnormal fetal presentation at birth in women with EDS.262 One could presume, 
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however, that an affected fetus could be an added risk factor of abnormal 
presentation. Indeed, an abnormal fetal presentation occurred in 20 % of cases in 
which mother and fctus were affected but, again, the numbers are too small to 
provide more than suggestive evidence. 
Postpartum bleeding was observed in 19% of cases when the mother had 
EDS, compared with 7% in the control group; a particular high incidence was noted 
in patients with EDS type I (33%). The elevated frequency of increased blood loss 
postpartum may be attributed to specific pathologic conditions of the EDS such as 
atonia of the uterus due to ineffective contractions, abnormal hemostasis336 • and 
ruptures of the birth canal. The use of DDA VP (l-desamino-8-D-argine 
vasopressine) in case of EDS-induced abnormal hemostasis may be useful.'J6 The 
mode of action of DDA VP is induction of large molecular weight forms of factor 
VIII I Von Willebrandt factor from endothelial cells"l. 
The frequency of third degree perineal tears and complicated vaginal and 
perineal lacerations was 8 % in affected women in OUf study, in general agreement 
with the literature (Chapter 4), and was not observed in the control group. It may be 
difficult to prevent this complication. The value of a primary, preventive episiotomy 
is not established"', and EDS patients may have slow and complicated healing of the 
episiotomy wound. Because of the laxity of the perineal tissue, an episiotomy may 
be even less often indicated than in nonaffected women. It may therefore be 
concluded that an episiotomy should be performed in patients with the EDS for the 
same reasons as in women without the Ehlers-Danlos syndrome. 
In conclusion, obstetricians should be aware of the clinical signs and 
symptoms that may indicate EDS in a pregnant patient, of the diagnostic 
possibilities, and the potential risks. Preconceptional diagnosis and evaluation of risk 
factors are corner stones of management in pregnant woman with EDS. In EDS type 
I, II, and III pregnancy is generally well tolerated, with favorable maternal and 
neonatal outcome, but maternal complications like joint luxations, and pelvic pain, 
and obstetric problems such as preteI'm delivery, postpartum hemorrhage and 
complicated perineal wounds occur more often than in the general population. EDS 
Type IV may be associated with severe maternal complications. More data are 
needed to provide a better estimation of risk factors in EDS pregnancies, especially 
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in the presence of type IV, to allow optimum preconceptional counseling and 
medical and obstetric care. 
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Chapter 7 
NEWBORNS AND THE MARFAN AND EHLERS-
DANLOSSYNDROMES 
7.1. Introduction 
In the study reported in Chapters 5 and 6 data were collected on pregnancies 
of women with the Marfan or EWers-DanIos syndrome. The analysis and discussion 
in those chapters focussed on maternal aspects of pregnancy in women with these 
conditions. Some observations suggest that the fact as to whether or not the fetus is 
affected could influence the course and outcome of pregnancy, e.g. with regard to 
the occurrence of preterm rupture of membranes (Chapter 6.3.2). The potentially 
increased flexibility or decreased mobility of fetuses with the Marfan or Ehlers-
Dallios syndrome may influence the presentation at birth or the occurrence of birth 
traumas. In patients with Ehlers-Danlos syndrome congenital deformities related to 
the underlying connective tissue disorder, like hernias and clubfoot, are reported in 
the literature. 27,235 
In this chapter the neonatal outcome is reported of infants born alive after 24 
completed weeks of gestation in the studies presented in the Chapters 5 and 6. Data 
are analyzed with reference to the condition of the mother and the affected or 
unaffected newborn. 
7.2. Subjects and methods. 
The study forms part of the assessment of the course and outcome of 
pregnancy in patients with the Marfan and Ehlers-Danlos syndromes, reported in 
Chapters 5 and 6. The design and results of data collection of these studies are 
sunnnarized in figures 5.1-5.3 with regard to the Marfan syndrome and figures 6.1-
6.3 concerning the Ehlers-Danlos syndrome. 
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Data from 103 live newborns with the Marfan syndrome were recorded; 53 
were born from a mother who was affected, and 50 were born from an unaffected 
mother. Fourteen liveborn nonaffected infants of Marfan mothers were registered 
and in 10 cases the condition of the newborn was not knowll. 
Ninety-one liveborn infants with the Ehlers-Danlos syndrome were recorded. 
Porty-eight were born from affected mothers, and in 43 pregnancies a nonaffected 
woman gave birth to an affected infant. Data on 55 nonaffected liveborn infants 
from affected women were collected, and in 24 cases the condition of the newborns 
was not known (Table 7.1). 
Table 7.1 Infants of affected and nonaffected women with Marfan or Ehlers-Danlos 
syndrome. Values are numbers 
Infants 
Mothers Affected (n) Nonaffectcd (n} 
Marfan + (n~38)' 53 14 
Marfan - (n~44) 50 
EDS + (n~46)ff 48 55 
EDS - (n~33) 43 
* : One twin pregnancy: one infant affected, one infant not affected 
# : One twin pregnancy: both infants not affected 
Unknown (n) 
10 
24 
A diagnosis of Marfan or EDS was often not established in the neonatal 
period, but later when the infant grew up; all such late diagnoses were included. 
Most of the early diagnoses were made on clinical grounds, but were later 
confIrmed when possible by biochemical or molecular analysis, or both, in a genetic 
center. When there was still doubt as to whether or not the child was affected, also 
at a later age, the case lVas booked as unknown, and not included in the comparison 
between affected and nonaffected infants. Comparisons were made between 
newborns of affected and nonaffected mothers, and between affected and 
nonaffected infants in order to assess the influence of maternal and fetal factors 011 
neonatal outcome. 
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Neonatal outcome was assessed and compared with regard to gestational age, 
presentation at birth, small-for-gestational-age, Apgar-score, acquired or congenital 
defects, and other neonatal pathology. 
The X2-test was used where appropriate to test differences between 
proportions in different groups. A p-value < 0,05 was taken to represent statistical 
significance. 
7.3. Results 
7.3.1. Mmiaa syadrome. 
The neonatal outcome is summarized in Table 7.2 (A) in relation to the 
presence or absence of the Marfan syndrome in the mother, in Table 7.2 (B) in 
relation to the condition of the neonate. Neonatal outcome did not differ between the 
groups of affected and nonaffected mothers. The preterm birth rate was not different 
between affected and nonaffected mothers (5-8%). Small-for-gestational age 
neonates occurred slightly more often in neonates of affected mothers (11 %) than of 
nonaffected mothers (4%), but the difference is not statistically significant. On the 
other hand, an abnormal fetal presentation was observed more often in nonaffected 
(12%) than in affected women (6%), but again the difference is not significant. The 
relative number of preterm infants seems somewhat higher in the group of 
nonaffected (28%) than in that of affected (4%) newborns, but no conclusions can 
be drawn because of the small absolute number. 
Exact Apgar scores were available in 85% of newborns and were similar in 
all groups, when newborns with congenital defects or floppy infant syndrome were 
excluded. The floppy infant syndrome occurred in 6% of the affected newborns. 
The difference between the proportion of small-for-gestational age in affected (8%) 
and nonaffected (14%) infants is not statistically significant. 
A few congenital defects and neonatal disorders were recorded, without 
obvious differences between groups. One nonaffected newborn had a spina bifida 
and was successfully operated, like the affected newborns with the diaphragmatic 
hernia and pylorus spasm. The Liddle syndrome occurred in two siblings. There 
were no neonatal deaths. 
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Table 7.2 Neonatal outcome in mothers (A) and newborns (B) with and without the 
Marfan syndrome. Values are numbers 
A. Mothers 
Affected Nonaffected 
(n~38) (n~44) 
Live births 77 50 
Infants with Marfan syndrome 53 50 
Neonatal death 0 0 
Preteml birth 4 4 
Small-for-gestational age 9 2 
Abnormal presentation 5 6 
Congenital defects 
- Spina bifida I 0 
- Diaphragmatic hernia I I 
- Liddle syndrome 2 0 
Other abnormalities 
- Pylorus spasm 0 I 
- Strabismus I 0 
- Spastic limbs 0 I 
- Floppy infant syndrome 3 3 
B. Infants 
Affected Nonaffcctcd Unknown 
(n~103) (n~ 14) (n~ 10) 
Pretenn 4 4 0 
Small-for-gestational age 8 2 I 
Abnormal presentation 8 2 I 
Congenital defects 
- Spina bifida 0 I 0 
- Diaphragmatic hernia 2 0 0 
- Liddle syndrome 2 0 0 
- Strabismus I 0 0 
Olher abnormalities 
- Pyloms spasm I 0 0 
- Spastic limbs I 0 0 
- Floppy infant syndrome 6 0 0 
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7.3.2. Ehlers-Dallios sYIlr/rome. 
The neonatal outcome is summarized in Table 7.3 (A) in relation to the 
presence or absence of the Ehlers-Danios syndrome in the mother, in Table 7.3 (B) 
in relation to the condition of the neonate. EDS type I lVas found in 11 %, type II in 
27 %, type III in 31 %, and type IV in 11 %. In 18 % the type lVas not known, and in 
the remaining 2% one of the other types was present (VI, VII, or VIID. For EDS 
type 1, n, lll, and Vlll the diagnosis was based on clinical signs and symptoms, 
whereas the diagnosis of types IV, VI, and Vll was confirmed by laboratory tests 
(See Chapter 2.9). The preterm delivery rate in affected mothers (21 %) is 
significantly lower than that in nonaffected women (40%). However, the data in 
Table 7.3 (B) show that of affected infants 31 % was born preterm, compared with 
13 % of nonaffected newborns. No other obvious differences are apparent between 
affected and nonaffected women with regard to the neonatal parameters that were 
recorded. 
Apgar scores were available in 80% of the newborns and were comparable 
between all groups, when newborns with neonatal pathology or congenital defects 
were excluded. The proportion of small-for-gestational age infants was not different 
between affected and nonaffected newborns. Small-for-gestational age occurred 
only in newborns of affected mothers. The proportion of abnormal presentations 
was similar in affected and nonaffected infants, but numbers are small. In 17% of 
the infants with EDS type III an abnormal presentation occurred. In 13% of the 
affected newborns, but in none of the healty infants the floppy infant syndrome was 
recognized. 
A few congenital or acquired defects were observed, without apparent 
differences between groups. All cases concerned affected newborns and all 
survived. One fractured cheekbone occurred as a result of forceps extraction 
following an unsuccessful attempt to vacuum delivery. The newborns with the spina 
bifida and the diaphragmatic hernia lVere successfully operated. In one case a fragile 
umbilical cord was described, which was torn off when the fetal head was delivered 
and was again torn when the cord was clamped. 
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Table 7.3 Neonatal outcome in mothers (A) and newborns (B) with and without the 
Ehlers-Danlos syndrome. Values are numbers 
A 
Live births 
Infants with EDS 
Neonatal death 
Pretenn birth 
Small-for-gestational age 
Abnormal presentation 
Congenital defects 
- Clubfoot 
- Spina bifida 
- Diaphragmatic hernia 
- Cardiac VSD 
Other abnormalities 
- Shoulder luxation 
- Fractured cheekbone 
- Floppy infant syndrome 
B. 
Affected 
(F46) 
127 
48 
0 
27 
10 
15 
1 
I 
0 
0 
2 
I 
7 
Affected 
(F91) 
Prcleml birth 29 
PROM 14 
Small-for-gestational age 6 
Abnormal presentation 11 
Congenital defects 10 
- Clubfoot 3 
- Spina bifida 1 
- Diaphragmatic hernia 1 
- Cardiac VSD 1 
Other abnormalities 
- Shoulder luxation 2 
- Fractured cheekbone 1 
Floppy infant syndrome 12 
Mothel's 
Nonaffected 
(n~33) 
43 
43 
0 
17 
0 
1 
2 
0 
1 
I 
0 
0 
5 
Infants 
Nonaffected Unknown 
(n~55) (n~24) 
7 8 
1 5 
4 0 
5 1 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
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7.4. Comment 
The Marfan and the Ehlers-Danlos syndromes are both inheritable 
connective tissue disorders, and an influence of the presence or absence of the 
syndromes in fetuses and newborns on the outcome may be expected. The diagnosis 
of the Marfan syndrome or EDS in the newborn is often difficult, and longterm 
pediatric follow-up is indicated. In our study also infants with a late diagnosis were 
included. Of the infants of Marfan mothers 69% were affected, and of the infants of 
affected mothers of the EDS group 38 %, instead of an expected percentage of about 
50. However, the numbers are small and a considerable percentage of diagnoses is 
labeled unknown (13% in the Marfan group, 19% in the EDS group). In the Marfan 
group selection bias could be present in the participation of recruited Marfan 
mothers. The neonatal diagnosis is often difficult to establish and, because babies 
resemble their parents and the Marfan syndrome has typical external characteristics, 
the external feanlfes could have led to a false diagnosis and therefore to a higher 
proportion of affected infants. In the EDS, establishing the diagnosis is extremely 
difficult in neonates and young children, even with the use of molecular analysis, 
which may explain the relatively low percentage of EDS infants. Longterm pediatric 
follow-up of children of Marfan and Ehlers-Danlos parents is warranted. 
An elevated preterm delivery rate has been reported in pregnancies with 
connective tissue disorders. 17,25.27,19,298,315 For the Marfan syndrome this observation 
is not supported by the results of our study. With regard to the Ehlers-Danlos 
syndrome we found evidence that the fetal genetic defect has more influence on the 
risk of preterm delivery than the condition of the mother. It has been shown that the 
membranes of fetuses with connective tissue disorders have an abnormal collagen 
content and structure218 and are weaker than normal membranes, which may be an 
explanation for the elevated preterm delivery rate. 
The incidence of small-for-gestational age was found to be similar in infants 
with and without the Marfan or Ehlers-Danlos syndrome. Only in the study of 
Pyeritz'" a slightly elevated rate of small-for-gestational age infants of 11 % was 
recorded in pregnancies of women with the Marfan syndrome compared to a control 
group of unaffected 1V0men (6%). 
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A few congenital defects were found, of which the hernial defects and joint 
luxations have been reported to occur in conjunction with the Ehlers-Danlos 
syndromes. 27.m The floppy infant syndrome is another, potentially severe 
manifestation, tbat was observed in 6% of the newborns with the Marfan syndrome, 
in 13 % of the newborns with the Ehlers-Danlos syndrome, and in none of the 
nonaffected infants. The syndrome is most likely due to the connective tissue-related 
weakness of muscle contraction and tendons. 27•37 Recognition of this condition is 
important because of its extensive differential diagnosis of, among others, neonatal 
respiratory distress and neuromuscular disease. 
In conclusion, there is evidence that both the Marfan and Ehlers-Danlos 
syndromes in the neonate may be associated with the floppy infant syndrome and 
some syndrome-related congenital defects, and that fetal Ehlers-Danlos syndrome 
affects the structure of the fetal membranes with an increased risk of pre term 
delivery, leading to increased neonatal morbidity. This analysis has not produced 
any evidence that the presence of Marfan's syndrome or EWers-Dallios syndrome in 
the mother affects the neonatal death rate. 
The results of this study underline the need for Iongterm pediatric follow-up 
of infants of mothers or fathers with Marfan or EDS, and for provision of 
appropriate specialized care when required. However, more information is needed 
to support the results of this study, in particular to be able to differentiate between 
the risks of specific types of EDS. 
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Chapter 8 
CONCLUSIONS AND GUIDELINES FOR 
COUNSELING 
8.1. Introduction 
A variety of medical complications may occur in patients with the Marfan or 
Ehlers-Danlos syndrome, in women also in pregnancy. The Dutch law (WGBO) 
requires that patients be fully informed about possible risks, in as far as this appears 
to be reasonable. The question as to what may be considered reasonable is not easy 
to answer. The true incidence of complications of the Marfan and Ehlers-Danios 
syndromes has not been reliably determined. Besides the medical complications, 
there are obstetric complications, with inherent risks for the mother, fetus and 
neonate, and the genetic risk for the future child. The decision to accept the risks 
associated with pregnancy or to refrain from pregnancy is an autonomous one, to be 
taken by the woman and her partner, based on information provided by the 
counselor. The perspective of a full, lifelong motherhood may be limited by the 
reduced life expectancy of patients with the Marfan syndrome and with EWers-
Danios syndrome type IV 27,210,,287, despite advances in cardiovascular surgery and 
medical treatment. 
Early recognition of complications in pregnant women with the Marfan or 
Ehlers-Danlos syndrome allows early treatment, which may reduce maternal and 
fetal risks. For that reason the diagnosis should preferably be known before 
pregnancy, and the attending physician should be familiar with the syndromes and 
their potential complications. 
In this chapter guidelines for preconceptional assessment of risk and 
counseling, and for the obstetric and medical care of pregnant women with the 
Marfan and Ehlers-Danlos syndromes are formulated, based on conclusions drawn 
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from data published in the literature and from the studies described in the previous 
chapters. 
Recommendations are classified in three levels as used by the American 
College of Obstetricians and Gynecologists (ACOG) and marked in the text with 
(A), (B), or (C). Level A: Recommendations based on good and consistent scientific 
evidence; Level B: Recommendations based on limited or inconsistent scientific 
evidence; Level C: Recommendations based primarily on consensus and expert 
opinion. 
8.2. Pl'econceptional assessment of risk and coullseling of women with 
the Marran syndrome 
8.2.1. Diagllosis. 
Risk assessment begins with confirmation of the diagnosis in the affected 
women and assessment of her partner I as discussed in Chapter 2. The diagnosis is 
based on characteristic musculoskeletal, cardiovascular. and ocular features apparent 
from clinical examination, and family history. The clinical diagnosis may be 
supported by detection of a fibrillin mutation (or rarely, in a large family, by 
linkage analysis).31,78.25o,252 There is a wide range of clinical expression or clinical 
severity, and in general the actual level of phenotypic expression in a patient cannot 
predict future complications. 19J,252 
8.2.2. Clil/ical featl/res. 
The cardiologist should be consulted before pregnancy (A). The aortic root 
diameter is all indicator of future risk of aortic dissection, the most lethal 
complication. As part of a full cardiological examination attention should be given 
to atrioventricular valve prolaps, valvular regurgitation, and conduction defects. 
(Esophageal) Echocardiography has become the primary tool for assessment of 
cardiac anatomy and function in these patients. 282,310 
Women with the Marfan syndrome, who have minimal cardiac involvement 
and an aortic root diameter of less than 40 mm seem to have a small risk of cardiac 
failure or aortic dissection in pregnancy (B).261 There is a marked increase in risk 
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with an aortic diameter of 40 mm or more, progressive dilatation of the aorta, 
cardiac insufficiency, or other severe cardiac problems Of failure (B).176,24-3,24-.5,261,265,288 
This study found an overall risk of aortic dissection of 4,5% per pregnancy, 
in accordance with risks of I - 6% based on patient series published in literature; 
three of the five cases of aortic dissection described in Chapter 5 had a 
preconceptional aortic root diameter of 40 mm or more. It is likely that a woman 
known to have the Marfan syndrome has a better chance to survive an aortic 
dissection in pregnancy or postpartum than a woman in whom the diagnosis is not 
known. 
When the aortic diameter shows relatively rapid dilatation or has a diameter 
of more than 55 IllIll, elective surgery appears to be indicated. In these cases 
elective replacement of the dilated part of the aorta with a composite graft has 
considerably improved life expectancy (A).I06.107.IOS,I09 
A woman with the Marfan syndrome who has undergone aortic surgery 
remains at increased risk of a cardiovascular event in pregnancy148,243 , dissections 
may occur at other parts of the aortic tract because vascular abnormalities persist 
after aortic repair. 5 On the basis of this information these women are usually 
counselled to refrain from pregnancy (C). 
Young women with the Marfan syndrome and a stable cardiovascular 
condition should consider having children at an early age, if social circumstances 
allow, because of the increasing risk of cardiovascular compromise with age 
(C).'10,287 
Other complications of pregnancy and delivery related to the clinical features 
of the Marfan syndrome are extremely rare, except for a small risk of an increase in 
the severity of pelvic pain, back pain, and pelvic instability. In the Netherlands 
women are advised to take 0,5 mg folic acid / day preconceptionally for prophylaxis 
of neural tube defects if the fetus is at average risk, and 5 mg / day if the fetus is 
considered to be at higher than average risk. There is no evidence to put women 
with the Marfan syndrome in the high risk group; dural ectasia is not considered to 
be part of a neural tube defect and the standard prophylactic procedure applies (A). 
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8.3. Medical and obstetric care in ,,",omen with the Madan syndrome 
8.3.1. Alltellatal diagllosis. 
This may be considered when a couple has a 50% risk (if a parent is 
affected) or after a previous affected child of healthy parents, taking in account the 
chances of gonadal mosaicism in either parent. The underlying cause is a defective 
fibrillin gene (FBN-l) and antenatal diagnosis either by mutation or linkage analysis 
may be possible in some families by amniocentesis and chorion villous 
biopsy.'OO.101.257,m Preimplantation genetic diagnosis has been established in a few 
cases. 117,147 Progression in the field is rapid, and a center for clinical genetics should 
be consulted to inform the patient about the latest developments and possibilities of 
antenatal diagnosis. Ultrasound examination does not allow a reliable diagnosis of 
fetal Marfan syndrome. 123,153,119 
Assisted reproduction with donor oocyte in vitro fertilization and embryo 
transfer procedures, or donor sperm if the partner is affected, may be considered to 
prevent an affected infant. The restricted availability of donor oocytes and the IVF-
associated risks of higher order multifetal gestation200•3lJ limit the practical 
applicability of these options. 
8.3.2. Medical alld obstetric care. 
The care of patients with Marfan syndrome is based on a multidisciplinary 
approach, and should take place in a third level hospital with cardiovascular 
facilities and expertise (C). 
Monitoring of cardiovascular function is the main concern in antenatal care. 
Serial echocardiography should be performed at a frequency depending on the 
degree of cardiovascular involvement and clinical condition. As a routine monthly 
echocardiographic examination is recommended; the procedure should be repeated 
once in the first week postpartum, and again once a month until 6 months after 
delivery (A)."" 
Hypertension is known to be an unfavorable factor in relation to dissection 
and care has to be taken to maintain normotension (A).I09.13I.152 Most authors of 
recent articles concerning pregnancy and the Marfan syndrome advise prophylactic 
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treatment with a beta-blocker in pregnant patients with the Marfan syndrome and an 
aortic diameter of 35 mm or more, at least from the midtrimester onward, because 
of the known increase in cardiovascular stress during pregnancy (B). 152,247.265,284 The 
beneficial maternal cardiovascular effects appear to outweigh the potential adverse 
effects for the fetus (bradycardia, hypoglycemia). 
Most acute dissections have been reported to occur in the late third trimester 
or thereafter, and for that reason it seems advisable not to prolong pregnancy 
unnecessarily and to counsel the woman to have labor induced at 38 weeks, in 
particular in cases with an aortic root diameter of 40 IlUll or more (C). 
Multifetal pregnancy is associated with a significantly higher cardiovascular 
load than singleton pregnancy. Triplet or higher order multifetal pregnancy in a 
Marfan patient may lead to severe cardiovascular complications260,323 and these 
patients are counselled to have selective reduction to singleton or twin pregnancy. If 
the patient is in good condition with an aortic root diameter of less than 40 nUll, the 
risk of significant morbidity in twin pregnancy seems to be not increased as 
compared with that in nonaffected women (C). 
There is no evidence that the spontaneous preterm delivery rate is increased 
in patients with the Marfan syndrome, and specific measures like prophylactic bed 
rest or cervical cerclage are not indicated (B). 
Pregnant women with Marfan syndrome are at a slightly increased risk of 
complaints of pelvic instability. If such complaints exist, the use ofa pelvic belt may 
be useful (C). 
In the majority of cases vaginal delivery can be accepted (A). Stabilization of 
blood pressure and cardiac output are important factors during delivery in patients 
with cardiovascular involvement. With epidural analgesia no hypertensive moments 
are observed and the cardiac afterload is reduced, which is a hemodynamic 
advantage.31I Continuous epidural infusion using a bupivacaine and opioid mix 
decreases the risk of hypotension and the degree of motor block, with minimal 
stimulation of the sympathic nervous system. 
In patients with moderate cardiovascular involvement, the prophylactic use 
of low vacuum or forceps extraction could be beneficial (C). When mitral prolapse 
or aortic regurgatation or other vascular or cardiac defects are present endocarditis 
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prophylaxis is recommended only in case of a complicated delivery or cesarean 
section (A)-' 
An episiotomy should be performed on the same indications as in patients 
without Marfan (C). The birth canal has to be inspected for unsuspected trauma to 
rectum or bladder. Although the Marfan syndrome is a connective tissue disorder, 
the incidence of complicated healing of perineal tears, episiotomy wounds or 
lacerations was not found to be increased compared with nonaffected controls. 
For patients with an aortic root diameter of 40 mm or more, or progressive 
dilatation, or cardiovascular limitations and a viable fetus, delivery by cesarean 
section seems to be the method of choice (C). Continuous intra-arterial measurement 
of blood pressure, central hemodynamic monitoring, continous ECG, and pulse 
oximetry are indicated in unstable hemodynamic conditions (A). 
Defective hemostasis and an abnormal uterine vascular wall structure as 
cause for severe postpartum hemorrhage in patients with the Marfan syndrome have 
been described in case reports. However, the incidence of postpartum hemorrhage 
in women with the Marfan syndrome appears to be similar to that in nonaffected 
women, and no special management of the third stage of labor is to be advised (B). 
There is general agreement in the literature to perform a cesarean section 
prior to aortic or cardiac surgery in a pregnant patient of more than 30-32 weeks 
gestational age (A). Before 26 weeks gestational age the fetus should not be 
delivered because chances of survival are minimal. Between 26 and 30-32 weeks 
there is a dilemma, which must be balanced against the risks of mother and fetus. In 
cases of surgery with an intrauterine living fetus hypothermia, and extreme 
hemodilution should be avoided, and the perfusion index should be kept above 3.0 
(C).21 
Doubt is expressed in the literature as to whether a uterine scar in a patient 
with the Marfan syndrome is as strong as in patients without a collagen disorder, but 
there is no clinical evidence to support or refute such doubts. For that reason it 
seems prudent to perform an elective repeat cesarean section in Marfan patients 
(C). 
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After delivery contraception should be discussed. The contraceptive pill, 
condoms, lUCD, and, if requested, sterilization are all possible methods in Marfan 
patients, and should be chosen on the same grounds as in the general population (B). 
The genetic risk of affected offspring and the risk of maternal complications 
indicates careful counseling to enable the woman and her partner to choose the 
contraception method with maximum efficiency. 
8.3.3. Neollatal Care. 
Neonatal care starts with careful assessment of a neonate (especially if at 
50% risk for the Marfan syndrome) by a pediatrician experienced with the Marfan 
syndrome205 • with evaluation of possible complications necessitating interventions, 
such as hypotonia, cardiac valve problems etc (A). The frequency of non-Marfan-
related anomalies is not increased. Follow-up appointments of affected children are 
essential, especially when there is a delay in motor development. Coordination with 
the pediatric cardiologist, orthopedic surgeon, ophthalmologist and the department 
of rehabilitational medicine may be essential to provide parents and child with a 
network of specialized care. 
8.4. Preconceptional assessment of risk and counseling of women with the 
Ehlers-Danlos syndrome 
8.4.1. Diagllosis. 
As in patients with the Marfan syndrome, diagnosis and typing are essential 
for proper risk assessment and counseling (A). The diagnosis is based on clinical 
recognition of the cardinal features of the syndrome; in some types biochemical or 
molecular analysis is possible. Not all types of EDS are associated with major 
complications; patients with type IV are at high risk of all kinds of complications, in 
particular rupture of all hollow organs.7I 
8.4.2. Clillical featllres. 
Preconceptional consultation of ophthalmologist and cardiologist is necessary 
(A). Retinal detachement and other ocular abnormalities have been described and 
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may have clinical implications for delivery e.g. an advice to abstain from pushing.41 
Mitral valve prolapse, conduction heart defects, and aneurysms occur and may have 
an impact on the course of pregnancy. 27 
Because of a significantly elevated risk of postpartum hemorrhage observed 
in our study and in the literature, screening for abnormal hemostasis should be done 
before pregnancy (B). In case of a prolonged bleeding t!tne or other abnormalities 
appropiate measures should be taken during delivery and the postpartum 
period.24,25,68,I43,178,217 
In case of assisted reproduction and hormonal ovarian stimulation the 
possibility of multifetal pregnancy and selective fetocide must be discussed. All four 
twin pregnancies of Ehlers-DanIos mothers in our study ended between 22-29 weeks 
of gestation. 
8.5. Medical alld obstetric care in women with the Ehlers-Danlos syndrome 
8.5.1. Alliellaial diagllosis. 
Most types of the EDS are autosomal dominant wit a 50% risk of an affected 
infant. In some types antenatal diagnosis is possible by DNA analysis (Type: IV, VI, 
Vll)30j , if affected relatives are available for investigation. In some families with 
EDS types I, II, and III the mutations in the collagen defect have been detected, and 
antenatal diagnosis may be offered for these families. 'J· l91,'15 Ehlers-Danlos patients 
are potentially more at risk for complications with invasive antenatal procedures 
(bleeding, rupture of membranes) (C), Assisted reproduction with donor oocytes, in 
vitro fertilization, and embryo transfer procedures, or donor sperm if the partner is 
affected offer a possibility to prevent of an affected infant. 
8.5,2, Medical alld obsletric care, 
The joint laxity is increased during pregnancy, and pelvic pain and instability 
during pregnancy were found in 26% of cases, in particular in types ll, III and IV 
(Chapter 7), Supportive therapy by means of a pelvic belt, or crutches may be 
recommended in such cases (C). There is no evidence that an elective cesarean 
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section will prevent the persistence of pelvic pain or instability after delivery 
(B). 11.2% 
Ruptures of vessels and bowels have been described during pregnancy in 
women with type IV EDS. Preeclampsia and other pregancy related disorders are 
not more frequently found than in a nonaffected population. 
Preterm delivery is the obstetric complication lllost often reported in the 
literature (20_25%),.25.315 , and confirmed in the study described in Chapter 6 with 
an incidence of 21 %. When the fetus is affected the preterm delivery rate is even 
more elevated (Chapter 6 and 7), usually due to spontaneous preterm rupture of 
membranes. Because of these figures it is advised to perform repeat cervical and 
vaginal cultures to assess the presence of infections and institute treatment if 
necessary, as in all patients at risk for preterm delivery (A). It is unlikely that 
cervical length measurements by vaginal ultrasound, or fibronectin determinations in 
pregnancies in which the Ehlers-Danlos syndrome is involved will have predictive 
value because the primary cause of preterm rupture of the membranes must most 
likely be sought in the fetal connective tissue abnormality (C). Since there is no 
evidence that cervical incompetence is involved, prophylactic cervical cerclage is 
not indicated (C). 
Consultation of the anesthesiologist before labor is indicated, because spinal 
or epidural analgesia carry a slightly increased risk of complications (leakage of 
spinal fluid, bleeding due to abnormal hemostasis, difficulties at insertion).1,82,10},242 
Because esophageal damage by applying cricoid pressure may occur321 and 
dislocations at intubation are described332 , the use of adequate doses of muscle 
relaxant to facilitate endotracheal intubation is indicated (C). 
As in women with the Marfan syndrome, it is advisable not to prolong 
pregnancy in patients with EDS unnecessarily, especially in type IV, in order to 
avoid exposure of the pregnant woman longer than necessary to a condition that may 
lead to complications as described in Chapter 4 and 6. Patients should be counselled 
to have labor induced at approximately 38 weeks (B). 
Vaginal delivery is the first option for all types of EDS. Although there tends 
to be agreement in the literature to perform an elective cesarean section in type 
IV70,232 , no complications occurred in 23 pregnancies with vaginal delivery in our 
115 
study and in that of Sorokin et aL 298 There are no parameters to predict intestinal or 
vessel ruptures, It is recommended that each case be considered individually and 
that in patients with EDS type IV cesarean section should be performed liberally 
(B), 
Endocarditis prophylaxis in cases complicated by mitral prolapse, or other 
cardiac abnormalities is indicated only in case of a complicated delivery or cesarean 
section (A).' The use of forceps may be hazardous, because of increased risk of 
damage to the birth canal. Vacuum delivery is believed to carry a smaller risk of 
perineal and vaginal tears compared to forceps delivery 129,139,201 and may therefore 
be recommended (C), However, if the fetus is affected there may be some risk of 
causing cephalic hematoma and skin lacerations with vacuum extraction; the use of a 
soft elastic cup could be an alternative. ISS 
An episiotomy should be applied for the same reasons as in women without 
EDS (C),343 Local analgesia is sometimes difficult to accomplish because of the 
abnormal subcutaneous structure.7,8 Surgical repair of perineal and vaginal lesions 
may be difficult because of pronounced tissue fragility and tearing of sutures, The 
use of DDA VP (1-desamino-8-D-argine vasopressine) in case of "EDS induced" 
abnormal hemostasis can be useful (C),1l7 Intravenous infusions should be handled 
with care in these patient; the infusion fluid may disperse easily subcutanously 
without being noticed (C), 
Care is indicated with regard to handling and ligation of the umbilical cord, 
and taping is advised instead of clamping (C),15,21 
It is emphasized in the literature that a cesarean section in a woman with the 
Ehlers-Danlos syndrome may need adaptation of surgical techniques due to the 
different tissue qualities,'" Indeed, surgical complications such as iatrogenic bowel 
ruptures and relaparotomies for bleeding are described in the literature332.342, but not 
in relation to cesarean sections. In the study described in Chapter 6, only two cases 
of secondary wound healing and one case of wound infection were found after 
cesarean section. There is no convincing evidence that surgical techniques and 
suture materials in pregnant patients with EDS undergoing a cesarean section should 
be different from appropiate techniques in nonaffected women (C), 
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The quality of the scar in the uterus may be less after a cesarean section in a 
patient with the Ehlers-Danlos syndrome; however, it remains speculative if a repeat 
cesarean section should be performed, or spontaneous vaginal delivery may be 
accepted (C). 
As in patients with the Marfan syndrome, the risks of maternal complications 
and the genetic risk of affected offspring require careful counseling of the patient 
with EDS and her partner with regard to contraception. The choice of a 
contraceptive method should be based on the same grounds as in the general 
population (B). An ruCD should be carefully placed in patients with EDS type IV. 
Menorrhage is a frequent complaint in Ehlers-Danlos patients'98 and the use of the 
new ruCD's with slow progesteron release could be a solution to that problem. No 
reports on subcutanous progesteron implants are available, but theoretically these 
should be avoided considering the (sub)cutanous abnormalities found in patients with 
the EDS. 
8.5.3. Neol/alai care. 
As in the Marfan syndrome, assessment of the neonate should be done by an 
experienced pediatrician (A). Some congenital defects which may be related to the 
syndrome, such as clubfoot or diaphragmatic hernia have been reported. Most types 
of EDS are autosomal dominant with a 50% risk of the baby to be affected. Signs of 
the Ehiers-Daillos syndrome are often not clear in newborns, and longterm pediatric 
follow-up is warranted (A). A floppy infant syndrome is found in about 15% of the 
cases (Chapter 7) if the newborn is affected and must be differentiated from other 
conditions. A multidisciplinary network of specialized medical care for these 
children is advisable. 
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SUMMARY 
In CHAPTER ONE an introduction is presented to the Marfan and Ehlers-Danlos 
(EDS) syndromes. Both syndromes are rare, inheritable, and result from 
multisystem connective tissue disorders. Pregnancy affects the signs, symptoms, and 
complications of these disorders, and the syndromes may affect the course and 
outcome of pregnancy. The paucity and potential selection and publication bias of 
data in the pertinent literature preclude adequate preconceptional assessment of risk 
and counseling, and of optimum medical and obstetric care of pregnant \Vomen with 
these syndromes. The membership of the Dutch Marfan and Ehlers-Danlos 
Associations offers an opportunity to collect data and analyze the relationship 
between these syndromes and pregnancy. The following objectives of the thesis are 
formulated: 
To review the literature on the Marfan syndrome and EDS, in particular in 
relation to obstetric aspects and the neonate. 
To assess the course and outcome of pregnancies in women with Marfan and 
EDS, based on data obtained from the membership of the Dutch patient 
associations. 
To formulate guidelines for preconceptional assessment of risk and for medical 
and obstetric care of pregnant women with these syndromes. 
In CHAPTER TWO the historical aspects, prevalence, and genetics of both 
syndromes are discussed. The biology of connective tissue is presented, including 
the synthesis and breakdown of collagen, and theories of the pathogenesis of both 
syndromes are discussed. The Marfan syndrome is caused by a defective fibrillin 
gene (FBN-l) causing deficient cross-linking of collagen fibers; EDS is mainly due 
to cnzymr defcct~ or mutations in collagen genes causing alterations in the 
morphology 01 collagen fibers. Diagnosis of the Marfan and Ehlers-Danlos 
syndromes is based on clinical signs and symptoms, and on the pattern of 
inheritance, and may sometimes be supported by molecular analysis of collagen. In 
the EDSdifferent types are recognized. Because of the important medical and 
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obstetric consequences it is essential that a correct diagnosis is made before 
pregnancy. 
In CHAPTER THREE the literature regarding the Marfan syndrome and 
pregnancy is reviewed. The Marfan syndrome is due to an inheritable autosomal 
dominant disorder of the connective tissue with a 50% risk of the fetus to be 
affected. Possibilities for antenatal diagnosis are emerging by means of DNA-
linkage and mutation analysis. The main complication in women with the Marfan 
syndrome in pregnancy is aortic dissection. Pregnancy affects the arterial 
vasculature and the therapeutic options in case of dissection are presented. A 
thorough search of the literature revealed three articles describing series of patients 
with 240 evaluable pregnancies, and 57 case reports covering 99 evaluable 
pregnancies. The incidence of severe cardiovascular events in the patient series was 
3-7% compared with 50% in the case reports. The case reports may be biased 
because a dramatic event was usually the reason for publication. An aortic diameter 
of 40 mm or more. progression of dilatation. and preconceptionai cardiovascular 
compromise are reported as risk factors for cardiovascular events in pregnancy. 
Other complications related to the Marfan syndrome are rare in pregnancy. Case 
reports show a high incidence of preterm delivery, but serial studies do not. The 
incidence of other obstetric complications seems to be similar to that in a general 
population of pregnant women. 
In CHAPTER FOUR the literature regarding the Ehlers-Danlos syndrome (EDS) 
and pregnancy is reviewed. The classification in nine different types as used before 
1997 was applied. Like Marfan's syndrome the EDS results from an inheritable 
connective tissue disorder, autosomal dominant in most cases. Antenatal diagnosis is 
possible for certain types and families by means of DNA-linkage and mutation 
analysis. A few patient series were found with 158 evaluable pregnancies, and 44 
case reports describing 70 evaluable pregnancies. A 25% maternal mortality rate for 
type IV EDS patients reported in one series of patient~ wa::- nol confirmed in other 
series. Major complications like uterine rupture and rupture of major blood vessels 
occurred only in type IV or unknown types of EDS. Complaints of joint laxity and 
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pelvic instability appeared to increase in pregnancy. The preterm delivery rate was 
increased (25 - 32%), in part iatrogenic, and the cesarean section rate was high 
(44%), mainly due to elective abdominal delivery because of the condition of the 
mother. Postpartum hemorrhage was reported in 14 % and complications of 
lacerations of the birth canal in 12% of cases. Neonatal outcome appeared to be 
mainly determined by the gestational age at delivery. 
In CHAPTER FIVE a retrospective study is presented, designed to collect data 
regarding pregnancy, delivery, the neonate and the postpartum period in women 
with the Marfan syndrome in an attempt to develop guidelines for preconceptional 
assessment of risks and counseling, and for providing optimum medical and 
obstetric care. Patients were recruited from the Dutch Marfan Association. Thirty-
eight affected women with 78 evaluable pregnancies beyond 24 weeks gestational 
age were collected, and data concerning the course and outcome of pregnancy were 
analyzed. A second group of 44 nonaffected women with 51 evaluable pregnancies 
beyond 24 week served as controls. Possible bias resulting from this study design 
are discussed in detail. Aortic dissection was observed in five patients (4,5%); all 
mothers and infants survived. Two patients were known to have the Marfan 
syndrome, three women had an aortic root diameter of 40 mm Of more before 
pregnancy. Two neurovascular events were recorded, a complication not previously 
reported in the literature in relation to pregnancy. The fmdings in this study support 
previously reported risk factors for severe cardiovascular events in pregnancy, in 
particular an aortic root diameter of 40 mm or more. Pelvic pain and instability was 
found in 8 % of the pregnancies of Marfan mothers and not in the control group. 
The obstetric course and outcome of pregnancy were similar in both groups. 
In CHAPTER SIX a similar study is presented concerning pregnancy and the 
Ehlers-Danlos syndrome (EDS). Patients were recruited from the Dutch Ehlers-
Danlos Association. Forty-six affected women with 128 evaluable pregnancies 
heyond 24 week~ were collected. and data concerning course and outcome of 
pregnancy analyzed. A second group of 33 nonaffected women with 43 evaluable 
pregnancies, who gave birth to one or more affected infants, served as controls. The 
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possible role of bias introduced by this study design is discussed. Ruptures of blood 
vessels or of the uterus were not reported in the patient group, but ODe woman with 
EDS type IV had a bowel rupture. Pelvic instability occurred in 25 % of pregnancies 
in women with EDS compared with 7% in controls. Only in women with EDS type 
IVan elevated abortion rate was found (26%). The preterm delivery rate was 21 % 
in EDS pregnancies, and 40% in controls; spontaneous preterm rupture of the 
membranes occurred in half the number of pregaucies with an affected fetus. 
Postpartum hemorrhage occurred in 19% and complicated lacerations of the birth 
canal in 8% of pregnancies in women with EDS, as compared with 7% and 0%, 
respectively, in controls. 
In CHAPTER SEVEN the neonatal outcome is reported of the pregnancies of the 
groups discussed in Chapters 5 and 6. Hundred and three infants with the Marfan 
syndrome, and 91 newborns with the EDS were included. Fourteen nonaffected 
infants of mothers with the Marfan syndrome and 55 nonaffected infants of mothers 
with the EDS were recorded. The neonatal outcomes of newborns of affected and 
nonaffected mothers, and the outcomes of affected and nonaffected newborns were 
compared. In the Marfan group small-far-gestational age was observed slightly more 
often in affected infants of affected mothers than in those of nonaffected women. 
The floppy infant syndrome occurred in 6% of the affected newborns. The incidence 
of preterm birth in infants with the EDS (31 %) was significantly higher than that in 
nonaffected infants (l3cr£). The preterm birth was usuall) ~aused by spontaneou!' 
rupture of the fetal membranes, which may be due to the abnormal connective 
tissue. The floppy infant syndrome was present in 13 % of the Ehlers-Danlos 
newborns. Few congenital or acquired defects were observed in infants with the 
Marfan or Ehlers-Danlos syndrome. The diagnosis of these syndromes in newborns 
is often difficult, and longtime follow-up is warranted for infants born to mothers 
with Marfan or EOS or with a father with one of the syndromes. 
In CHAPTER EIGHT conclusions are presented and recommendations and 
guidelines for preconceptional assessment of risk, counseling, and medical and 
obstetric care are proposed. In women with the Marfan syndrome assessment of the 
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cardiovascular status and evaluation of other clinical signs and symptoms in relation 
to the syndrome is essential. Guidelines for management of obstetric and medical 
care are formulated. An event-free pregnancy and delivery can never be guaranteed, 
but the risk of aortic dissection appears to be small in women with an aortic root of 
less than 40 mm, and no progression of dilatation. There is no evidence of an 
elevated incidence of obstetric complications in women with the Marfan syndrome. 
Only in EDS type IV or women with type unkown severe complications in 
pregnancy are described, like bowel and vessel ruptures. Preterm delivery, joint 
laxity, pelvic instability, laceratioll5 of the birth canal and postpartum hemorrhage 
are important complications of pregnancies of women with all types of EDS. The 
choice of anticonception must be well considered in women with these inheritable 
connective tissue disorders. The optimum preconceptional, antenatal and perinatal 
care of women with the Marfan or Ehlers-Danlos syndrome requires adequate 
counseling and a multidisciplinary approach to the surveillance and management of 
pregnancy, delivery, the postpartum period, and the newborn. 
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SAMENV ATTING 
In HOOFDSTUK EEN wordt eell inleiding gegeven over de syndromen van 
Marfan en Ehlers-Danlos (EDS). Beide syndromen zijn zeldzaam, erfelijk, en 
berusten op een afwijking in het bindweefsel. Zwangerschap heeft invloed op de 
k1inische verschijnselen van de syndromen en omgekeerd kunnen de syndromen 
invloed hebben op het verloop en uitkomst van de zwangerschap. In de literatuur is 
over deze onderwerpen betrekkelijk weinig te vinden en wat beschikbaar is, is niet 
altijd betrouwbaar tengevolge van selectieve verzameling en publicatie van 
gegevens. Daardoor is cell juiste scilatting van het risico van zwangerschap en 
preconceptioneel zwangerscbapsadvies tcn aanzien van antenatale diagnostiek en 
verloskundige zorg niet goed mogelijk. Het bestaan van de Contactgroep Marfan en 
de Vereniging van Ehlers-Danlos patienten biedt een gelegenheid om gegevens over 
zwangerschap en beide syndromen te verzamelen en te analyseren. 
Dit heeft geresulteerd in de volgende doelstellingell van dit proefschrift : 
Een overzicht gevell van de literatuur betreffende de syndromen van Marfan en 
Ehlers-Danlos, vooral met betrekking tot zwangerschap, bevalling, kraambed en 
de pasgeborene. 
Het analyseren van het verloop en de uitkomst van zwangerschappen van 
vrouwen met het syndroom van Marfan of Ehlers-Danlos, met behulp van 
gegevens verkregell van de leden van de Contactgroep Marfan en de Vereniging 
van Ehlers-Danlos patienten. 
Het opstellen en formuleren van aanbevelingcll en richtlijnen voar het 
preconceptioneel vaststellen van risicofactoren en het geven van zwangerschaps-
advies met betrekking tot de medische en verloskundige zorg aan vrouwen met 
deze syndromen. 
In HOOFDSTUK TWEE worden de historische aspecten, de prevalentie en de 
erfelijkheid van beide syndromen besproken. De synthese en afuraak van collageen 
en de pathogenese van beide syndromen worden toegelicht. Het syndroom van 
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Marfan wordt veroorzaakt door een defect in het fibrilline-gen (FBN-l) resuIterend 
in onvoldoende cross-linking van collageenvezels; bij het EDS is er sprake van 
enzym stoornissen of mutaties van collageen genen met als gevolg veranderingen in 
de morfologie van de collageenvezels. De diagnose van het syndroom van Marfan 
en EDS wordt gesteld door middel van lichamelijk onderzoek en erfelijkheids-
patroon, en kan 80ms worden bevestigd door laboratoriumdiagnostiek van collageen. 
Het syndroom van EDS kent verschillende typen. Het stellen van de diagnose van 
deze syndromen v66r de zwangerschap is belangrijk, gezien de consequenties voor 
de medische en verlosknndige zorg. 
In HOOFDSTUK DRIE wordt de literatuur betreffende het syndroom van Marfan 
en zwangerschap besproken. Het syndroom van Marfan berust op een autosomaal 
dominant erfelijke aandoening van het bindweefsel met een 50% risico dat de foetus 
is aangedaan. In sonllnige families is antenatale diagnostiek mogelijk door lniddel 
van DNA-linkage en mutatie analyse. De belangrijkste complicatie is dissectie van 
de aorta. De effecten van de zwangerschap op het arteriele vaatstelsel worden 
besproken en de therapeutische mogelijkheden in geval van een dissectie van de 
aorta worden aangegeven. Een uitgebreid literatuuronderzoek leverde drie artikelen 
op waarin een serie patienten wordt beschreven met 240 evalueerbare 
zwangerschappen en 57 artikelen met casuistische mededelingen. waarin 99 
zwangerschappen konden worden geevalueerd. De incidentie van ernstige 
cardiovasculaire complicaties in de grotere onderzoeken was 3-7 % vergeleken met 
50% in de casuistische artikelen. Meestal was het voorkomen van een dissectie van 
de aorta de reden VODr het schrijven van het arlike!. Een aortadiameter van 40 mm 
of meer, progressie van de aortadilatatie en verminderde hartfunctie worden 
genoemd als risicofactoren voor het ontstaan van cardiovasculaire complicaties 
tijdens de zwangerschap. bevalling en kraambed. Andere ernslige complicaties met 
betrekking tot het syndroom van Marfan tijdens de zwangerschap zijn zeldzaam. De 
artikelen waarin casuistiek wordt beschreven, geven een hoge incidentie van 
vroeggeboorte; dit werd niet in de onderzoeken van grotere groepen patienten 
bevestigd. De incidentie van overige obstetrische complicaties lijkt niet anders te 
zijn dan die in de algemene populatie van zwangeren. 
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In HOOFDSTUK VIER wordt de literatuur betreffende het syndroom van Ehlers-
Danlos (EDS) en zwangerschap besproken. In dit overzieht wordt de indeling in 
negen typen, zoals gehanteerd voor 1997, aangehouden. Het syndroom van EDS 
berust op een meestal autosomaal dominate erfelijke bindweefselziekte. Antenatale 
diagnostiek is voor sonunige typen en families mogelijk door middel van DNA-
linkage en mutatie analyse. Er werden enkele publicaties gevonden, waarin cen serie 
patienten beschreven wordt met in totaal 158 evalueerbare zwangerschappen, en 44 
casulstische mcdedeJingen met 70 evalueerbare zwangerschappen. In een onderzoek 
van zwangeren met EDS type IV, wordt een maternale sterfte van 25% genoemd, 
maar dit mortaliteitscijfer wordt in de andere onderzoeken met grotere groepen 
patienten niet bevestigd. Darmrupturen, het scheuren van grote bloedvaten en 
uterusrupturen zijn de meest belangrijke complicaties die werden gevonden in het 
literatuuronderzoek. Deze complicaties kwamen aIleen voor bij vrouwen met type 
IV of een onbekend type. Klachten van bekkeninstabiliteit en gewrichtsklachten 
leken te verergeren tijdens zwangerschap. In de verzamelde casulstische mededelin-
gen was het percentage vroeggeboorten 25 - 32 %, deels tengevolge van medisch 
ingrijpen, en het sectio percentage 46, voornamelijk tengevolge van slechte conditie 
van de zwangere. Ernstige nabloedingen werden gezien in 14 % van de bevallingen, 
hematomen, uitgebreide rupturen en gestoorde wondgenezing in 13 %. De 
zwangerschapsduur bepaalde in hoofdzaak de toestand van de pasgeborenen. 
In HOOFDSTUK VIJF wordt een retrospectief onderzoek besproken, ctat werd 
verricht om gegevens te verzamelen betreffende de zwangerschap, de bevalling, de 
pasgeborene en het kraambed bij vrouwen met het syndroom van Marfan, met als 
doel risieofactoren te bepalen, en richtlijnen op te stellen voor preconceptioneel 
zwangerschapsadvies en begeleiding van zwangerschap en baring. Hiervoor werden 
leden benaderd van de vereniging Contactgroep Marfan Nederland. Na 
inventarisatie konden 78 zwangerschappen van meer dan 24 weken bij 38 aangedane 
vrouwen worden geevalueerd. Een tweede groep van 44 gezonde vrouwen met 51 
evalueerbare zwangerschappen met cen zwangerschapsduur van meer dan 24 weken 
diende als controlegroep. De mogeJijk gejntroduceerde bias door deze opzet van het 
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onderzoek wordt uitvoerig besproken. Bij vijf patienten trad een dissectie van de 
aorta op (4,5%); aUe moeders en kinderen bleven in leven. Van twee patienten was 
illet bekend dat ze het syndroom van Marfan hadden en drie hadden Vaal" de 
zwangerschap een aortadiameter van 40 rum. of meer. Twee vrouwen maakten een 
cerebraal vasculair accident door. Dit laatste is ruet eerder beschreven bij zwangeren 
met het syndroom van Marfan. De resultaten van dit onderzoek steunen de in de 
Iiteratuur genoemde risicofactoren, met als belangrijkste risko een aortadiameter 
van 40 mOl of meer. Bekkeninstabiliteit en pijn kwam bij 8 % van de moeders met 
het syndroom van Marfan voor en bij geen van de gezonde moeders. Verloop en 
uitkomst van de zwangerschap waren in beide groepen gelijk. 
In HOOFDSTUK ZES wordt een identiek onderzoek beschreven, maar dan met 
betrekking tot het Ewers-Danlos syndroom. Leden van de Nederlandse Vereniging 
van Ehlers-Danlos patienten werden benaderd voor dit onderzoek. Van 46 vrouwen 
konden 128 zwangerschappen van meer dan 24 weken worden geevalueerd. Een 
tweede groep van 33 niet-aangedane vrouwen, die een of meer aangedane kinderen 
hadden gekregen, werd gebruikt als controle. Eventuele bias ontstaan door de opzet 
van het onderzoek wordt besproken. In de patientengroep kwamen geen rupturen 
van uterus of bloedvaten voor, maar bij een vrouw met type IV trad een darmrup-
tuur op. Bekkeninstabiliteit en ernstige gewrichtsklachten werden in 25 % van de 
zwangeren met EDS gevonden, vergeleken met 7% in de controle groep. Aileen bij 
de vrouwen met EDS type IV werd een verhoogd percentage lillskramen gevonden 
(26%). Vroeggeboorte kwam in 21 % van de gevaUen voor bij EDS 
zwangerschappen en in 40% in de controle groep; spontane voortijdige vliesscheur 
kwam voor bij de helft van aUe zwangerschappen met een aangedaan kind. Ernstige 
nabloedingen traden bij 19% van de bevaUingen van zwangeren met EDS op en bij 
8 % van de vrouwen ontstond een gecompliceerde ruptuur van het baringskanaal, 
vergeleken met respectievelijk 7 en 0 % in de controle groep. 
In HOOFDSTUK ZEVEN worden de bevindingen vergeleken en besproken bij 
ruet-aangedane en aangedane kinderen geboren uit de zwangerschappen beschreven 
in de hoofdstukken 5 en 6. Er werden 103 kinderen met het syndroom van Marfan 
128 
geboren en 91 met EDS. Veertien gezonde kinderen van Marfan moeders werden 
geregistreerd en 55 gezonde kinderen van EDS moeders. De kinderen van de 
moeders met Marfan werden vergeleken met de kinderen van de moeders die geen 
Marfan hadden. Tevens werden de aangedane kinderen vergeleken met de gezonde 
of mogelijk aangedane kinderen. Dezelfde analyse werd uitgevoerd bij de groep met 
EDS. In de groep van Marfan-kinderen werd wa! vaker een te laag geboortegewicht 
vastgesteld, indien de moeder eveneens was aangedaan. Het "floppy infant" 
syndroom kwam in 6 % van de pasgeborenen met het syndroom van Marfan voor. 
De incidentie van vroeggeboorte was bij kinderen met EDS (31 %) significant hoger 
dan bij de niet-aangedane kinderen (13%). De vroeggeboorte was meestal het 
gevolg van vroegtijdig breken van de vliezen, wat te maken kan hebben met een 
abnormale bindweefselstructuur. Het "floppy infant" syndroom werd bij 13% van 
de EWers-Danlos pasgeborenen gevonden. In alle groepen, Marfan syndroom en 
EDS, kwamen enkele aangeboren en verworven afwijkingen voor. Het vaststellen 
van de diagnose Marfan of EDS syndroom is vaak niet direct na de geboorte 
mogelijk. Consultatie van de kinderarts, langdurige follow-up en eventuele 
multidisciplinaire specialistische medische zorg is belangrijk voor kinderen van 
moeders of vaders met het syndroom van Marfan en EDS. 
In HOOFDSTUK ACHT worden de resultaten van de onderzoeken samengeva!, en 
worden conc1usies getrokken, richtlijnen voorgesteld en aanbevelingen gegeven voor 
preconceptionele schatting van risico's, zwangerschapsadvisering en medische en 
obstetrische zorg. De cardiovasculaire toestand is bij vrouwen met het syndroom 
van Marfan zeer belangrijk. Een ongestoord verloop van de zwangerschap en 
bevalling kan nooi! worden gegarandeerd, maar de kans op cardiovasculaire 
problemen lijkt gering als de aorta diameter kleiner is dan 40 mm en er geen 
progressie van dilatatie is. Er zijn geen aanwijzingen dat het voorkomen van 
obstetrische complicaties bij vrouwen met het syndroorn van Marfan verhoogd is. 
Bij vrouwen met EDS kUlmen bij type IV ernstige complicaties in de zwangerschap 
voorkomen, zoals darm- en vaatrupturen. Vroeggeboorte, gewrichtsklachten, 
bekkeninstabiliteit, scheuren van het baringskanaal en nabloedingen vormen de 
voornaamste problemen tijdens zwangerschap en bevalling van vrouwen met EDS. 
129 
Anticonceptie verdient zeker aandacht bij vrouwen met deze erfelijke 
bindweefselaandoening. Optimale preconceptionele, antenatale en perinatale zorg 
voor vrouwen met het Marfan of Ehlers-Danlos syndroom vereist goede counseling 
en een multidisciplinaire benadering van de begeleiding van zwangerschap, baring, 
kraambed en pasgeborene. 
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Appendix I 
Diagnostic manifestations of the Marfan syndrome according to the Berlin 
nosology meeting (1986)" 
(Listed in approximate order of decreasing specificity), 
Major manifestations indicated by an asterisk (* ), 
Skeletal anterior chest deformity ,especially asymetric 
pectus excavatum I carinatum 
Ocular 
Cardiovascular 
Pulmonary 
Skin and integument 
dolichostenomelia not due to scoliosis 
arachnodactyly 
vertebral column deformity 
scoliosis 
thoracic lordosis or reduced thoracic kyphosis 
tall stature, especially compared to unaffected 10 
relatives 
high, narrowly arched palate and dental crowding 
protrusio acetabulae 
abnormal appendicular joint mobility 
congenital flexion contractu res 
hypermobility 
ectopia lentis * 
flat cornea 
elongated globe 
retinal detachement 
myopia 
dilatation of the ascending aorta * 
mitral regurgitation due to mitral valve prolapse 
calcification of the mitral annulus 
aortic dissection * 
aortic regurgitation 
mitral valve prolapse 
abdominal aortic aneurysm 
dysrhythmia 
endocarditis 
spontaneous pneumothorax 
apical bleb 
striae distensae 
inguinal hernia 
other hernia (umbilical,diaphragmatic,incisional) 
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Celltl'alllerVous system 
Genetics: 
lumbosacral meningocele 
dural ectasia * 
dilatated cisterna magna 
learning disability (verbal-performance 
discrepancy) 
hyperactivity with or without attention deficit 
disorder 
autosomal dominant inheritance 
25-30% of cases are sporadic; paternal age effect 
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Appendix 2 
Revised diagnostic criteria of the Marfan syndrome (1996)" 
A major criterion is one that carries a high diagnostic specificity, because it is 
relatively infrequent in other conditions and in the general population. 
Skeletal system 
i\1ajor criteria: Presence of at least 4 of the foHowing manifestations. 
pectus carinatum 
pectus excavatum requiring surgery 
reduced upper to lower segment ratio or arm span-to-height ratio greater than 1.05 
wrist and thumb signs 
scoliosis of more than 20, or spondylolisthesis. 
reduced extension of the elbows « 170,) 
medial displacement of the medial malleolus causing pes planus 
protusio acetabulae of any degree (ascertained on radio graphics) 
Minor criteria 
pectus excavatum of moderate severity 
joint hypermobility 
highly arched palate with crowding of teeth 
facial appearance (dolichocehaly, malar hypoplasia, enophthalmos, retrognathia, 
down-slanting palpebral fissures) 
For the skeletal system to be considered involved, at least 2 components comprising the 
major criterion or one component comprising the major criterion plus 2 of the minor 
criteria must be present. 
Ocular system 
Major criteria 
ectopia lentis 
Millor criteria 
abnormal flat cornea (as measured by keratometry) 
increased axial length of globe (as measured by ultrasound) 
hypoplastic iris or hypoplastic ciliary muscle causing decreased miosis 
For the ocular system to be involved, at least 2 of the minor criteria must be present. 
161 
Cardiovascular system 
Major criteria 
dilatation of the ascending aorta with or without aortic regurgitation and involving 
at least the sinuses of Valsalva 
dissection of the ascending aorta 
Minor criteria 
mitral valve prolapse with or without mitral valve regurgitation 
dilatation of the main pulmonary artery. in the absence of valvular or peripheral 
pulmonic stenosis or any other obvious cause, below the age of 40 years 
calcification of the mitral annulus below the age of 40 years 
dilatation or dissection of the descending thoracic or abdominal aorta below the age 
of 50 years 
For the cardiovascular system to be involved a major criterion or only one of the minor 
criteria must be present 
Pulmonary system 
Major criteria 
none 
Millor criteria 
spontaneous pneumothorax 
apical blebs (ascertained by chest radiography) 
For the pulmonary system to be involved one of the minor criteria must be present. 
Skin and intugement 
Major criteria 
none 
Minor criteria 
striae atrophicae not associated with marked weight changes, pregnancy or 
repetitive stress 
recurrent or incisional herniae 
For the skin and intugement to be involved one of the minor criteria must be present. 
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Dura 
Major criteria 
lumbosacral dural ectasia by CT or MRI 
Minor criteria 
none 
For the dura to be involved the major criterion must be present. 
Family I Genetic History 
Major criteria 
having a parent, child, or sib who meets these diagnostic criteria independently 
presence of a mutation in FBN 1 known to cause the Marfan syndrome 
presence of a haplotype around FBN I, inherited by descent, known to be associated 
with unequivocally diagnosed Marfan syndrome in the family 
Millor criteria 
none 
For the family/genetic history to be contributory, one of the major criteria must be 
present. 
Requirements of the diagnosis of the Marfan syndrome 
For the index case 
if the family/genetic history is not contributory major criteria in at least 2 different 
organ systems and involvement of a third organ system 
jf a mutation known to cause Marfan syndrome in others is detected, one major 
criterion in an organ system and involvement of a second organ system. 
For a relative of all tllde.r case 
presence of a major criterion in the family history and one major criterion in an 
organ system and involvement of a second organ system 
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Appendix 3 
Cardinal and additional featnres of the Ehlers-Danlos syndrome 
Skin manifestations 
The clinical signs of the skin concern a different structure and appearance, 
abnormal scarring, hyperextensibility. and fragility. 27,305 
The skin is often pale, thin, smooth, soft with a doughy feel. The forehead shows scars 
as remoants from early childhood, the nose is crooked with a soft cartilage, and the 
patient has crowded teeth and lop sided, floppy ears. 
CutaneOlls hyperextensibility. Skin and mucosa are elastic, they extend easily and snap 
back after release. The skin seems loosely attached to the subcutaneous tissues, and 
when traction is applied there is a sensation of the skin "coming awayH. This is 
particular striking over areas such as the thenar, and other parts of the body where the 
skin is usually tightly fixed. 
Curaneolls fragility. Splitting of the dermis or mucosa following relatively minor 
trauma, mainly over pressure points (knees, elbows) and areas prone to trauma. The 
wounds often present a gaping Hfish-mouth lf appearance with protruding subcutaneous 
fat lobules, and usually bleed little because the edges retract due to the elasticity of the 
adjacent skin, thereby compressing the ends of the blood vessels. Stitches may hold 
poorly, because the thread cuts through the skin, and dehiscence may occur; wound 
healing per se is delayed." Stretching of scars after apparently succesful primary 
wound healing is a characteristic of all EDS types; the scars become wide, thin and 
shiny, with a "cigarette paper" , or "burn scar" -like appearance. 
Hematoma and bruising. 
Easy occurrence of hematoma and bruising. When the correct diagnosis is not 
made, the bleeding tendency may lead to an extensive search for a coagulopathy. 
Molluscoid pseudotumors and spheroids are frequently found and probably develop 
through frequent microtrauma and bleeding. Spheroids are small, cyst-like, hard shot-
like nodules, freely movable in the subcutis over the bony prominences of the legs and 
arms. 
Hyperextensibility and dislocations of the joints 
Joint laxity is usually generalized, affecting both large and small joints and is 
often noted for the first time when the child starts to walk.2& Occasional or habitual 
dislocation of the patella, shoulder, hip, radii, and clavicles is common,21,305 
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COllllective tissue fragility 
In addition to the features discussed above, the connective tissue fragility shows 
itself in a variety of manifestations. 
Gastrointestinal manifestations. Constipation is a common complaint. Inguinal and 
umbilical hernias are frequent and may recur after surgical correction. Femoral, 
incisional, hiatal, and diaphragmatic herniae, or even eventration of the diaphragm, 
have been reported. 24 Gastric, duodenal, jejunal, and colonic diverticula may lead to 
bleeding or perforation and chronic abdominal pain. 97,1I6,190,278.286 
Neuromuscular manifestations, Muscular hypotonia in the newborn, especially when it 
is preterm, is a frequent finding in EDS. It may be so severe, especially in EDS VI, 
that affected infants cannot be breast-fed and need teats with large holes. 30' 
Cardiovascular manifestations. Structural cardiac malformations are rare, but mitral 
valve and tricuspid valve prolapse are not. 248 Tortuosity of the aorta and its major 
thoracic divisions, including the coronary arteries, and peripheral pulmonary stenose, 
aneurysm of the sinus Valsavae, aortic root dilatation, and dissection of the aorta, have 
been observed.248 Spontaneous rupture of large arteries and the occurrence of intra-
cranial aneurysms and arteriovenous fistulae are characteristic of EDS IV, but may 
occur also in EDS 1.52.59.190,215,279.283 
OClllar manifestations. A variety of abnormalities has been described, such as blue 
sclerae, strabismus, myopia, keratoconus, subluxation of the lens, retinal detachement, 
and retinal proliferatioll due to hemorrhage. 41 ,223 
Additional manifestations. Hemoptysis, hematothorax, and spontaneous and recurrent 
(hemato)pneumothorax with or without mediastinal and subcutaneous emphysema (type 
IV), and tracheobronchiomegaly have been reported to occur in patients with EDS. The 
teeth are often crowded. The Gorlin sign, i.e., the ability of the patient to extend the 
tongue to the tip of the nose, is more amusing than specific; 50 % of EDS patients have 
this ability compared with 10% of controls. 30' 
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Appendix 4 
Simple clinical screening test for the diagnosis of the EDS'18 
1) joint hypermobility 
(for each item 1 point) 
dorsalflexion of the pink > 900 
passive opposition of the thumb to the underarm 
hyperextension of the elbow > 100 
forward flexion of the body,with stretched legs, and the palms of the hand on 
the floor 
hyperextension of the knee> 100 
2) skin elasticity 
pulling the skin in the middle of the stretchside of the underarm 
Points Lifted skin 
o < 4cm 
I 4 cm 
2 5 em 
3 6cm 
4 7cm 
5 8 em or more 
3) "cigarette paperll, scarred skin at : 
(I point for each item) 
a. left elbow and underarm 
b. right elbow and underarm 
c left knee 
d. right knee 
e. forhead 
4) bl'Uising 
Points 
a. 0 
condition 
no history 
b. 1 
c. 2 
light bruising, no clinical evidence 
bruising (moderate) 
d. 3 
e. 4 
f. 5 
bruising (moderate at clinical examination) 
conspicious bruising 
very conspicious bruising 
A score of 7 or more gives 99 % odds of the presence of EDS 
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Appendix 5 
New classification of tbe EWers-Danlos syndrome according to tbe nosology 
meeting in Villefrancbe (1997)" 
1. Classic type (autosomal dominant): 
Major criteria: 
skin hyperextensibility; widened atrophic scars; joint hypermobility 
l\-1illor criteria: 
smooth, velvety skin; molluscoid pseudotumors; subcutaneous spheroids; 
complications of joint bypermobility; muscle hypotonia; easy bruising; 
manifestations of tissue fragility and extensibility; surgical complications. 
Laboratory tests: 
abnormal electrophoretic mobility of tbe pro-al(V) or pro-a2(V) chains of collagen 
V. A " cauliflower" deformity of collagen fibrils by electron microscopy. 
2. HyperIDobility type (autosomal dominant): 
Major criteria: 
skin involvement; generalized joint hypermobility. 
Millor criteria: 
recurrent joint dislocations; chronic joint/limb pain 
Laborato/y tests: 
none 
3. Vascular type (autosomal dominant): 
Major criteria: 
thin, translucent skin; arterial and intestinal ruptures; extensive bruising; 
characteristic facial appearance. 
Millor criteria: 
acrogeria; hypermobility of small joints; clubfoot; varicose veins; arteriovenous 
and carotid-cavernous sinus fistula; pneumothorax; gingival recession. 
Labomto/y tests: 
abnormal collagen type III 
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4. Kyphoscoliosis type (autosomal recessive): 
Major criteria: 
generalized joint laxity; severe muscle hypotonia at birth; scoliosis at birth; scleral 
fragility and rupture of ocular globe. 
MillOI' criteria: 
tissue fragility; easy bruising; arterial rupture; marfanoid habitus; microcornea; 
osteopenia. 
LaboratOlY tests: 
measurement of total urinary hydroxylysyl pyridinoline and of cross links of lysyl 
pyridinoline after hydrolysis; determination of lysyl hydroxylase activity in 
fibroblasts. 
5. Arthrochalasia type (autosomal dominant): 
Major criteria: 
severe generalized joint hypermobility congenital hip dislocations. 
Minor criteria: 
skin hyperextensibility; tissue fragility; easy bruising; muscle hypotonia; 
kyphoscoliosis; osteopenia. 
LaboratOlY tests: 
electrophoretic demonstration of pN-a l(l) or pN-a2(1) chains extracted from 
dermal collagen or skin fibroblasts. 
6. Dermatosparaxis type (autosomal recessive): 
Major criteria: 
severe skin fragility; sagging/redundant skin. 
Millor criteria: 
soft skin; easy bruising; large hernias. 
Laboratory tests: 
electrophoretic demonstration of pN-al(l) and pN-a2(1) chains in collagen type I 
extracted from dermis in the presence of protease inhibitors from fibroblasts 
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Appendix 6 Summary of case reports of pregnancies of women with the Marfan syndrome. 
NR: Not Reported. CS: Cesarean S 
--"._."" 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery 
# : footnote relevant medical complicati- age at complicati-
history ODS delivery ons 
I Aubard et a1. 27 GI, PO preterm labor 34 none 
1995" weeks 
2 Bailey et al. 20 G2, PI external 39.5 CS, fetal 
1989" version at weeks distress 
term, not suc-
cessful 
3 Baltazar et a1. 31 GI, PO dyspnea 14 -
1983" (11f) weeks 
4 Barker & 40 G3, P2. After none term none 
Burnand, 198919 first pregnancy 
(21f) severe pain in 
the back, second 
pregoancy 
uneventful 
Gestational age 14 weeks: flrst trimester. 1# : ad3) 
211 : ad 4) Includes tvlO evaluable previous pregnancies with good fetal and maternal outcome. 
Fetal 
outco-
me 
good 
good 
-
good 
Cardiovas~ Therapy Mater-
cular corn- nal 
plications outco-
me 
none, aortic none good 
root 40 mm 
none, aortic none good 
root 49 nun 
aortic dissec- resuscita- death 
tion exten- tion not 
ding to abdo- successful 
minal aorta 
dissection conserva- good 
abdominal tive and 
aorta exten- medication 
ding to ilea-
cal vessels. 
fIrst day 
postpartum 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater-
relevant medical compJicati- age at complicati- out- cular coro- nal 
history ons delivery ons come plicatioDS outco-
me 
5 Borglin and 23 Gl, PO none term none good pulmonary . death 
Bach, 1961" edema and 
dissection 
third day 
postpartum 
6 Buchanan & 25 G2, PI, previous none term breech, rou- death, none none good 
Wyatt, 198550 pregnancy nor- tine forceps post-
:::; 
'" 
(3#) mal for deliver- parmm, 
ing head rupture 
falx 
cerebri 
7 Cava & Drier. 21 G2,Pl dyspnea term induction of good dissection, de conserva- good, 
1970" labor becau- Bakey type tive. medi- I year 
se of dysp- Ill, third tri- cally post-
nea mester treated partum 
acute 
dis· 
section 
and de-
ath 
3# : ad6) Includes one evaluable previous pregnancy with good fetal and maternal outcome. 
~ 
-..l 
w 
Nr. 
8 
9 
10 
llA 
11 
B 
Author Age 
Chow. 199358 23 
Cola & Lavin, 34 
1985" 
Criscuolo et al. NR 
1987" 
Donaldson & De 24 
Alvarez, 196584 
32 
Obstetric and Prenancy Gest. 
relevant medical complicati- age at 
history ODS delivery 
GI, PO pregnancy- 34 
induced weeks 
hypertension 
GI, PO dissection term 
third trimes-
ter. 34 weeks 
GI, PO none term 
G2, PI none term 
G4, P3 dissection at 8V, 
8V, month months 
Delivery Fetal Cardiovas- Therapy Mater-
complicati- out- cular COID- nal 
ODS come plications outco-
me 
elective CS good dissection at repair good 
because of 34 weeks aortic arch 
dissection and triple 
coronary 
artery 
bypass first 
day post· 
panum 
elective CS good dissection at surgery 16 good 
because of 34 weeks months 
dissection at after deli-
34wks very 
elective CS good none none good 
none good, dissection . death 
Marian aorta first 
+ day postpar-
tum 
CS post- good dissection at - death 
mortem 8V, months 
~ 
:;;: 
Nr. 
lie 
II 
D 
liE 
IIF 
IIG 
II 
H 
111 
4# 
5# 
6# 
7# 
Author Age Obstetric Pregnancy com~ Gest. Delivery 
and relevant plications age at complicati-
medical delivery ODS 
history 
Donaldson, 21 Gl. PO dissection at 6 6 . 
1965" (4#) months months 
(51f) 
(61f) 
(71f) 
27 G3.P2 dissection at 31h 3" -
months months 
35 G2. PI none tenn none 
26 G2. PI none tenn none 
36 G7. P6 preterm labor 6mon- perterm deli-
th, very 
18 Gl. PO pretenn labor 8 man- none 
th, 
28 Gl. PO dissection NR termination 
of pregnancy 
Dissection at 6 months: evaluated as cardiovascular event in third trimester 
Dissection at 3 112 month: evaluated as cardiovascular event in first trimester. 
Pretenn delivery at 6 months: evaluated as delivery in third trimester. 
Fetal 
out~ 
come 
death 
death 
good. 
Marfan 
+ 
good 
death. 
IRDS 
good, 
Marfan 
+ 
death 
ad 11c) 
ad 11d) 
ad l1g) 
ad 11i) Termination of pregnancy with unknown gestational age: evaluated as termination in flrst trimester. 
Cardiovas- Therapy Maternal 
cular com- outcome 
plications 
dissection at - death 
6 months 
dissection at - death 
3Vl months 
-
· good 
- - good 
. 
· good 
-
· good 
aortic dis- surgery death 
section 
:::; 
'" 
Nr. 
11J 
11K 
11L 
12 
13 
8# 
9# 
Author Age Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater-
relevant medical complicati- age of complicati- out- cular COID- nal 
history ons delivery ons come plications outco-
me 
Donaldson & De 53 GI. PO abortion first tri- - death - - good 
Alvarez. 1965". mester 
(81f) 
33 G2.PI none tenn elective CS good - - good 
47 G2, PI, first none tenn none good, - - good 
pregnancy no Marfan 
complications + 
Elias & 32 G3, Pl. previous first admis- ±22-24 termination death, - - good 
Berkowitz, pregnancies une- sian at ± 22- weeks of pregnancy tenni-
197587 (9#) ventf.ll. First 24 wks, re- by seetio nation 
child Marfan quest for parva and of 
abortion sterilization. preg-
nancy 
Ferguson et al. 42 G2,PO pregnancy- 39 CS followed good aortic dissec- surgical good 
198391 induced weeks by aortic re- tion exten- repair 
hypertension, pair ding to ileac following 
dissection at bifurcation CS 
tenn 
Includes one evaluable previous pregnancy with good maternal and fetal outcome. ad 1lI) 
ad 12) Includes two evaluable previous pregnancies with good maternal and fetal outcome. Gestational age 22~24 weeks: evaluated as second trimester 
abortion. 
Nr. Author Age Obstetric and Preguancy Gest. Delivery Fetal Cardiovas- Therapy Mater-
relevant medical complicati- age et complicati- out- cular coro- nal 
history ons delivery ODS come plications outco-
me 
14 Godfrey et aI. 32 Gl.PO normal preg- 37 none good none - good 
1993101 nancy weeks 
15A Gordon & 38 GI, PO B-blocker, term low forceps, good . B-blocker good 
Jobnson, 199310$ aorta 38 mm epidural, mi-
nimal push-
ing 
~ 15B 25 Gl, PO B-blocker. term low forceps, good - B-blocker good aorta 47 nun epidural, mi-
nbnal push-
ing 
16 Grondin et ai. 30 G3, P2 22 wks, se- term elective CS good, congestive conserva- good, 
1969112 (1O#) vere retro- and steriliza- Marfan heart failure rive death 6 
sternal pain tion + 6 months months 
postpartum post-
and sudden partum 
death 
17 Haberstroh, 20 Gl, PO dissection at 31 CS good dissection at aortic good 
1982113 31 weeks weeks 31 weeks repair 
during CS 
10#: ad 16) Died of cardiovascular event 6 months postparrum: 
cardiovascular event not included in review and not regarded as maternal death. 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater-
relevant medical complicati- age at complicati- out- cular com- nal 
history ons delivery ons come plications outco-
me 
18 Hayashi et al. 23 GI. PO dissection at term CS good dissection at conserva- good. 
1991 119 (II#) 31 wks 6 months rive, at 10 death 
months 10 
postpartum month 
fatal ruptu- later; 
re dissec-
tion 
-.J 
-.J 19 Reid et a1. 22 NR. large arte· acute dissecti- 31 emergency good acute dis- CS and death 
1993 121 rial vessel ope- on at 31 wks, weeks CS and vas- section at 31 vascular 
ration at 11 years ischemia and cular repair wks, 13" day repair, dis-
of age paralysis of postpartum section 
the legs again dissec- from aorta 
tiOD, died du- to femoral 
ring surgery vessels, 
died 
during 2nd 
operation 
20 Herlicoviez et 34 NR dissection at 34 emergency good dissection at CS follo· good 
al. 1992'22 34wks weeks CS followed 34wks wed by 
by aortic re- aortic 
pair repair 
11#: ad IS) Maternal death 10 months postpartum: not included in maternal deaths. 
Nr. Author Age. Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater· I 
relevant medical complicati- age at complicati- out- cuIar com- nal 
history ODS delivery ons come plications outco-
I me 
21 Husebye et a1. 30 G3, P2 dissection at 34 elective CS good dissection surgery death 
I 1958'" 6 month weeks during CS 
22 Irons & Pollard, 28 G2, PI, first aorta 38 nun 38 elective CS good - . good, 
1993'36 (12#) prenancy CS be- weeks and steriliza- 3 
cause of face don weeks 
presentation post-
partum 
:::; 
00 
fluxus, 
curet-
tage 
and 
hyste-
rec-
tamy 
23 Jayaram et a1. 33 GVI, PO aortic dis- 36 CS. extradu- good type B medically good 
1995138 section, type weeks ral anes- dissection 
Bat 26 weeks thesia 
12#: ad 22) Includes one evaluable previous pregnancy with good maternal and fetal outcome, 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater-
relevant medical complicati- age at complicati- out- cular com- nal 
history ons delivery ons come plications outco-
me 
24A K6ningsberg et 22 G2, PI, first antenatal dia- 24 termination death, - - good 
aI. 1981 153 pregnancy une- gnosis of weeks of pregnancy termi-
(l3#) ventful, affected Marfan by because of nation 
child ultrasound at affected ch- at 24 
24 weeks ild. Prostag- weeks 
landines in-
tra amniotic 
:::; 
~ 
24B 19 G I, PO sickle none term none good - - good 
cell heterozygous 
25 Kotter et al. 26 GI, PO dissection in 38 CS followed good, dissection in aortic good 
1991 155 third tri- weeks by aortic re- Marfan third trime- repair after 
rnester pair + ster CS 
26 Liang, 1985171 32 G6, P5, 4x pre- preterm labor 27 breech ex- good - - good 
(14#) term delivery weeks traction 
(27-30 wks), 3 x 
neonatal de-
ath,Ix cerclage, 
1 term delivery 
13#: ad 24a) Includes one evaluable previous pregnancy with good maternal and fetal outcome. 
Termination at 24 weeks: evaluated as third trimester. 
14#: ad 26) Includes five evaluable previous pregnancies with good maternal outcome. 
Neonatal death: three times. 
00 
o 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery 
relevant medical complicati- age at complicati-
history ons delivery ons 
27 Lind & Hoynck 20 GI. PO aorta 37 mm 39 recto-vaginal 
van weeks rupture 
Papendrecht, 
1984174 
28 Lindeboom& 23 GI. PO preeclampsia 7mon- -
Bouwer. 1950 175 hematemesis ths 
29 Lopes et al. 33 GI. PO antenatal term none 
1950'''' echocardio-
grafic abnor-
malities sus-
pect for Mar-
fan 
30 Mandel et a1. 20 GI, PO third month 41/2 -
1954'" (15#) hypertension months 
and cardi-
avascular 
disease, 
medication, 
readmission 
4'12 months 
15#; ad 30) Dissection at 4 1/21 month: evaluated as cardiovascular event in second trimester. 
Fetal Cardiovas- Therapy Mater-
out- cular COffi- nal 
come plicalions outco-
me 
good. - - good 
Marfan 
+ 
death dissection at - death 
7 months 
good. - - good 
Marfan 
+ 
death severe hyper- conserva- death 
tension third tive, medi-
month, read- cation 
mission 4112 
months. died 
15 minutes 
after admis-
sian 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater-
relevant medical complicati- age at complicati- out- enlar coro- nal 
history ODS delivery ODS come plications outco-
me 
31 Maruyama et a1. 29 NR dissection at 32 elective SC good dissection at aortic arch good 
1990'83 32 weeks weeks followed by 32 weeks repair 
repair aortic 
arch 
32 Maruyama et al. 38 NR none 38 dissection good dissection surgery good 
1993184 weeks during deli-
very 
00 33 Massumi et a1. 35 G2. PI, first progression 33 elective CS good progression . death 
1967'86 (I6#) prenancy CS, 30 of aortic dila- weeks because of of dilatation 
wks. cation progression 
of aortic di-
latation, 
ventricular 
fibrillation. 
resuscitation 
not success-
full 
34 Mayet et a1. 32 NR progression 41 elective CS good aortic dilata- aortic good 
1998'88 of dilatation weeks tion and repair after 
8.1 severe aortic postpartum 
-> 8.9 mm regurgitation period 
16#: ad 33) Includes one evaluable previous pregnancy with good maternal and fetal outcome at 30 weeks. 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery Fetal Cardiovas~ Therapy Mater- I 
relevant medical compJicati- age at complicati- out- cular COrn- nal 
I history ons delivery ons come plications outco-
me 
35 Metcalfe et al. 31 G2, PO, dissection at 28 - NR dissection at emergency death, 
1986'96 hypertension. 28 weeks, weeks 28 weeks. valve re- 7 hours 
superimposed cardiogenic placement after 
hypertension shock start 
surge-
ry 
36 Moore. 1965203 24 G2, PI none term none good dissection 8th - death 
I day postpar-
?:i tum 
I 
37A Mor-Yosef et a1. 28 GI, PO preeclampsia 34 CS for fetal death 6 - - good I 
*1 198820' weeks distress. 34 days 
weeks post-
partum. 
IRDS 
*2 Same G2, PI preeclampsia term CS good - - good 
pati-
ent 
~ 
00 
'" 
Nr. Author Age Obstetric and Pregnancy Gest. Delivery 
relevant medical complicati- age of complicati-
history ons delivery ons 
37B 35 G4. P2 aortic aneu- 36 elective CS 
rysm, conge- weeks followed by 
stive heart aortic repair 
failure at 28 
wks 
37C 26 GI. PO before preg- 20 cesarean 
nancy normal weeks section parva 
aortic diame- at 20 weeks 
ter 
38 Mul et al. 22 G2.PI, first admitted at 38 induction of 
1998'" pregttancy 29 weeks: weeks labor, 
(I7#) uncomplicated aortic dis- normal 
section vaginal 
delivery 
17#: ad 38) Includes one evaluable previous pregnancy with good maternal and fetal outcome. 
Fetal CardiovaM Therapy Mater-
out- cular com- nal 
come plications outco-
me 
good progressive aortic repair good 
dilatation after CS. 6 
and dissecti- weeks after 
on birth repla-
cement of 
aortic valve 
death aortic dis- medically good 
section at 20 treated 
weeks 
spastic aortic dis- aortic repair good 
tetrap- section at 29 at 29 weeks 
Jegia, weeks, type 
small- A 
for-
gesta-
tional 
age 
Nr. Author Age Obstetric Pregnancy Gest. Delivery Fetal CardiovasM Therapy Mater 
and relevant complicaw Age at complicati- outco- cular coro- nal 
medical history tions delivery ons me plications outeo 
me 
39 Novell & Asher 24 G3.P2 none tenn none good dissection - death 
1958'" 11th day 
postpartum 
40 Paternoster et a1. 22 Gl. PO. aortic bloodloss 37 weeks CS good none - good 
1998219 diameter 41 mm second 
trimester, 
placenta 
-:i:' 
previa. 
cervical 
cerclage at 
25 weeks. 
pretenn 
labor 
41 Pinosky et aJ. 36 G2. PI. first near term tenn elective CS good near term aortic good 
1994'26 (l8#) prenancy no pro- progression + ligation progression repair 
blems. child of dilatation a.a. uterinae of dilatation 
Marfan +, aorta and ovaricae 
50mm then repair 
aorta 
18#: ad 41) Includes one evaluable previous pregnancy with good maternal and fetal outcome. 
Nr. Author Age Obstetric Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater 
and relevant complicatio age at complicati- outco- cular COffi- nal 
medical history ns delivery ons me plications outco 
me 
42 Pumphrey et al. 37 GI. PO dissection at 37 weeks elective CS, good dissection at aortic good 
1986243 37 weeks 48 hours Ia- 37 wks valve re-
ter aortic placement 
valve repIa- at 2 days 
cement postpartum 
43 Quinn & 20 GI. PO gonorrhea term normal deli- good - · good 
Mukerjee, treated at 20 very, post-
-
1982"5 weeks partum in-
00 
'" 
versio uteri 
and fluxus 
44A Rivlin, 1967259 33 G3, P2 rupture of 24 weeks - death rupture of · death 
(19#) aneurysma aorta at 24 
aortae at 24 weeks 
weeks 
44B 25 G2, PI dissection at 30 weeks - death dissection at · death 
30 weeks 30 wks 
19#: ad 44a) Rupture of aneurysm of aorta at 24 weeks: evaluated as cardiovascular event in third trimester. 
~ 
00 
Q, 
Nr. 
45 
46 
Author Age 
Rosenblum et al. 28 
!98326' 
Sanrucci et al. 35 
1994'" 
Obstetric Pregnancy Gest. 
and relevant complicatio age at 
medical history ns delivery 
G2,P! dissection at 36 weeks 
36 weeks 
G3, P2 normal preg- term 
nancy 
Delivery Fetal Cardiovas- Therapy Mater 
complicati~ outco- cular com- na! 
ons me plications outco 
me 
elective CS good dissection at surgical good 
followed by 36 wks repair 
aortic repair aorta on 
on the third third day 
day postpar· postpartum 
tum 
none good aortic dis- medical good 
section 2 
days postpar· 
mm, myo-
cardial 
infarction 7 
days post-
partum, 
dissection of 
left anLdes-
cending 
coronary 
branch 
Nr. Author Age Obstetric Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mater 
and relevant complicatio age at complicati- outco- cular com- nal 
medical history ns delivery ons me plications outco 
me 
47 Schnitker & 22 Gl. PO none term elective fcre- good 6 days post- medical, death 
Bayer, 1944275 eps under partum pro- conserva-
analgesia gressive pul- tive 
monary con-
gestion and 
cardiac fail-
ure. died 
16th day 
-co 
postpartum 
" 
48 Shime et aI. NR G3. P2 dissection at 38 weeks resuscitation good dissection at Resuscita- good 
1987282 38 weeks, and cesarean 38 weeks and tion, aortic 
cardiac ar- section follo- cardiac arrest repair, 3 
rest wed by months 
aortic repair postpartum 
dissection 
of abdomi-
nal aorta 
49 Simpson et al. 24 GI,PO none 
1997'" 
36 weeks none good none - Good 
-00 00 
Nr. 
50 
51 
52 
Author 
Smith et aI. 
1989'" 
Spencer, 1952300 
Sutinen & 
Piiroinen, 
1971311 
Age Obstetric 
and relevant 
medical history 
19 Gl. PO 
32 G3. P2 
28 G2, PI 
Pregnancy Gest. 
complicatio age at 
DS delivery 
aorta 55 29 weeks 
mm, pro-
gressive 
aortic insuf-
ficiency, 
aortic valve 
replacement 
at 22 weeks, 
successful 
resuscitation 
10 days after 
surgery, pre-
term labor 
dissection at 37 weeks 
37 weeks 
none 39 weeks 
Delivery Fetal Cardiovas- Therapy Mater 
complicati~ outco- cular corn- nal 
ODS me plications outco 
me 
none good, severe aortic aortic good 
Marfan insufficiency valve re-
+ at 22 weeks placement 
at 22 
weeks, 10 
days later 
successful 
resuscita-
tion 
CS post good dissection at . death 
mortem 37 wks 
dissection death dissection . death 
I 
during labor during deli-
very 
00 
'" 
Nr. Author Age Obstetric Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mate 
and relevant complicatio age at complicati- Qutco- cular com- mal 
medical history DS delivery ODS me plications outco 
me 
53 Thaler et al. NR G1, PO dissection at 24.4 preterrn, in- death dissection at aortic good 
1992'" (201t) 24.2 weeks, weeks tra uterine 24.2 wks repair 24.2 
aortic repair, death wks 
2 days later 
fetal death 
54A Tricomi, 1965320 30 G3, P2, intraute- aortic aneu- 36 weeks low forceps good acute dis- conserva- death 
(21#) rine death lx, rysm sus- section of tive, died 2 
preterm delivery peeted on aorta 5th day days later 
1 x routine X- postpartum 
ray at 18 
weeks 
54B (22If) 25 G4, P3, acute dis- 36 weeks . death acute dis- . death 
pulmonary section at 36 section at 36 
tuberculosis. Ix weeks wks 
preterm delivery 
Dissection at 24 217 weeks gestational age: evaluated as cardiovascular event in third trimester. 20#: ad 53) 
21#: ad 54a) 
22#: ad 54b) 
Includes two evaluable previous pregnancies; one intrauterine death at term; one preterm delivery with good maternal and fetal outcome. 
Includes three evaluable previous pregnancies with good maternal and fetal outcome. 
Includes one preterm delivery. 
Nr. Author Age Obstetric Pregnancy Gest. Delivery Fetal Cardiovas- Therapy Mate 
and relevant complicatio age at complicati- outco- cular com- rna! 
medical history ns delivery ons me plications outco 
me 
55 Williams et aL 29 NR dissection at 39 weeks CS followed good dissection at aortic good 
1988'" 39 weeks, de by aortic re- 39 weeks repair and 
Bakey, type pair medication 
IlIA 
56 Yanez 1994345 17 GI, PO, aortic none 38.6 elective CS good none . good 
diameter 23 mm, weeks 
mitral valve 
to prolapse 
o 57 Zeebregts et al. 24 GIl, PI hypertension 32 weeks CS good dissection aortic good 
A. 1997'" (23#) , aortic type A at 24 repair 
dissection at weeks 
24 weeks, 
aortic repair. 
3x lapa· 
rotomy_ 
B. Zeebregts et al., 28 GIl, PI type B dis· 35 weeks death typeB medical good 
section at 35 none 1997'" dissection at 
weeks, fetal 35 weeks 
death becau· 
se of mater-
nal hypoxia, 
MOF 
23#: ad 57a) Aortic dissection at 24 weeks: evaluated as cardiovascular event in third trimester. 
-'-0 
Appendix 7: Summary of case reports of pregnancies of women with the Ehlers DanIos syndrome. 
NR: Not Reoorted. CS: Cesarean Sec,' ~~ ... 
Nr. Author Age Type Obstetric and Pregnancy com- Gest. age at Delivery COID-
# footuote relevant medical plicatious delivery plicatious 
history 
1A Abo1eish, 31 ? G1,PO normal pregoancy 40 weeks CS, cephalopel-
19801 vic dispropor-
tion, failure to 
progress 
1B * same pa- 34 ? G2, PI normal pregnancy 40 weeks elective CS 
tient 
1C (I#) 19 ? G2, PI, first pre- polyhydramnion Term repeat elective 
gnancy: PROM fa- CS 
ilure to progress, 
breech, CS 
2 Attala & 29 ill G1, PO, prolaps of admission severe 35 weeks CS because of 
Page, intervertebral disc back pain, nerve severe back pain 
1988" entrapment at 35 weeks 
1#: ad Ie) Includes one evaluable previous pregnancy at tenn with good maternal and fetal outcome. 
Special featoreslfeial outeo-
me/maternal outcome 
maternal outcome: good fetal 
outcome : good 
maternal outcome: good 
fetal outcome: good 
maternal outcome: good 
fetal outcome: good 
maternal outcome: good 
fetal outcome: good 
Nr. Author Age Type Obstetric and Pregnancy com~ Gest. Age at Delivery com- Special features/fetal outco-
relevant medical plications delivery plications me/maternal outcome 
history 
3 Athanas- 26 N G2, PI preterm labor. 30.3 weeks CS because of maternal death at 30.3 weeks 
siou& myocardial infarc- deterioration of because of cardiopulmonary arrest 
Turrentine tion maternal condi- after myocardial infarction. Fetal 
, 199610 tion, resuscita- outcome: good 
tion not succes-
sful 
4 Babatasi et 33 N GI, PO aortic dissection 37 weeks CS followed by maternal outcome: good, 
al. 1998" third trimester, aortic repair fetal outcome good hypertension, 
pneumothorax 
~ 
::s 5 Blumen- 25, ? Same patient, 3 normal pregnan- term 3 times normal delive- maternal outcome : good 
feld& 28, deliveries and cies, 3 times ries, 3 times fetal outcome: good (3x) 
Gilhar, 34 pregnancies 
1989'" 
(2/f) 
6 Brees & 25 N G2, PO rupture of external 29 weeks CS and repair of massive transfusion during CS, 
Gall, ileaca1 atery iliac artery frrst postoperative day intraperito-
1995" neal bleeding, aorta ruptured by 
crossclamping of aorta; died du-
ring surgery. Fetal outcome: 
good. 
7 BrigbDuse 25 N GI, PO patella luxation: 36 weeks elective CS 
& Guard, preventive admissi- atonic uterus, maternal outcome: good 
1992" on at 29 weeks hemorrhage fetal outcome: good. 
1700 ml 
2#: ad 5) Includes three evaluable normal pregnancies and deliveries with good maternal and fetal outcome. 
Nr. Author Age Type Obstetric and Pregnancy com- Gest. age at Delivery com- Special features/fetal outeo· 
relevant medical plications delivery plications me/maternal outcome 
history 
8 Bruno et 27 V GI,PO normal pregnancy 39 weeks CS, failure to fragile tissue during CS. 
a1. 1997" progress maternal outcome: good 
fetal outcome: good 
9 Charvet et 30 III GI, PO normal pregnancy 36 weeks elective CS at 36 in labor at 36 weeks, elective CS 
a1. 1991" weeks because vaginal delivery was con-
sidered to much risk. maternal 
outcome: good 
fetal outcome: good 
~ lOA DePaepe 28 N GI, PO Normal 37 weeks DOnna! delivery maternal outcome: good 
et al. huge orbital fetal outcome: good 
198970 bleeding, third 
degree tear 
lOB * same pa- N G2, PI 38 weeks: uterine 38 weeks emergency CS. subtotal hysterectomy, fetal 
tient rupture uterine rupture outcome: good Patient died at 33 
years, rupture of renal artery. 
11 De Vas et 33 III Gi,PO primary eervical 26 weeks nonnal delivery maternal outcome: good 
al. 1999" cerclage at 14 fetal outcome: good, EDS + 
weeks, PROM at 23 
weeks 
12 Diaz 28 I Gl,PO normal pregnancy 39 weeks CS, failure to maternal outcome: good 
Arguello et progress fetal outcome: good 
al. 199577 
':i? 
Nr. Author Age Type Obstetric and Pregnancy com- Gest. age at 
relevant medical plicatioDS delivery 
history 
13 Dolan et 29 ? NR normal term 
al. 1980" 
14 Flachow- 31 VIII Gl, PO. lost all normal pregnancy 37 weeks 
sky et al. teeth before 24 ye-
1990" ars. Severe post-
operative bleeding 
and bowel rupture 
earlier 
15 Georgyet 22 II GI. PO nonna! pregnancy term 
al. 1997" 
16 Goldstein 38 II GIV. PII. retained rupture of 34 weeks 
& Miller. placenta second membranes at 34 
1997103 pregnancy weeks 
(3/f) 
17 Hammer- NR X Gl. PO. mitral normal pregnancy 40 weeks 
Schmidt et prolapse, aortic 
al. 1982"5 root 38 nun 
3# : ad 16) Includes two evaluable previous pregnancies at tenn with good maternal and fetal 
outcome. 
Delivery COID- Special features/fetal outcome 
plications lmaternal outcome 
nonnal delivery, retro-orbital aneurysm, perineal 
perineal hema- hematoma, intractable 
toma developed hemorrhage postpartum, hys-
during second terectomy on second day. extreme 
stage, postpar- tissue friability, rupture of splenic 
tum hemorrhage artery. died during operation. 
Fetal outcome: good. 
CS. fetal distress maternal outcome: good. 
during second fetal outcome: good 
stage 
perineal delivery first stage 12 hours, large central 
perineal laceration. maternal 
outcome: good 
fetal outcome: good 
breech/primary bradycardia and hypotension 
CS during CS (spinal analgesia). 
maternal outcome: good. fetal 
outcome: good 
prolonged first 
stage, normal maternal outcome: good 
delivery fetal outcome: good 
~ 
Nr. 
18 
19B 
20 
21 
22 
23 
Author Age Type Obstetric and Pregnancy com-
relevant medical plications 
history 
Hordnes. NR I NR pre-eclampsia 
1994'" 
* same pa- 23 II 02. PI admitted electively 
tient at 37 weeks 
Leduc & 22 ? 02. PI, Ix late cervical Smith-
Wasserstru abortion at 19 wks, Hodge pessary, 
m, 1992165 painless cervical bedrest from 29 
(5/f) dilatation weeks onwards 
Leis et al. 31 ? G2, PI, first pre- diabetes mellirus 
1980169 gnancy no COffi- type II, cerclage at 
(6If) plications 13 weeks, removed 
at 36.2 weeks 
Morales et 23 ill G1,PO blood loss first 
a1. 1997"" trimester 
MukeIji, 34 ? 01, PO blood loss at 32 
1975209 weeks 
Fetal death at 26 weeks, evaluated as fetal death in third trimester. 
Includes one evaluable second trimester abortion. 
Gest. age at 
delivery 
NR 
38 weeks 
33 weeks 
37.3 weeks 
39 weeks 
39.5 weeks 
4#: ad 19a) 
5#: ad 20) 
6#: ad 21) Includes one evaluable previous pregnancy with good maternal and fetal outcome. 
Delivery COID- Special features/feta! outco-
plications me/maternal outcome 
forceps, minimal maternal outcome: good 
pushing because fetal outcome: good 
of hypertension 
nonnal delivery maternal outcome: good. fetal 
at 38 weeks outcome: good, SGA 
nonnal delivery maternal outcome: good 
fetal outcome: good 
vacuum deli- dehiscence of episiotomy 
very, fetal dis- maternal outcome: good 
tress fetal outcome: good 
normal delivery epidural analgesia. maternal 
outcome: good. fetal outcome: 
good 
head not enga- maternal outcome: good 
ged, dispropor· fetal outcome: good 
tion, CS at 39 
weeks i 
Nr. Author Age Type Obstetric and Pregnancy com- Gest. age at Delivery COID- Special features/fetal outco-
relevant medical plications delivery plications me/maternal outcome 
history 
24 Nachtwey 24 ? GI,PO sudden 36 weeks vacuum delivery irreversible shock at 36 weeks, 
& Kreibs, hypovolemic shock because of fetal maternal death. Obduction: retro~ 
1975211 during labor and maternal peritoneal hematoma near vena 
distress cava. Fetal outcome: neonatal 
death. 
25 Nakamura 24 ? GI,PO pretenn labor 36 weeks vacuum deli- massive bloodloss. retroperitoneal 
et a1. very, and parametral hematoma, hyste-
1983212 hemorrhage rectamy, uterine rupture evident 
-;g postpartum at operation. maternal outcome: good 
fetal outcome : good 
26 Peaceman 30 IV Gl, PO 37 weeks 37.2 weeks forceps, delivery blood transfusion 4th clay 
& spontaneous rupture because of postpartum, 6th day massive re-
Cruikshan of membranes prolonged 2nd troperitoneal hemorrhage, rupture 
k, 1987'" phase, third de- renal artery, maternal death. Fetal 
gree perinatal outcome: good 
tear 
Nr. Author Age Type Obstetric and Pregnancy com- Gest. age at Delivery com- Special featureslfetal outcomel 
relevant medical plications delivery plications maternal outcome 
history 
27 Pearl & 29 IV G2, PI rupture pulmonary 7 months - maternal death, dissection 
Spicer, artery, 7 months pulmonary anery. fetal outcome: 
1981'" death 
28 Ploeckin- 25 II GI, PO prophylactic 41 weeks normal delivery maternal outcome: good 
ger et al. cervical cerclage fetal outcome: good 
1997'" 
29 Rivera et 20 ? Gl, PO pre-eclampsia 35 weeks CS, worsening friable umbilical cord and 
aI. 1984'" of severe pre- membranes. maternal outcome: 
~ eclampsia good. fetal outcome: good 
30A Roop& 28 ill Gl, PO None 42 weeks es, face maternal outcome: good 
Brost. presentation fetal outcome: good, decreased 1999'" 
muscle tone 
30B * same 31 ill G2, PI None 40 weeks none maternal outcome: good 
patient fetal outcome: good 
30e * same 34 ill G3, P2 None 39 weeks low forceps maternal outcome: good 
patient delivery for fetal fetal outcome: good. EDS + distress, brow 
presentation 
'0 
00 
Nr. 
31A 
31B 
· 32A 
· 
• 
• 
• 32B 
• 
• 33A 
• 
• 
• 33B 
• 
Author 
Sakala & 
Harding, 
1991'" 
* same pa-
tient 
Shemwell 
& Weed, 
1976''' 
* samepa-
tient 
Smith & 
Phelan, 
1982292 
Smith & 
Phelan, 
1982"2 
Age Type Obstetric and 
relevant medical 
history 
24 ill G2. PO. ,pontane· 
OtiS abortion 
28 ill G3, PI 
22 ? GI, PO, retrobul· 
bar hemorrhage 
23 ? G2, PI 
27 II GI, PO 
24 II G4. PO 
Pregnancy com- Gest. age at Delivery com- Special feature/fetal outco-
plications delivery plications me/maternal outcome 
gestational diabetes 40 weeks nonnal delivery midline episiotomy. maternal 
outcome: good. fetal outcome: 
good 
preterm labor, 38 weeks normal delivery midline episiotomy. maternal 
tocolysis outcome: good., fetal outcome: 
good 
normal pregnancy 39 weeks outlet forceps. extensive lacerations pelvic wall, 
lacerations both urethra tom off from bladder, 
lateral pelvic vaginal wall tom off and anached 
walls only to anterior lip of cervix. 
maternal outcome: good. fetal 
outcome: good 
normal pregnancy ± 32 weeks normal delivery maternal outcome : good 
fetal outcome : good 
pre-eclampsia 38 38.1 weeks normal delivery dehiscence of episiotomy. 
weeks maternal outcome: good 
fetal outcome: good 
nonnal pregnancy 40 weeks normal delivery. maternal outcome: good 
lateral vault fetal outcome: good 
laceration 
'" 
'" 
Nr. 
34 
35 
36A 
36B 
37 
Author Age 
Smith et 17 
al. 1986'" 
Snijder et 22 
al. 1983297 
Stoddard 26 
& Myers, 
1968308 
* same pa- 29 
tient 
Superti et 25 
al. 1992li1 
Type Obstetric and Pregnancy com~ 
relevant medical plications 
history 
? GI, PO nonna! pregnancy. 
elective admission 
at 38 weeks 
IV GI, PO none 
? G2, PI normal pregnancy 
? G3, P2 normal pregnancy 
IV GI, PO numerous short 
periods of amau-
rosis due to throm-
bosis of left into 
carotid artery 
Gest. age at Delivery com- Special feature/fetal outeo· 
delivery plications me/maternal outcome 
39 weeks low forceps, epi- two weeks postpartum: large 
siotomy not hematoma perineal floor drained 
necessary spontaneously to the posterior 
fourchette. maternal outcome: 
good. fetal outcome: good 
tenn prolonged first aortic rupture 5th day postpartum. 
stage, CS maternal outcome: death. fetal 
outcom~: good 
36 weeks emergency CS severe abdominal pain, shock, 
because of sus- emergency CS, 500 rnl blood in 
peeted uterine abdominal cavity, no bleeding 
rupture points or rupture found.maternal 
outcome: good 
fetal outcome: good 
39 weeks elective CS, maternal outcome: good 
large window in fetal outcome: good 
uterine wall at 
the site of the 
previous scar 
tenn normal delivery maternal outcome: good 
fetal outcome: good 
Nr. Author Age Type Obstetric and Pregnancy com- Gest. age at Delivery COID- Special feature/fetal outco-
relevant medical plications delivery plications me/maternal outcome 
history 
38 Taylor et 32 II 01. PO hip function 39 weeks elective CS at 39 maternal outcome: good 
aJ. 1981'" limited. pregnancy- weeks fetal outcome: good 
induced 
hypertension 
39 Vimercati 23 ? Gl, PO, retinal blocdloss first 36 weeks CS, because of maternal outcome: good 
et ai, bleedings, mitral trimester retinal pathology fetal outcome: good 
1999'" valve prolapse 
40 Weinbaum 19 IV G2, PO, Ix mis- 32 weeks bedrest. 36.5 weeks elective CS at maternal outcome; good 
'" :5 
et a1. carriage after trau- hernartb.ros and 36.5 weeks; fetal outcome: good 
1987'" rna, prolonged severe nose blee- DDVAP to 
bleeding time dings prevent bleeding 
41 Wilkenet 21 ? Gl, PO bruising, pregnancy 40 weeks prolonged se- maternal outcome: good 
aI., 1975'" induced hyper- cond stage, va- fetal outcome: good 
tension cuum delivery 
42 Wood, 24 IV Gl, PO varicosis, bedrest term elective CS ecchymosis, not able to carry own 
1993'" 29 weeks, dislo- weight. maternal outcome: good. 
cation mee fetal outcome: good 
43 Yamashita NR IV Gl, PO nonna! pregnancy 37 weeks CS, rupture of maternal outcome: good 
et al. uterus, massive fetal outcome: good 
• 1987'" bleeding 
· 44A Young et 28 ? NR spontaneous rupture 30 weeks nonnal delivery maternal outcome: good. fetal 
• I aI., 1985'" of membranes 29 at 30 weeks outcome: good, calcaneovalgus 
weeks 
N 
o 
-
Nr. 
44E 
Author 
YOllIlg et 
al., 1985'" 
Age Type Obstetric and 
relevant medical 
history 
26 ? NR 
Pregnancy com- Gest. age at Delivery com~ Special feature/fetal outco-
plications delivery plications me/maternal outcome 
persisting hyper- 33 weeks 33 weeks, nor- maternal outcome: good. fetal 
emesis, ruptured mal delivery outcome: good, talipes equino-
varicose veins, varus 
spontaneous rupture 
of membranes 32 
weeks 
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